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Abstract 
 
The gastrointestinal tract is the major route of entry for enteric pathogens. Current models are 
not suited for the study of early invasion which limits the use of systems biology approaches 
to study host-pathogen interactions. Therefore, there is a demand to develop a suitable model 
to study early-stage host-pathogen interactions. 
Recent developments in stem cell research have led to the establishment of “mini-gut” 
organoids that encapsulate the cellular diversity and structural arrangement of the small 
intestinal epithelium in vivo. Due to these features, they have been proposed as a promising 
tool for infection studies. 
Several aspects of organoid optimization are required before exploiting this model for 
infection. Firstly, recent works have demonstrated the amenability of organoid cultures to be 
driven toward Paneth or goblet cell phenotype for the study of specialized host defence 
functions. However this model requires further validation. Secondly, luminal access is 
restricted, and infection can only be established via microinjection of pathogens. Lastly, mass 
spectrometry approaches have not yet been validated for use in these models. 
This doctoral thesis addresses these issues by firstly validating the use of drug-skewed 
organoid models using quantitative label free mass spectrometry, and then by modifying 
cultures to establish differentiated and polarized murine epithelial monolayers with an 
accessible apical surface. This collagen-supported monolayer is exploited to study host-
proteome changes during early infection with Toxoplasma gondii via quantitative label-free 
mass spectrometry.  
Label-free mass spectrometry of Paneth and goblet-enriched organoids detected unique 
organoid proteome profiles that reflect the phenotype of these subpopulations as expected in 
vivo, and demonstrate the suitability of mass spectrometry to study changes in protein 
abundance in this model. Here, we also identified a protein, DNAJC3, enriched within Paneth 
cells which may play a role in specialized cell function or differentiation. 
Modification of 3D organoid culture on collagen scaffolds has established a novel stem cell 
derived collagen-supported epithelial monolayer culture. Confocal microscopy demonstrated 
retention of differentiated features, such as the presence of Paneth and goblet cell sub-
populations and apical polarization. Label-free mass spectrometry was used to detect the 
presence of intestinal epithelial cell markers in both 3D and collagen-supported epithelial 
sheets. The findings here demonstrate that many of the differentiated epithelial cell markers 
are detectable in the collagen-supported epithelial monolayer, and that this model can mimic 
the in vivo epithelial composition. 
 
A series of pilot studies and time-course infection studies were performed to establish a 
working protocol to exploit the collagen-supported epithelial sheet for infection studies. 
Quantitative label-free mass spectrometry was exploited to examine host-proteome changes in 
response to infection with two strains of Toxoplasma gondii; Veg (type III, avirulent) and RH 
(type I, virulent). In agreement with current literature, we observed modulation of proteins 
associated with host cell cycling, apoptosis and lipid metabolism. Interestingly, we observed 
a lag in parasite replication compared to reported observations in cell line cultures and an 
aggregative behavior along epithelial sheet perimeters previously not reported. The findings 
in this chapter demonstrate the suitability of this model for infection studies, and highlights 
some parasite behaviours that are not observed in cell line models. 
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Chapter 1 – General Introduction 
 
1.1 The Impact of Enteric Diseases 
 
Food-borne illnesses have major impacts on both human and animal health and are a 
major cause of morbidity and mortality on a global scale (World Health Organisation, 
2015). However, the global public health burden of food-borne diseases is not fully 
quantified. In 2006 the world health organisation (WHO) recognised the significance 
of food-borne diseases and launched an initiative to accurately estimate the global 
burden of food-borne diseases (Kirk et al., 2015; World Health Organisation, 2015). 
Since the establishment of this initiative, over 200 pathogens have been identified as 
causing food-borne disease in humans with varying symptoms and severity of disease 
(World Health Organisation, 2015). Of these 200 pathogens, 32 pathogens have been 
attributed as the cause of over half of all cases of food-borne disease (World Health 
Organisation, 2015). These 32 disease agents can be further characterised into either 
diarrhoeal disease-causing, invasive infectious disease-causing, enteric intoxications 
and helminthic agents (Table 1) (World Health Organisation, 2015). In 2010, these 32 
pathogens were estimated to have caused 600 million incidences of food-borne 
diseases globally resulting in 420,000 deaths, with over 40% of cases of diseases 
reported in children under the age of 5 (World Health Organisation, 2015).  
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Table 1). Major Causes of Food-Borne Illnesses as Reported by WHO in 2015 
Diarrhoeal Disease Agents 
Norovirus Virus 
Campylobacter spp. 
Bacteria 
Enteropathogenic Escherichia coli 
Enterotoxigenic Escherichia coli 
Shiga toxin-producing Escherichia coli 
Non-typhoidal Salmonella enterica 
Shigella spp. 
Vibrio cholerae 
Entamoeba histolytica 
Protozoa Cryptosporidium spp. 
Giardia spp. 
Invasive Infectious Disease Agents 
Hepatitis A Virus Virus 
Brucella spp. 
Bacteria 
Listeria monocytogenes (perinatal) 
Listeria monocytogenes (acquired) 
Mycobacterium bovis 
Salmonella Paratyphi 
Salmonella Typhi 
Toxoplasma gondii (congenital) 
Protozoa 
Toxoplasma gondii (acquired) 
Enteric Intoxications 
Bacillus cereus  
Bacteria 
Clostridium botulinum 
Clostridium perfringens 
Staphylococcus aureus  
Helminths 
Echinococcus granulosus (cases seeking treatment) 
Cestodes 
Echinococcus granulosus (cases not seeking treatment) 
Echinococcus multilocularis 
Taenia solium 
Ascaris spp. 
Nematodes 
Trichinella spp. 
Clonorchis sinensis 
Trematodes 
Fasciola spp. 
Intestinal flukes 
Opisthorchis spp. 
Paragonimus spp. 
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The incidence of food-borne diseases is globally variable with the highest burdens 
associated with low-income regions, namely Africa and South-East Asia (World 
Health Organisation, 2015). These infections are primarily associated with diarrhoheal 
disease agents, whereas in the USA the CDC reports that the most common causative 
agents are Norovirus, Salmonella, Clostridium perfringens, Campylobacter and 
Staphylococcus aureus (Centres for Disease Control and Prevention, 2017). The WHO 
reports that premature mortality can be attributed to diarrhoeal-causing agents, but 
infections with helminths such as Taenia solium, Ascaris spp and Fasciola spp, along 
with the protozoal parasite Toxoplasma gondii contribute to a large proportion of cases 
of long term morbidity as a result of food borne illness (World Health Organisation, 
2015). The global burden of food-borne diseases in 2010 was estimated at 33 million 
disability-adjusted life years (DALYs), with over half of these attributed to diarrhoeal 
disease causing pathogens; Norovirus, Campylobacter, enteropathogenic and 
enterotoxigenic E. coli, Vibrio cholera and Shigella, causing 1-3 million DALYs each 
(World Health Organisation, 2015).  Of the invasive infectious disease agents, 
Salmonella Typhi caused 3 million DALYs, with Salmonella Paratyphi and 
Toxoplasma gondii causing approximately 800,000 DALYs each (World Health 
Organisation, 2015). 
Due to the large number of causative agents of food-borne disease, there are difficulties 
diagnosing disease. Many of these pathogens exhibit non-specific symptoms that are 
acute and self-limiting, so often patients do not seek medical care. However, in some 
cases, a lack of treatment and the development of chronic infection can lead to the 
development of complicated morbidities such as haemolytic uraemic syndrome, 
inflammatory bowel disease, organ failure, and in cases of congenital Toxoplasmosis, 
foetal neurological damage, visual impairment or sporadic abortions in sheep 
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(Montoya and Liesenfeld, 2004; Munday and Dubey, 1986; Rees et al., 2004; 
SYROCOT, 2007; Tarr et al., 2005). The development of chronic diseases can often 
be wrongly diagnosed and not attributed to the initial enteric infection. For these 
reasons, the numbers of cases reported by the WHO are considered conservative 
estimates. In reality, the true burden of food-borne illness may be much higher, 
especially in low-resource areas where diagnosis and reporting of diseases is not well 
documented.  
The burden of these food-borne infections has economic impacts due to the cost of 
healthcare in both acute and chronic infections leading to a loss of workforce 
productivity, and the loss of agriculture productivity in cases of animal infections. 
 
1.2 Enteric Diseases in Food-Producing Animals 
 
To truly understand how to prevent the incidence of food-borne disease in humans, we 
must consider the role of zoonotic enteric infections in disease transmission, 
particularly in food-producing species. Enteric infections in food-animals are a 
common zoonotic risk of human enteric disease through the ingestion of contaminated 
meat and dairy products (Centres for Disease Control and Prevention, 2017; Kirk et 
al., 2015; World Health Organisation, 2015). In some cases, infections can be 
asymptomatic in livestock resulting in a lack of prompt pathogen detection and onward 
transmission throughout flocks and to the human population. In particular, 
Campylobacter spp. infections can asymptomatically infect broiler chickens making 
them an important reservoir for human infections through the consumption of 
undercooked meat products,  and environmental contamination (Larson and Spickler, 
2013). Due to close housing practices of food-producing animals, pathogen shedding 
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from a single animal can rapidly result in the spread of disease throughout a herd or 
flock of animals (Hollenbeck, 2016; Kleinlützum et al., 2013; Lupindu et al., 2015). 
This is reflected by the multitude of enteric pathogens contaminating food-products 
including Listeria monocytogenes in beef, Salmonella in stir fry products and turkey 
products, and Escherichia coli 0157 in cheese products as reported by the Food 
Standards Agency (FSA) (Food Standards Agency, 2017). Therefore, the incidence of 
disease in animals, especially food-producing animals, bears huge importance for the 
prevention of disease in humans.  
 
The emergence of antimicrobial resistance means that these infections are becoming 
increasingly difficult to treat, and new treatments or vaccines are urgently required. 
Recently, resistance in several pathogens including carbapenem-resistant Klebsiella 
pneumoniae, fluoroquinoline-resistant E. coli, artemisin-resistant Plasmodium 
faciparum and multi-drug resistance in Mycobacterium tuberculosis  have been 
identified as pressing threats to public health (Glasner et al., 2013; Pickering, 2004; 
Smith et al., 2013; WHO, 2014). To combat antimicrobial resistant strains, the 
development of novel vaccines and therapeutics are urgently required. To do this, a 
better understanding of the earliest post-infection events, such as pathogen-epithelial 
cell interactions and the initiation of mucosal immune responses is required. This 
requires species-appropriate sophisticated models of the intestinal epithelium.  
 
 
1.3 The Gastrointestinal Tract as a Route of Infection 
As food-borne pathogens are ingested into the host, the gastrointestinal (GI) tract is a 
major system in determining the outcome of infection. Following ingestion, enteric 
pathogens enter the host gastrointestinal tract, consisting of the stomach, small and 
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large intestines, colon and the rectum where initial invasion events may take place. 
Enteric pathogens differ in their host-pathogen interactions with some species 
exhibiting site-specific invasion patterns. For example, protozoal Eimeria spp exhibit 
a high degree of site specificity to invade distinct anatomical regions within the host 
intestine (Augustine, 2001). Similarly Giardia spp infect the duodenum and jejunum 
of the small intestine nut not the ileum (Wolfe, 1992). These site specific invasion 
strategies directly impact the host cell response to infection, as demonstrated by 
Campylobacter jejuni infection of human ileal and colon tissues in vitro, which 
induced different levels of IL-8 secretion in response to bacterial invasion (MacCallum 
et al., 2006).  
Due to its anatomical location as one of the first sites to become exposed to the 
pathogen, the small intestine is considered a major route of infection. Following 
ingestion, pathogens reach the small intestine where initial invasion events may take 
place. Studying these early stage host-pathogen interactions are key for the 
identification of novel targets for the prevention of enteric disease within this organ. 
To do this, we must firstly understand the small intestinal homeostatic processes. 
Several aspects of intestinal biology will be discussed here; gut homeostasis and the 
renewal of the epithelium, the signalling pathways that drive this process, secretory 
cells of the intestine and their roles in host defence and the tight junctions of the 
epithelium for host defence. 
 
1.3.1 Small Intestinal Epithelial Regeneration 
The intestinal epithelium can be considered as the crypt domain, transit amplifying 
region and villus domain, all of which undergo continual regeneration as part of gut 
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homeostasis (Figure 1 and Figure 2). The continual regeneration of the small 
intestinal epithelium is facilitated by the presence of intestinal stem cell populations 
which can be identified by specific markers leucine-rich repeat-containing G-protein 
coupled receptor 5 (LGR5+), polycomb group protein (BMI1+) and atypical 
homeobox protein (HOPX) (Barker et al., 2007; Montgomery and Breault, 2008; Yan 
et al., 2012).  
 
 
 
Figure 1) Anatomy of the small intestine 
Self-regeneration of the small intestinal epithelium is primarily facilitated by the LGR5+ stem 
cell population at the base of the crypt base columnar units, which then proliferate and 
differentiate into each of the intestinal epithelial cell types (Paneth, goblet, enteroendocrine 
and enterocytes) within the transit amplifying region under exposure to different signalling 
cascades. As new cells are generated, the older cells are pushed further along from the base of 
the crypt columnar unit up into the villus tip where they are eventually shed into the lumen via 
a process called anoikis, with the exception of Paneth cells that migrate downwards toward 
the base of the crypt. Another stem cell population at the +4 location (BMI1+) can also give 
rise to all the differentiated epithelial cell types, however the regenerative role of this sub-
population is not well understood. 
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Within the crypt domain lie two intestinal stem cell populations; LGR5+ cells at the 
base of the crypt, and BMI1+ cells at the +4 location relative to the crypt base (Figure 
1) (Barker et al., 2007; Bevins and Salzman, 2011; Specian and Oliver, 1991; Yan et 
al., 2012; Zhu et al., 2013). The LGR5+ stem cells are thought to function as the main 
source of regeneration, whereas BMI1+ cells are quiescent (Dehmer et al., 2011; Yan 
et al., 2012; Zhu et al., 2013). However, the relationship between these sub-populations 
is not fully understood. It has been suggested that +4 cells expressing atypical 
homeobox protein (HOPX) can give rise to crypt base columnar cells, and that crypt 
base columnar cells can similarly generate HOPX-expressing +4 stem cells 
demonstrating a bidirectional relationship between these populations (Takeda et al., 
2011). This suggests that the functional role of the two subpopulations may be 
determined upon the environmental cues to increase or suppress proliferation of either 
population. Furthermore, the expression of known stem cell markers LGR5 and BMI1, 
which were previously thought to be population-specific, are now known to be co-
expressed within crypt base columnar cells (Itzkovitz et al., 2011). Clearly, the 
intestinal stem cell populations are not fully understood, however the mechanisms of 
homeostasis and epithelial regeneration have been identified. 
 
LGR5+ stem cells proliferate at the base of crypt columnar units, to push daughter cells 
upwards through the transit amplifying region where they terminally differentiate into 
distinct epithelial cell types; mucin-secreting goblet cells, hormone-secreting 
enteroendocrine cells or absorptive enterocytes (Garcia et al., 2009; He et al., 2004; 
Kuhnert et al., 2004; Milano et al., 2004; Nakamura et al., 2007; Turck et al., 2006; 
VanDussen et al., 2012; Walton et al., 2015; Zhang and Li, 2005). Through the action 
of LGR5+ cell proliferation, older cells are eventually pushed to the villus tip where 
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they undergo a form of programmed cell death, termed anoikis, and are sloughed off 
into the lumen and routinely removed with the mucus layer  (Gilmore, 2005) (Figure 
1). Unlike other epithelial cells, anti-microbial (AMPs) secreting Paneth pre-cursor 
cells migrate downwards towards the crypt base columnar units where they terminally 
differentiate and reside alongside LGR5+ stem cells (Bry et al., 1994; Farin et al., 2012; 
Toshiro Sato et al., 2011).  
Stem cell proliferation and differentiation are tightly controlled by several signaling 
pathways as part of normal gut homeostasis. Three pathways have been identified that 
determine the outcome of cell differentiation; Wingless-Related MMTV Integrated 
Site (Wnt), Notch and bone morphogenesis protein (BMP) signaling (Figure 2) (Fevr 
et al., 2007; He et al., 2004; Nakamura et al., 2007; Ormestad, 2006; Pin et al., 2012; 
Yang et al., 2001; Yin et al., 2014).  
Within the intestine, Wnt signaling is highest within the crypt base columnar units and 
decreases towards the villus tip, whereas BMP signaling is the inverse, increasing 
toward the villus tip (Figure 2). Notch signaling can be observed throughout the transit 
amplifying region and at the border of the crypt base columnar units (Figure 2). Under 
these signaling pathways, intestinal stem cells terminally differentiate into four major 
epithelial cell types; absorptive enterocytes, or secretory Paneth, goblet or 
enteroendocrine cells to replenish the small intestinal epithelial cell population 
(Figure 2 B). 
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Figure 2) Intestinal stem cell signalling cascades, modulating self-renewal and cell 
differentiation 
A) At the very base of the crypt in the absence of Notch signaling, lie Paneth cells that 
provide a source of Wnt signaling within the epithelium to maintain stem cell proliferation. 
Moving upward, Wnt signaling becomes weaker, allowing for the differentiation of epithelial 
cells within the transit amplifying region. Toward the tip of the villus BMP signaling is 
strongest, which inhibits cell proliferation and replication. B) Under the conditions in the 
small intestine, stem cells terminally differentiate into four major lineages of epithelial cells; 
absorptive enterocytes, or secretory cells Paneth, goblet and enteroendocrine cells (Clevers, 
2006; Clevers and Nusse, 2012; Lazzeri et al., 2012; VanDussen et al., 2012). 
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1.3.2 Wingless-Related MMTV Integrated Site (Wnt) Signalling Modulates Cellular 
Proliferation 
The Wnt signalling pathway plays a major role in the maintenance and activation of 
the intestinal stem cell population. There are 5 mammalian intestinal Wnt proteins, 
which upon binding to the Frizzled (FZ)/low density lipoprotein (LDL) receptor-
related protein (LRP) complex, induces the inactivation of glycogen synthase kinase 
3β (GSK3β), a major component of the β-catenin destruction complex (Figure 3) 
(Clevers and Nusse, 2012; Logan and Nusse, 2004).  The inactivation of GSK3β leads 
to a de-phosphorylation and migration of β-catenin into the cell nucleus to interact 
with transcription factors (TCF) to activate target genes (Figure 3) (Clevers and 
Nusse, 2012; Nakamura et al., 2007; Toshiro Sato et al., 2011; Spence et al., 2010). 
Specifically, mutational activation of TCF4 induces adenoma formation, whereas it’s 
removal results in the loss of the proliferative cell population (Korinek et al., 1998). 
The presence of a Wnt signalling gradient originating in the crypt domain allows for 
the terminal differentiation of daughter cells within the transit amplifying region of the 
villus domains. An accumulation of β-catenin has been observed in the cells of the 
crypt columnar base units where the intestinal stem cells are located, and with a 
reduced effect in epithelial cells located towards the top of the crypt unit and within 
the villi forming a Wnt signalling gradient (Haegebarth and Clevers, 2009). Under 
normal gut homeostasis, newly produced daughter cells migrate from the crypt to the 
villus tip, however an exception to this rule are Paneth cells which migrate toward the 
source of Wnt signalling at the base of the intestinal crypt units. Studies of cell 
differentiation have determined that the Paneth cell population is critically dependent 
upon the presence of TCF4 activation for complete maturation and terminal 
differentiation in the small intestine (Es et al., 2005; Farin et al., 2012). In vitro, Paneth 
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cells provide essential niche signals including Wnt3a to LGR5+ stem cells which 
contributes to the maintanence of stem cell proliferation, and a Wnt gradient (Toshiro 
Sato et al., 2011). 
 
Figure 3) Canonical Wnt signalling pathway  
(Left panel) In the absence of ligand, the frizzled (fz) receptor remains unbound and β-catenin 
is a target for ubiquitination and degradation by the proteasome. (Right panel) In the presence 
of ligand, binding to a Fz/LRP5/6 complex stabilizes β-catenin through the inactivation of 
GSK3β, resulting in the migration of β-catenin into the nucleus and activation of downstream 
transcriptional factors (Clevers, 2006; Clevers and Nusse, 2012) 
 
 
 
Wnt signalling is regulated by the R-spondin family (RSPO) of secreted proteins 
(Figure 4). There are four known members of the R-spondin family with high shared 
homology and expression patterns. All four RSPO are ligands for the Wnt signaling 
receptor complex and are capable of activating the Wnt signalling pathway, with the 
highest potency attributable to RSPO2 and 3, followed by RSPO1 and poor activation 
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by RSPO4 (Kim et al., 2008). Currently, very little is known about the source of R-
spondin in vivo, however there is evidence to suggest that the intestinal stroma may be 
a potential source of these proteins (Kang et al., 2016).  
 
Figure 4) Co-operative signalling within stem cells 
R-spondins activate membrane protein LGR, which is also a stem cell marker protein. LGR 
recruits the LRP-frizzled receptor complex, which binds to Wnt ligands, and reinforces Wnt 
signalling after phosphorylation of LRP. Β-catenin is then stabilised and translocated to the 
nucleus, which induces gene expression (Birchmeier, 2011). 
 
It is evident that Wnt signaling regulates the proliferative ability of stem cells, however 
the differentiation of other cell lineages requires a fine-tuned balance of additional 
signalling pathways. 
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1.3.3 The Notch Signalling Pathway Determines Secretory Cell Fate 
Like Wnt signalling, Notch signalling occurs within the crypt domains, however, can 
also be detected in proliferating cells at the border of the crypt domain and the transit 
amplifying region (Tian et al., 2015).  
Notch receptors are activated through binding with a neighboring cell presenting an 
appropriate ligand. The majority of Notch signalling is induced by a family of Delta, 
Serrate and Lag2 domain (DSL) ligands. Mammalian DSL ligands are classified into 
Delta-like (Dll1, Dll3 and Dll4) or Serrate (Jagged)-like (Jagged 1 and Jagged 2) 
(Kopan and Ilagan, 2009). The binding of these ligands induces a series of proteolytic 
cleavage steps in Notch, which ultimately releases the intracellular domain which 
functions as a biologically active signal transducer. 
Upon ligand binding, the conformational change to the Notch receptor makes this 
complex susceptible to cleavage by an A-Disintegrin-And-Metalloprotease (ADAM). 
Notch cleavage generates a membrane-anchored extracellular fragment (NEXT), 
which is a substrate for γ-secretase. Γ-secretase then cleaves the Notch transmembrane 
domain to release an active form; Notch intracellular domain (NICD). NICD enters 
the nucleus associating with DNA binding CSL, which ultimately activates 
transcription (Kopan and Ilagan, 2009; Nakamura et al., 2007; VanDussen et al., 
2012). 
 
 Chapter 1 – General Introduction  P a g e  | 15 
 
Figure 5) The Notch signalling pathway 
Upon activation of this signalling pathway, Notch proteins are cleaved by ADAM 
metalloproteases to generate a Notch extracellular truncation (NEXT) fragment. NEXT is 
cleaved by γ-secretase, releasing the Notch intracellular domain (NICD) which enters the cell 
nucleus to associate with DNA-binding CSL. This association leads to an activation of down-
stream transcription involved with suppression of secretory cell lineages (Kopan and Ilagan, 
2009; Nakamura et al., 2007; VanDussen et al., 2012). 
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The presence or absence of active Notch signaling determines the fate of secretory cell 
lineages within the small intestine, and several genes have been identified that regulate 
this process basic helix-loop-helix (bHLH) transcription factors (Hes1) and atonal 
homolog 1 (Atoh1) (Schonhoff et al., 2004; VanDussen et al., 2012). Under active 
Notch signaling, progenitor cells follow the absorptive enterocyte cell lineage, 
however in the absence of Notch signaling, progenitor cells differentiate along the 
secretory cell lineage at the expense of absorptive cell differentiation (Figure 6) 
(Jensen et al., 2000; Tian et al., 2015; VanDussen et al., 2012).  
 
Figure 6) Notch signalling regulates secretory cell homeostasis 
Notch signalling directly targets stem cells to activate olfactomedin-4 (OLFM4) transcription 
to maintain stem cell proliferation and promotion of cell survival. Notch acts to promote 
absorptive cell lineage through suppression of ATOH1 transcription. Later, Notch indirectly 
segregates Paneth and goblet cell lineage to generate a mature Paneth cell phenotype, however 
this mechanism is not fully understood (VanDussen et al., 2012) 
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Disrupting Notch signalling with a γ-secretase inhibitor DAPT, blocks the conversion 
process of the Notch receptor into its transcriptionally active form, which results in a 
loss of proliferating LGR5+ stem cells within crypt domains, and an increased 
proportion of secretory cell types (VanDussen et al., 2012). Notch signalling must 
therefore act by suppressing the differentiation of secretory cells leading to the 
sporadic distribution of these cell types within the small intestine in vivo (Schonhoff 
et al., 2004; Tian et al., 2015; Yin et al., 2014). 
The determination of secretory cell fate is not regulated by Notch signalling alone. 
Blocking of Notch signalling, and attenuation of Wnt signalling increases the number 
of goblet cells and suppressed stem cell proliferation, and there is evidence to suggest 
an upregulation of Wnt underlies secretory cell amplification when Notch signalling 
is removed (Tian et al., 2015).  
1.3.4 Bone Morphogenesis Protein Signalling (BMP) Represses Cell Replication 
Bone morphogenesis proteins (BMP) are involved with tissue re-modelling and 
regeneration. There are currently over 20 known BMPs classified as a subset of 
transformation growth factor beta (TGFβ) proteins (Zhang and Li, 2005). There are 
three type 1 BMP receptors; ALK2, ALK3 (BMPR1A) and ALK6 (BMRPR1B), and 
one type 2 BMP receptor, (BMPRII) (Zhang and Li, 2005). The BMP signalling 
cascade can be trigger by BMPRII in combination with any type 1 receptor, leading to 
different downstream processes dependent upon the stem cell niche (Figure 7) 
(Miyazono et al., 2005; Wang et al., 2014; Zhang and Li, 2005).  
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Figure 7) BMP signalling pathway via canonical Smad-dependent and non-canonical 
pathways 
During canonical activation, binding to type I or type II serine/threonine kinase receptors by 
BMP ligands forms a complex. The constitutively active type II reporter transphosphorylates 
the type I receptor, which phosphorylates R-smads (smad1/5/8). Phosphorylated R-smads 
associate with smad-4 and translocates into the nucleus. Here, the complex associates with co-
activators or –repressors  to regulate gene expression (Wang et al., 2014). 
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Within the small intestine, BMP signalling occurs primarily in the mesenchymal cells 
neighbouring villus epithelial cells and is regulated by noggin to suppress Wnt β-
catenin signalling (He et al., 2004). The suppression of Wnt represses stem cell 
proliferation and replication (Haramis et al., 2004; He et al., 2004). The suppression 
of “stemness” allows for the terminal differentiation of epithelial cells through the 
transit amplifying region.  
To date, the interactions between signalling pathways, remains to be fully clarified and 
the role of these following injury or invasion by enteric pathogens are still unknown. 
In tandem, these signalling cascades give rise to differentiated epithelial cell types 
which are important for small intestinal functions in both nutrient absorption and host 
defence against invading pathogens.  
 
1.4 Secretory Epithelial Cells Play a Significant Role in Host Defence 
 
As the site of initial exposure, the small intestine must defend against invading 
pathogens whilst maintaining a balance of healthy gut microbiota. To do this, it relies 
on the presence of differentiated secretory cells that each have distinct roles in host 
defence, the immune system and nutrient absorption. 
1.4.1 Goblet Cells Renew the Mucus Barrier 
The first line of intestinal defence is the presence of a highly-glycosylated mucus 
barrier loosely adhered above the epithelial cell layer (Figure 1). This mucus layer 
traps and physically separates invading microorganisms from the underlying epithelial 
cells to protect the host, and like the epithelium itself, is routinely renewed to facilitate 
microbial clearance (Ermund et al., 2013a, 2013b; Rodriguez-Pineiro et al., 2013).  
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The regeneration of the mucus layer is driven by the presence of goblet cells 
sporadically distributed along the intestinal epithelium. These specialised secretory 
cells continually replenish the mucus layer through secretion of mucus components 
such as mucin-2 and trefoil factor 3 (Birchenough et al., 2015; Ermund et al., 2013a, 
2013b; Hansson, 2012; Johansson et al., 2013; Pelaseyed et al., 2014; Rodriguez-
Pineiro et al., 2013). In addition to contributing to a physical barrier against invading 
pathogens, mucus components themselves play roles in activation of host immune 
response to infection. For example, deficiency of trefoil factor 2 , a gastrointestinal 
secretory protein,  is reported to protect host cells from low-dosage infection of 
Toxoplasma gondii (McBerry et al., 2012).  Here it is reported that trefoil factor 2 plays 
a role in mucosal barrier function and the release of type I cytokines during oral 
infection (McBerry et al., 2012). More recently, Wlodarska et al., 2014 demonstrated 
that disruption to normal goblet cell function in mice leads to deficient microbial 
clearance within the gut, resulting in persistent Citrobacter rodentium and Salmonella 
enterica infections, which demonstrates the importance of this secretory cell lineage 
for host intestinal defence (Johansson and Hansson, 2014; Wlodarska et al., 2014).  
1.4.2. Paneth Cells Secrete Antimicrobial Peptides 
As well as goblet cells, Paneth cells also play a significant role in host defence. Some 
enteric pathogens have evolved mechanisms to exploit or avoid the mucus barrier to 
establish infections. Upon reaching the epithelial cells, microbial stimulation causes 
Paneth cells of the crypt domains to secrete AMPs such as lysozyme and alpha-
defensins into the crypt lumen to regulate intestinal ecology (Clevers and Bevins, 
2013; Elphick and Mahida, 2005; Farin et al., 2014; Fernandez et al., 2008; Peeters 
and Vantrappen, 1975; Wilson, 1999). In particular, Paneth cell AMPs are important 
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for the regulation of bacterial pathogens such as Salmonella and Shigella (Fernandez 
et al., 2008; Salzman et al., 2003a, 2003b).  
Defects in either of these differentiated cell types can lead to significant disease thus 
play an important role in maintaining gut homeostatic processes and protection against 
invading pathogens.  
 
1.5. Tight Junctions of the Epithelium Inhibit Pathogen Invasion 
The intestinal epithelium acts as a barrier between microbes in the lumen and the host 
mucosal immune system in the underlying lamina propria. Maintenance of a secure 
barrier is heavily dependent upon the presence of tight junctional proteins (Figure 8) 
(France and Turner, 2017).  
Paracellular permeability is regulated through protein complexes known as tight 
junctions which reside just beneath the apical surface of adjacent cells (Figure 8). 
Epithelial permeability is variable throughout the small intestine dependent upon the 
tight junctional complex which consists of three families of proteins; occludin, 
claudin and junctional adhesion molecules (JAM) (Citi and Cordenonsi, 1998; Wells 
et al., 2014). Beneath tight junctions lie adherens junctions, desmosomes and gap 
junctions to regulate intracellular signalling and cell-cell adhesion (Figure 8) (France 
and Turner, 2017; Wells et al., 2014). The presence of these tight junctional 
complexes compartmentalises the luminal contents from the underlying lamina 
propria to support epithelial polarisation (Oshima and Miwa, 2016). 
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Figure 8) A simple schematic representing the arrangement of epithelial cell junctions. 
Tight junctions form at the apical junction and laterally connect neighbouring epithelial cells. 
Tight junctions allow for paracellular selection of small molecules. Adherens junctions and 
desmosome regulate cell-cell adhesions and intracellular signalling to maintain epithelial 
integrity. Gap junctions and desmosomes associate the remaining lateral membranes. 
Intermediate filaments dock into desmosomes whereas actin filaments attach to tight 
junctions and adherens junctions [Figure is modified and adapted from (Guttman and Finlay, 
2009; Wells et al., 2014)]. 
 
Although tight junctions can restrict microbial access to the underlying lamina 
propria some enteric pathogens have evolved mechanisms to disrupt tight junctions 
during invasion including using tight junctions as receptors for attachment and 
invasion, or by disrupting normal tight junction protein expression and localisation 
(Muza-Moons et al., 2004; Roxas et al., 2010; Simonovic et al., 2000). Tight 
junctional alterations caused by bacterial invasion results in a disruption in ion and 
water transport across the epithelial membrane, which presents as classical acute 
gastroenteritis symptoms such as diarrhoea. A prime example of this can be observed 
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during infections with either enterohaemorrhagic Escherichia coli (EHEC) or 
enteropathogenic E. coli (EPEC). Both EHEC and EPEC utilise a type-three secretion 
system (T3SS) to inject effector proteins into the host cytoplasm and re-arranges the 
host cytoskeleton to disrupt intercellular tight junctions (Muza-Moons et al., 2004; 
Roxas et al., 2010; Simonovic et al., 2000).  
Similarly, Salmonella spp induce host cell membrane ruffling, leading to actin re-
arrangement and engulfment of the bacteria by the host cell to establish infection. 
Exposure to extracellular Salmonella also induces tight junctional disruption, which 
presents with a lower transepithelial resistance and increased permeability in vitro 
(Boyle et al., 2006; Collazo and Galán, 1997; Kohler et al., 2007). Both these bacteria 
are well characterised, however in the majority of cases it is unknown how host-
pathogen interactions at the epithelial surface lead to successful invasion. 
 
For the purposes of preventing the incidence of enteric diseases, it is imperative to 
study the invasion events within the small intestinal interface. Identification of key 
molecular pathways could lead to the development of novel therapeutics. 
 
 
1.6 Polarisation of the Intestinal Epithelium 
 
Intestinal epithelial cells are polarized: the apical surface faces the lumen of the 
intestine, and the basal surface faces the lamina propria. Epithelial polarization is 
maintained through the exclusive targeting of proteins to either the apical or basolateral 
sides, and this separation is maintained by tight junctions (Abreu, 2010). An important 
feature of epithelial polarisation is the regulation of surface protein expression on the 
relevant interface. For the study of infections and host-pathogen interactions, the 
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regulation of pattern recognition receptors (PRRs), such as toll-like receptors (TLRs) 
are important. 
The localization of toll-like receptors (TLRs) have been studied in both human and 
murine tissues revealing that TLR expression can be spatially restricted to either the 
apical or basolateral surfaces of the epithelium depending on the epithelial cell type, 
location along the intestinal tract, and the cell developmental stage (Abreu, 2010). This 
polarized expression of TLRs may help the host to respond appropriately to 
commensal and pathogenic microbes. Interestingly, stimulation of the same TLR at 
either the apical or basolateral surface has distinct outcomes. Basolateral stimulation 
of TLR9 results in textbook activation of the NF-κB pathway, whereas apical 
stimulation inhibits this pathway and reduces responsiveness to subsequent TLR 
stimulation. In addition to polarized expression of TLR, host cell receptors utilized by 
pathogens for invasion may also show polarized patterns of expression. It is therefore 
important that any models of the small intestinal epithelium are correctly polarized, 
and that pathogens of interest are applied to the apical surface, as they would during 
the progression of natural infections.  
 
1.7 Existing Models of Intestinal Biology 
To study the intestine, a suitable model that fully mimics the intestinal epithelium is 
required. Existing intestinal infection models can be split into several types each with 
their own advantages and limitations (Table 2):  
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1. In vitro immortalised cell line cultures; a cheap and convenient method of 
studying host-pathogen interactions, however these models may be 
physiologically irrelevant as they lack cell diversity and structural complexity 
which severely limits their ability to accurately mimic and recapitulate the in 
vivo environment.  
 
2. In vitro 3D explant models: more physiologically relevant models than cell 
line cultures as these incorporate the cellular diversity and structural 
architecture of small intestinal tissues in vivo. However, models developed 
from donor tissues can be highly variable and explant models are restricted in 
duration of study due to poor tissue viability. 
3. In vivo models: are the most biologically relevant as they incorporate host 
innate and adaptive immune responses to infection, however in some instances 
may be unsuited for the purposes of studying infections. Smaller models 
(rodent and avian) are routinely exploited for infections studies, however the 
use of species-specific pathogens within these models creates a species 
incompatibility. In vivo models of larger animal species could be used, 
however the cost and technical difficulties of these is a major limiting factor. 
Furthermore under the NC3R’s recommendations, we should be aiming to 
replace the use of animals in research for alternative models to reduce the 
numbers of animals in research.  
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Table 2) Common models of the intestine, their uses and limitations 
 
Origin Features Uses Limitations References 
In vitro cell lines: immortalised cell line cultures provide a cheap and convenient method of studying host-pathogen interactions, however lack 
cell diversity and the structural architecture of the small intestine so are physiologically inaccurate. Cell lines are often used to study host-
pathogen cell interactions and bacterial pedestal formation. 
CaCo2 
Human Colon 
Colorectal 
Epithelial Cells 
Polarised with apical 
microvilli, tight junctions 
and intestinal hydrolase 
enzyme activity 
 
Can be co-cultured with raji B cells 
on transwell inserts to generate 
microfold cells. This model 
identified E.coli targeting of M 
cells for translocation across the 
epithelium. 
Enterocytes may more closely 
represent foetal and not adult 
enterocytes. Colonic epithelial cells do 
not represent small intestinal 
epithelium 
(Roberts et al., 
2010; Sambuy et 
al., 2005) 
HeLa (I407) 
Human Cervical 
Adenocarcinoma 
Epithelial Cells 
Jejunum and ileum of 2 
month old embryo, 
contaminated with HeLa 
cell markers 
Previously used to study the 
internalisation of Salmonella and 
Yersinia. 
 
Non-polarised cells which are not 
representative of the gastrointestinal 
epithelium.  Also known to over-take 
other cell cultures in vitro and 
therefore pose a risk of contamination. 
(Devenish and 
Schiemann, 
1981; Gianella et 
al., 1973; 
Kihlstrom, 1977) 
HT-29 
Human 
Colorectal 
Adenocarcinoma 
Morphology can be 
induced to enterocyte 
differentiation to form 
polarised epithelial with 
brush border 
Widely used for adherence and 
invasion assays. 
Colonic epithelial cells do not 
represent small intestinal epithelium. 
(Cohen et al., 
1999; Martin et 
al., 2004) 
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Table 2 Continued) Common models of the intestine, their uses and limitations 
 
Origin Features Uses Limitations References 
MDCK 
Canine Kidney 
Epithelial Cells 
Apico-basolateral 
polarity and tight cell 
junctions 
 
Previous uses include: adherence, 
invasion and transcytosis of bovine 
E. coli through monolayer cultures, 
and Salmonella migration through 
MDCKs grown on transwell 
membranes. 
 
Lack of validated canine antibodies 
available. Cells are renal in origin and 
may not accurately mimic small 
intestinal interactions. 
(Dukes et al., 
2011; Finlay et 
al., 1988; Korth 
et al., 1994; 
Tafazoli et al., 
2003) 
T84 
Human Colon 
Carcinoma 
Epithelial Cells 
Contains goblet-like cells 
and forms polarised 
monolayers 
T84 has been used to study 
intestinal epithelial integrity and 
IFN-γ signalling. 
 
 
Shown to be more susceptible to 
infection by enteroaggregative E. coli 
strain 042 than CaCo2 cells and so 
findings are not comparable between 
studies. 
 
(McCool et al., 
1990; Nataro et 
al., 1996) 
IEC-6  
Rat Small 
Intestine 
Epithelial Cells 
Small intestinal in origin 
making it more suited 
than colonic epithelial 
cell lines 
Has been previously used to study 
transmigration  of Toxoplasma 
gondii and wound healing 
 
In comparison to human cell line 
cultures, IEC6 is relatively 
uncharacterized. It is unknown what 
cell types are present within this 
model 
 
(Jones et al., 
2016) 
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Table 2 Continued) Common models of the intestine, their uses and limitations 
 
Origin Features Uses Limitations References 
 
In vitro 3D models: these models are favourable over monolayer cultures are they introduce more complexity to produce more physiologically 
relevant findings. However models utilising live tissues are subject to donor variability, and poor availability of animal tissues may hinder the 
study of zoonotic infections. 
 
Scaffold Models 
Immortalised CaCo2 or 
primary cells cultured on 
villus hydrogel structures 
Culture on scaffold forms polarised 
epithelial monolayer with brush 
border phenotype at the villus tip.  
 
Models exploiting CaCo2 cells lacks 
diversity. Primarily developed for drug 
permeability and has not been optimised 
for infection. 
 
(Nakase et al., 
2006; Yu et al., 
2012) 
Ex vivo tissues 
Human or animal 
biopsies/tissues 
More complex than monolayer 
cultures as they contain structural 
complexity and cellular diversity. 
 
Tissue thickness limits the use of 
traditional microscopy techniques. 
Tissues deteriorate and are not able to 
be cultured long term due to poor 
oxygenation. 
(Bansal et al., 
2009; Grivel and 
Margolis, 2009) 
Precision-cut 
intestinal slices 
(PCIS) 
Viable explants of tissues 
ex vivo 
More complex than monolayer 
cultures containing structural 
complexity and cellular diversity. 
Can be sliced thinly to extend tissue 
viability allowing the use of imaging 
techniques. 
PCIS requires using specialist slicing 
equipment. Optimised for the study of 
drug transport and toxicology and not 
infection. Tissue viability limited to 24 
hours. 
(de Graaf et al., 
2010; de Kanter 
et al., 2005; Fahy 
et al., 2013; van 
de Kerkhof et al., 
2005) 
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Table 2 Continued) Common models of the intestine, their uses and limitations 
 
Origin Features Uses Limitations References 
Ussing chamber  
Stripped intestinal 
mucosae mounted in 
chambers with stirring 
conditions. 
More complex than monolayer 
cultures as they contain structural 
complexity and cellular diversity. 
 
Used primarily for the study of 
intestinal permeability and not 
infections. Not optimised for imaging 
techniques and short term viability 
comparable to PCIS. 
(Ungell et al., 
1998; Van De 
Kerkhof et al., 
2006) 
Gut-on-Chip 
CaCo2 induced on 
micro-fluidic chip 
forming 3D villus 
structures 
Polarised and differentiated 
epithelial layer in 3D conformation. 
Incorporates dynamic flow of 
microfluids. 
 
Developed primarily for the study of 
intestinal permeability and not yet 
fully evaluated for infection studies. 
Unknown what cell types are present. 
(Kim and Ingber, 
2013) 
Organoids Stem cell derived model 
 
“Mini-guts” containing 
differentiated epithelial cells in 3D 
conformation. Can also be 
developed using tissues from stem 
cells from other anatomical sources 
to generate region specific cultures 
(jejunal, ileal) or organ specific 
cultures (e.g. colon, rectum) 
 
Access to lumen is restricted and 
requires the use of microinjection 
equipment. 
(Sato et al., 
2009; Wilson et 
al., 2014; Zhang 
et al., 2014) 
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Table 2 Continued) Common models of the intestine, their uses and limitations 
 
Origin Features Uses Limitations References 
 
In vivo models: these models form the gold standard for study of host-pathogen interactions as they are physiologically and incorporate host 
immune and systemic responses to infection, however are not suited for optimised for studying early stage infections by confocal imaging or 
proteomic approaches 
 
Ileal loop model 
 
Ligation of ileum 
through surgical means 
under anesthesia to study 
host response to infection 
Treatments can be replicated within 
the same animal maximizing 
outputs. Identified M cells as the 
target for Salmonella typhi strain 
10007 
Requires animal husbandry facilities 
and project licenses. 
Limitations of 24 hour experiments. 
 
(Kohbata et al., 
1986) 
Whole animal 
models 
Infection of whole 
animals by oral gavage, 
or intraperitoneal 
injection 
Include systemic and host immune 
response to infections. Can produce 
transgenic murine models to study 
immune responses to pathogen 
infection. 
Difficult to obtain approval for large 
animal studies which is required to 
species-specific pathogens/host 
adaptations. Not optimised for early 
stage invasions. Method of infection 
may not always mimic the natural oral 
route of infection. 
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1.7.1 In vitro Monolayers Lack Structural Complexity  
Existing 2D in vitro models of the gastrointestinal epithelium have been significant for 
the study of gastrointestinal pathogens. A notable example of such a model is the 
CaCo2 cell-line, which when grown as a monolayer show polarised morphology with 
tight junctions between adjacent cells, and microvilli on the apical surfaces (Sambuy 
et al., 2005). Conventionally, these are used for the study of basic attachment and 
invasion assays and have been invaluable in furthering our understanding about the 
mechanisms involved in bacterial invasion in pathogens such as Escherichia coli, 
Salmonella spp, and Clostridium difficile.  
Immortalised cell lines were previously favoured for the study of infections due to the 
ease of sub-culturing and reproducibility of these cell lines, however it has since been 
established that repeated passage can lead to structural changes within the model (Lu 
et al., 1996). Firstly, it was observed that regions of CaCo2 cells at high passage 
number formed multiple cell layers rather than monolayers as observed in early 
passage number cells (Lu et al., 1996). Secondly, it was reported that high passage 
number cells exhibit an enhanced trans-epithelial electrical resistance (TEER) when 
compared to those of a lower passage, potentially due to the stacking of multiple cells 
(Lu et al., 1996). Thirdly, high passage number cells show a significantly higher rate 
of proliferation in comparison to low passage number CaCo2 cells. Finally, the 
expression of small intestinal hydrolase enzymes are altered in high passage number 
CaCo2 cell lines which may affect cell functionality (Sambuy et al., 2005). Although 
CaCo2 cells are a heterogenous mix of cells, over time through repeated passage, sub-
populations of enterocytes become dominant within the culture resulting in the 
changes described (Briske-Anderson et al., 1997; Lu et al., 1996; Senarathna and 
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Crowe, 2015; Siissalo et al., 2007). Furthermore, the maintenance of CaCo2 across 
different laboratories has likely led to the selection of different sub-populations and 
ultimately variation within the cell line, resulting in the reporting of contrasting 
experimental findings (Briske-Anderson et al., 1997; Sambuy et al., 2005).  
In addition to the morphological changes acquired through long term passage, 
monolayer cultures are considered too simplistic and unable to fully mimic the in vivo 
cellular physiology. Traditionally immortalised cell lines contain one dominating cell 
type, in the case of CaCo2, enterocytes. Characterisation of CaCo2 cell lines have 
suggested that long term culture may have induced a foetal and not adult enterocyte 
phenotype (Sambuy et al., 2005). As foetal cell responses differ to mature cell 
response, this is likely to result in misleading observations during infection studies. 
 A lack of secretory cell types in cell lines also limits their use in recapitulating the in 
vivo epithelium. A method of co-culture with raji B cells has demonstrated that CaCo2 
cells are able to be further differentiated into M cells, however using co-culture 
techniques does not generate cell lines cultures containing Paneth or goblet cells that 
are important for host defence. 
The limitations described above result in host-pathogen interactions that do not occur 
as they do naturally. For example, in vivo enteropathogenic E. coli (EPEC) localises 
specifically with intestinal epithelial cells, however in vitro the host cell specificity is 
ablated and EPEC also interacts with non-intestinal epithelial cells (Law et al., 2013). 
Thus, immortalised cell lines will not produce physiologically accurate representations 
of complex gastrointestinal pathogen infections of the epithelium 
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1.7.2 Scaffold Models Lack Cell Diversity 
In terms of structural arrangement, 3D scaffold models are advantageous when 
compared to immortalised cell lines. Hydrogel structures moulded to accurately 
replicate the shape and size of human small intestinal villi are used as a scaffold to 
overlay immortalised cells such as the CaCo2 cell line (Yu et al., 2012). This model, 
characterised by confocal imaging, describes variable enterocyte maturation along the 
villus length with polarized cells at the top of the villus tip exhibiting brush border 
characteristics, and less mature enterocytes at the villus base (Yu et al., 2012). 
However, due to its dependence on an immortalised cell line, this model is likely to 
succumb to the formation of multiple cell layers which again affects the permeability 
of the culture and altered epithelial integrity (Yu et al., 2012). More importantly, this 
model still lacks Paneth and goblet cell types involved with host, as these cell types 
are absent in the CaCo2 cell line (Yu et al., 2012). Currently, primary cells have not 
been cultured in this way, but could offer a suitable model to study intestinal biology 
if the structural arrangement mimics the in vivo environment. 
Existing scaffold models have primarily been developed for the study of drug 
permeability and has not been utilised for infection studies. However the 
characteristics described above make this model less desirable for infection studies, 
and an alternative model may be more appropriate. 
1.7.3 Explant/Tissue Based In vitro Models Have Short Term Viability 
In vitro explant tissue-based models incorporate all the differentiated epithelial cell 
types, as well as the complex structural architecture in vivo, making them an attractive 
in vitro alternative to study host-pathogen interactions. However, many of these 
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models were primarily designed and optimised for the study of intestinal permeability, 
and may not be suitable for infection studies. 
A major drawback of using explant and tissue-based models is the rapid tissue 
degeneration of this tissues leading to short viability.  Recently, modifications have 
been described to generate precision cut intestinal slices (PCIS) to produce thin 
transverse sections of intestinal tissues (de Graaf et al., 2010; de Kanter et al., 2005). 
Using this method, oxygenation of the tissues are improved to prolong it’s viability for 
up to 24 hours. Modification of these methods through the integration of more 
sophisticated perfusion systems may further improve tissue viability, however these 
are challenging to implement and the benefits are not yet fully understood. 
Ultimately, this technique is still heavily reliant on experimental animals or biopsies 
for donor tissues. The repeated use of experimental animals is unfavoured, and donor 
biopsies often introduce biological variation into experiments. The rapid degeneration 
of intestinal tissues and dependence on repeated animal use or donors makes explant 
models undesirable for the study of host pathogen interaction studies.  
1.7.4 In vivo Models are Not Suited for Short Term Infection Studies 
Due to the limiting factors of in vitro models, it is still necessary to utilise in vivo 
experimentation to accurately mimic host-pathogen interactions of enteric pathogens. 
There are currently two in vivo models of enteric disease; ileal loop models and whole 
animal models.  
Ileal loop models involve surgical ligation of ileum tissues to form multiple loops 
within a single animal and pathogens or treatments are then injected into the intestinal 
lumen for study (Kohbata et al., 1986). A unique feature of this model is that several 
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treatments can be administered as these ileal loops are separated by ligation, which 
allows for the study of multiple conditions in one biological donor, and consequently 
the collection of experimental data is restricted to the intestinal tissues. The use of this 
model is also generally limited to a maximum of 24 hours and requires the use of live 
animals under anesthesia which requires surgical expertise and careful monitoring for 
animal welfare purposes (Kohbata et al., 1986).  
In contrast, whole animal models involve studying the whole animal response to 
infection following either oral gavage or injection (intravenous or intraperitoneal), 
which allows researchers to study multiple tissues of interest or bodily fluids, 
generating multiple sets of experimental data in the process. With the development of 
new technologies, the production of knockout or gene silenced models make in vivo 
models indispensable. However, several challenges arise when considering whole 
animal models for the study of early stage host-pathogen interactions.  
Firstly, oral gavage of animal models is technically challenging due to difficulties with 
administering standardized pathogen doses, as well as in culturing the relevant 
invasive life stages for oral infection. Therefore, many studies of in vivo enteric 
infection are established through intraperitoneal injection which does not mimic the 
natural route of infection. Secondly, during early host invasion, enteric pathogens often 
infect small regions of the small intestine which are difficult to identify and study in 
vivo. Similar to explant tissues, live imaging of in vivo models is limited due to rapid 
tissue degeneration, which is further complicated by the thickness of native tissues. 
Thirdly, systems biology approaches are not suited for in vivo intestine models. Due 
to the large volume of uninfected cells present in vivo, small changes in protein 
abundance in foci of infection may be masked. The signal-to-noise ratio is favoured 
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toward the more numerous non-infected cells within the gut, meaning that subtle 
changes exhibited by infected cells may be missed. 
In addition to these issues, generally in vivo models are often rodent based which is 
unsuitable for the study of pathogens with species-specific adaptations. This species 
mis-match produces physiologically irrelevant host-pathogen interactions which do 
not mimic the response in the natural hosts. An example of this is the limitation of 
study of Listeria monocytogenes. The bacterial surface proteins required for invasion 
are poorly recognized by murine cells, so establishing infection requires a high 
bacterial dose administered intravenously which bypasses the natural route of infection 
(Hoelzer et al., 2012; Pizarro-Cerda et al., 2015). The administration of infectious dose 
via this method does not mimic the natural progression of infection where systemic 
symptoms may not appear until several weeks after initial bacterial exposure (Hoelzer 
et al., 2012; Pizarro-Cerda et al., 2015). Consequently, the study of Listeria in murine 
models may poorly mimic human infection. 
Alternatively, larger models of farm or companion animals for the study of infections 
are not as feasible as small murine models of infection. Acquiring ethical approval for 
these studies is challenging due to potential animal welfare issues, and the cost of 
establishing animal housing facilities is limiting. Furthermore in vivo models require 
repeated animal use which we should be aiming to reduce, for both ethical and welfare 
reasons. For these reasons, in vitro models may provide an advantageous means of 
studying host-pathogen interactions over in vivo models. With these limitations in 
mind, there is a clear need for the modification and improve current in vitro techniques 
for the study of infection within the small intestine as an alternative to simplistic 2D 
models and in vivo models that are both routinely used in this context.  
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1.7.5. 3D Organ Models Form a New Generation of Enteric Models 
Due to the limitations of classic enteric models, there has been an increased interest in 
the development of novel enteric models. In recent years, two promising new models 
have been developed; gut-on-chips and stem cell derived organoid models. 
Microfluidics and organ-on-a-chip approaches are upcoming engineering technologies 
developed for the study of drug toxicity and permeability that integrate small volumes 
of fluids to fabricate functional units of organs (Kim and Ingber, 2013; Kim and 
Takayama, 2015). Gut-on-chips feature CaCo2 cells continuously perfused in 
chambers to induce morphogenesis of 3D villus structures forming a polarised, 
differentiated epithelial monolayer (Kim and Ingber, 2013). It is unknown how the 
establishment of gut-on-chip models is affected by sub-clones of CaCo2 cells and 
whether this introduces variability between different laboratories. However due to the 
limitations of CaCo2 cells as a monolayer, it would not be surprising if this model was 
subject to some challenges. Furthermore, the colonic origin of CaCo2 cells is likely to 
generate differentiated epithelial cells that do not mimic the small intestinal epithelial 
cells in vivo. As we know that CaCo2 enterocytes are more likely to mimic foetal 
enterocytes, and are colonic in nature, this model requires further characterisation 
before its use in host-pathogen interactions can be introduced. For these reasons, the 
organoid model will more likely become a more promising tool for the study of enteric 
pathogens.  
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1.8. An Introduction to Small Intestinal Stem Cell-Derived Organoids  
Since the identification of  LGR5+ stem cells within the small intestine (Barker et al., 
2007), we have seen the establishment of “organoid” cultures. These “mini-guts” are 
stem cell derived 3D models representative of the intestine that incorporates all the 
major differentiated cell types and complex structural architecture found in vivo (Sato 
et al., 2009) (Figure 9). Prior to the establishment of organoid cultures, there has never 
been a long-term in vitro culture system to maintain the crypt-villus physiology 
observed in vivo, making these an exciting prospect for the future of intestinal biology. 
1.8.1 The Generation of Organoid Cultures 
To generate organoid cultures, the LGR5+ stem cells must be isolated, either as single 
cells or within crypt base columnar units. Firstly, small intestinal tissues are flushed 
and cut into small sections, then are subjected to several cycles of dissociation through 
shaking in PBS/EDTA. Each dissociation cycle gently removes the mucus, followed 
by the villi to eventually generate a crypt-enriched fraction. The crypts are then briefly 
quantified and concentrated via centrifugation. Crypts are then plated within 
Matrigel® at 10 crypts/µL and overlaid with organoid media containing growth factors 
r-spondin-1, epidermal grown factor (EGF) and noggin that are known to modulate 
intestinal signalling pathways involved with normal gut homeostasis (Mahé et al., 
2014; Sato et al., 2009). 
Within 4-6 days in Matrigel®, stem cells within crypt units proliferate and differentiate 
into terminal epithelial cell types to form spheroid structures with clearly defined villus 
and crypt domains that are representative of the complex architecture observed in vivo 
(Figure 9) (Sato et al., 2009). The presence of stem cells within organoid crypt 
domains drives self-renewal and cell proliferation under intestinal homeostatic 
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signaling cascades as described in vivo. By days 7-9, the organoid cultures can be 
passaged by syringing to generate fragments, and re-plating into fresh Matrigel®.  
 
Figure 9) Intestinal crypt dissociation and organoid culture. 
Small intestinal tissue (murine or human) is flushed with PBS. Incubation of tissues in a series 
of EDTA followed by PBS washes fractionates the tissues to sequentially remove mucus, villi 
and crypts into enriched fractions. The optimal enriched crypt fraction is concentrated via 
centrifugation and crypt units embedded into Matrigel®. Media containing R-spondin, Noggin 
and EGF is overlaid onto Matrigel® domes. Cellular proliferation and differentiation occurs 
to generate multilobular “organoid” cultures with an enclosed lumen. Figure generated from 
published organoid culture protocols (Andersson-Rolf et al., 2014; Sato et al., 2009). 
 
 
In addition to the advantages of the self-renewal abilities of organoid models, their 
microscopic size is much smaller than whole gut tissues that currently pose a challenge 
when identifying foci of infection. For this reason, organoids are advantageous over in 
vivo models as they can be easily visualised by confocal imaging. Moreover, unlike 
tissue biopsies, organoid models are not as susceptible to degradation and therefore 
have a longer durability which opens the potential of studying multiple time courses 
during an infection.  
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Currently the organoid culture technique has been mainly utilised by culturing murine 
small intestinal stem cells and human tumour cells for the purposes of studying cancer 
development and drug development (Ranga et al., 2014; T Sato et al., 2011). Organoid 
culture technology has also been expanded and exploited to generate other types of 
epithelial organoids of the gastrointestinal tract including stomach organoids 
(gasteroids), small intestinal organoids (enteroids) and colon organoids (colonoids) 
(Stelzner et al., 2012). 
1.8.2 Organoids Have Not Been Fully Utilised For Infection Studies 
To date, with the exception of a few studies, there has been limited work on developing 
organoid cultures for the purposes of studying intestinal pathogens (Macartney et al., 
2000; Wilson et al., 2014; Yin et al., 2015; Zhang et al., 2014). Due to their closed 
conformation, luminal access is severely restricted. Preliminary work in this area have 
demonstrated that infection of the intestinal organoid cultures is achievable through 
the use of a microinjection system to apply bacterial and viral pathogens directly into 
the luminal interface of the organoids (Finkbeiner and Spence, 2013; Wilson et al., 
2014; Zhang et al., 2014). Using PCR, immuno-staining and western blotting, 
organoids have been utilised to investigate morphological and chemical changes 
occurring during infections (Finkbeiner and Spence, 2013; Wilson et al., 2014; Zhang 
et al., 2014). Through these methods, the bacterial restrictive abilities of alpha-
defensins has been successfully studied within a sealed anatomical region. 
Furthermore, organoids can be cultured from reporter mice strains making them a 
promising tool for the generation of in vitro reporter models (Wilson et al., 2014). 
Currently, the use of organoid cultures for infection within its infancy and further 
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expansion into this field would provide a promising tool for the study of host-pathogen 
interactions. 
More recently organoid cultures have been established in various animal species 
including cats, dogs, cows, horses, pigs, sheep and chickens (Powell and Behnke, 
2017) as well as organoids produced from various anatomical regions within the 
gastrointestinal tract (Klotz et al., 2012). The generation of animal small intestinal 
organoids provides a solution to the current species mis-match which occurs through 
use of murine in vivo models and animal pathogens. The ability to generate organoids 
of food producing animals makes this model an attractive prospect for the study of 
zoonotic enteric pathogens, and to elucidate species specific pathways that we can 
exploit for the development of novel vaccines and therapeutics. For the reasons above, 
these organoid cultures have the potential to propel the field of intestinal biology 
forward.  
1.9. Enteric Protozoan Parasites 
 
Protozoa are a diverse group of eukaryotic unicellular protists. The classification of 
protozoa has been difficult and so the majority of species identification performed is 
dependent upon morphological characteristics. Over 50,000 species of protozoa have 
been described geographically worldwide. The protozoa group can be divided into 
flagellates, amoeboids, ciliates and sporozoans, many of which are free-living 
organisms with sizes ranging from 10 to 50µm in size.  
This group of organisms infects a wide range of human and animal hosts to varying 
degrees. Pathogenic protozoa are commonly transmitted via the consumption of 
contaminated food and drink. However, this is more frequently observed in developing 
countries due to the poor sanitation and occurrence of microbial contamination. 
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Consequently, these diseases are often neglected and receive less interest than bacterial 
diseases.  
Many protozoal pathogens have been implicated in both human and veterinary disease. 
Examples of these include Eimeria spp, Entamoeba spp, Cryptosporidium spp, 
Giardia spp, Toxoplasma spp and Neospora spp (Fayer et al., 2000; Fletcher et al., 
2012; Kaltungo and Musa, 2013; Nichols, 2000; Stark et al., 2009). These infections 
may be asymptomatic in agricultural animals, which eventually leads to unintentional 
onward transmission throughout herds or flocks of animals. In other instances, disease 
in farm animals results in a loss of milk and meat yield, and thus a loss in agricultural 
productivity. However, the primary concern is the zoonotic risk of transmission to 
humans upon consumption of contaminated meat products. 
The ability to study these diseases in both human and animal models will further our 
understanding of key host-pathogen interactions to identify molecular signaling 
pathways to develop novel therapeutics. A significant group of protozoa with 
relevance to both human and veterinary health are the Apicomplexa. 
1.9.2 Unique Features of Apicomplexa 
This phyla of parasitic alveolates are named as such due their polarised phenotype and 
the presence of shared unique features. Apicomplexa are obligate intracellular 
parasites that invade host cells and establish a parasitophorous vacuole for replication 
using shared morphological structures, many of which are found in the apical complex. 
The apical complex contains an apical polar ring, and several secretory organelles; 
micronemes (MICs), rhoptries (ROPs) and dense granules (GRAs) (Figure 10). 
 
 Chapter 1 – General Introduction  P a g e  | 43 
 
Figure 10) Structural Characteristics of Apicomplexan Parasites 
Apicomplexa are polarised cells containing unique organelles. Rhoptries, micronemes 
and dense granules are secretory organelles required for motility, host cell invasion 
and the establishment of a parasitophorous vacuole. Adapted from (Morrissette and 
Sibley, 2002) 
 
The apical pole serves as a microtubule-organising centre (MTOC), and some 
apicomplexa also contain conoids that are composed of spiral filaments which is 
thought to be mechanically involved with host cell invasion. The secretory organelles 
are crucial for parasite motility, host cell invasion and the establishment of 
parasitophorous vacuoles. Another unique feature of this phyla is the apicoplast, a 
chloroplast-like organelle. Apicoplast are contained within an inner membrane 
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complex (IMC) composed of pellicles that are also associated with cytoskeletal 
constructs such as actin, myosin, intermediate filaments and microtubules (Figure 10). 
Comparison of apicomplexan cytoskeleton against eukaryotic models reveal 
interesting features.  The survival of Apicomplexa parasites is attributed to the 
presence of subpellilcular microtubules that exhibit heightened stability to withstand 
unusual pressure and temperature conditions (Morrissette and Sibley, 2002). The 
subpellilcular microtubules run through the cytosolic face of the parasite pellicle, and 
span approximately 2/3 of the parasite length to the region just below the nucleus to 
regulate apical polarity (Figure 10) (Morrissette and Sibley, 2002). The arrangement 
of these microtubules is variable within the phylum and are specific to different life 
stages for host cell invasion and parasite replication. However extracellular life stages 
of apicomplexan parasites appear to contain two forms of microtubules; the 
subpellicular and spindle microtubules to facilitate with extracellular survival and 
function (Morrissette and Sibley, 2002). 
Apicomplexa also share a substrate-dependent “gliding motility” for tissue migration 
and host cell invasion, which is made possible by a glideosome located between the 
IMC and parasite plasma membrane (PPM) (Figure 11 A). Structural proteins of the 
apicomplexa have been identified for gliding motility named gliding-associated 
proteins (GAPs); GAP40, GPA45 and GAP50 that are thought to maintain the integrity 
of parasite pellicle during gliding and invasion (Bargieri et al., 2014). The pairing of a 
myosin light chain through GAPs forms a class XIV myosin (MYOA) to generate 
moving force (Figure 11 A). The interaction of the actin-myosin motor to the plasma 
membrane adhesions forms short actin filaments (F-actin) (Bargieri et al., 2014; 
Drewry and Sibley, 2015; Jewett and Sibley, 2003; Morrissette and Sibley, 2002).  
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Figure 11) Molecular mechanism of apicomplexan gliding motility and host cell invasion 
(A) A parasite motor (glideosome) is located between the parasites inner membrane complex 
(IMC) and plasma membrane (PPM). The action of parasite motility is mediated through 
binding of the ectodomain of transmembrane TRAP-family proteins, to a solid substrate as the 
cytoplasmic tail of the protein links to the parasite motor. The integrity of the glideosome is 
regulated by the gliding-associated protein 45 (GAP45), which anchors to the PPM and IMC 
via GAP40 and GAP50 at either end. Binding of GAPs, the IMC and actin is mediated by 
myosin A (MyoA) and the MyoA light chain (MLC1). Capping of the TRAP-family protein 
by myosin-actin consequently generates a moving force to provide movement of the parasite 
cell. (B) Upon adhesion to host cell plasma membrane (HCPM) by parasite surface adhesins 
and host cell surface receptors, parasite apical membrane antigen 1 (AMA1) and rhoptry neck 
protein 2 (RON2) are inserted into host cells and associates with RON4 and RON5 to form a 
junction. Host actin recruited to the parasite junction links the parasite to host cell 
cytoskeleton. The forward propulsion of parasites provided by the glideosome towards the 
interior of the host cell forms a parasitophorous vacuole (PVM). Images from (Bargieri et al., 
2014). 
 
Apical deployment of these adhesins results in a forward movement from the apical 
end to induce parasite internalization (Figure 11). Upon identification of host cells, 
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Apicomplexa attach and invade these targeted cells via an attachment cascade 
regulated by the secretory organelles (Drewry and Sibley, 2015; Jewett and Sibley, 
2003; Morrissette and Sibley, 2002). 
The mechanisms by which apicomplexan parasites invade host cells varies between 
species due to their stage specific adaptations. Due to their ability to invade almost all 
mammalian cell types, Toxoplasma gondii is considered the most successful invasive 
enteric protozoan. For this reason, T. gondii will be the focus of this doctoral thesis for 
the discussion of apicomplexan invasion strategies and as a model parasite for 
development of a suitable model.  
1.10 An Introduction to Toxoplasma gondii  
Since its discovery in the early 1900s, T. gondii has been heavily studied. Despite this, 
there are still several aspects of this parasite’s life cycle that elude our understanding. 
The definitive host for Toxoplasma are members of the Felidae family, and an array 
of mammalian species of intermediate host, including humans, mice, birds and food-
producing farm animals have been identified (Bonapaz et al., 2010; Dubey et al., 2002; 
Esteban-Redondo and Innes, 1997; Guo et al., 2015; Hutchinson et al., 2011; Limon 
et al., 2017; Tenter et al., 2000). 
The geographical presence of human Toxoplasmosis has been reported with variable 
rates of infection estimted; 9% in the USA, 30% in the UK and up to 50-80% in Central 
and South America (Hill and Dubey, 2002; McAuley, 2014; NHS, 2015).  The 
majority of T. gondii infections are asymptomatic or cause only mild flu-like 
symptoms, however the acquisition of infection by immuno-suppressed individuals or 
during early pregnancy can have severe consequences. Alternatively, if an infected 
person subsequently becomes immunocompromised, parasite re-activation can result 
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in the development of neuro- or ocular toxoplasmosis leading to long term morbidities 
(Carruthers and Suzuki, 2007; Hill and Dubey, 2002).  
Although the majority of cases of severe disease involve immunocompromised 
patients, infection of immune competent hosts can alter brain function. The formation 
of neuronal tissue cysts has been reported to alter the behaviour of infected rodents 
and is thought to increase the likelihood of parasite transmission to the definitive feline 
host (Gatkowska et al., 2012). It has been suggested that the formation of brain cysts 
results in neuronal atrophy in these mice and an enhanced dilation of ventricles in the 
brain. Comparatively, examination of the human schizophrenic patients have 
highlighted reduced grey matter in infected patients when compared to non-infected 
patients associated to a loss of brain parenchyma. These findings have led to the theory 
that the development of brain cysts during infection has implications for the 
manipulation of behaviour in infected hosts (Berenreiterová et al., 2011; Torrey and 
Yolken, 2003). 
Acquisition of infection during pregnancy results in congenital toxoplasmosis. The 
risk of congenital toxoplasmosis is variable in relation to the stage of pregnancy that 
infection is acquired, with the lowest rates of foetal transmission reported during the 
first trimester which increases as pregnancy proceeds (McAuley, 2014). Animal 
studies have demonstrated that initial infection occurs within the uterus which 
eventually migrates to the foetus through multiple mechanisms (Jones et al., 2016; 
McAuley, 2014). Congenital toxoplasmosis has a wide range of clinical presentations, 
and is inversely related to the gestational age of infection, with more severe clinical 
disease if acquired during the first trimester (McAuley, 2014). These manifestations 
include birth defects, anaemia, seizure, developmental delay and sporadic abortion in 
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both humans and animal species impacting both human and animal health (Gilbert et 
al., 2006; Kravetz and Federman, 2005; McAuley, 2014).  
In humans, the threat of congenital toxoplasmosis is primarily the highest when the 
mother is previously uninfected, however in farm animals the subsequent chronic 
infection and transmission within flocks is problematic. Importantly, the acquisition 
of toxoplasmosis results in chronic latent infection in animal species resulting in 
subsequent transmission to offspring, posing both a risk of repeated animal abortions 
and onward human transmission upon entering the food chain. For these reasons, the 
development of more effective treatments, or vaccines for the prevention of disease is 
desirable. 
1.10.1 Existing Therapeutics against Toxoplasma gondii Infection 
To date, several drugs have been used for the treatment of Toxoplasma infections, such 
as; pyrimethamine, sulfadiazine, spiramycin, azithroymycin, clindamycin, 
minocycline, dapson and rifabutin. The most effective treatment against Toxoplasma 
generally involves the administration of pyrimethamine in combination with other 
drugs (Alday and Doggett, 2017; Derouin et al., 1991; Köksal et al., 2016). However, 
overuse of the same drugs for prevention of malaria in pregnancy have increased drug 
resistance in other apicomplexan pathogens and in Toxoplasma mutants in vitro, 
posing a threat to the future use of these therapies (Gatton et al., 2004; Köksal et al., 
2016). Furthermore, the drugs mentioned here are not effective against slow growing 
bradyzoites, which limits the treatment options for immune-suppressed patients at risk 
of re-activation of infection (Köksal et al., 2016).  
Currently only one commercial vaccine, Toxovax®, has been licensed for veterinary 
use (MSD Animal Health, 2017). However Toxovax® is not suitable for widespread 
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use as it is a live-attenuated vaccine and risks the development of adverse effects. 
Moreover, this vaccine is expensive to purchase and has a short shelf-life making it 
less attractive. Although many efforts have been made to further the development of 
an alternative vaccine, multiple challenges are inhibiting progress. The use of 
inactivated or killed antigens are unable to produce effective immune progression, 
whereas live attenuated vaccines are able to do so but have the potential to revert to 
pathogenicity (Liu et al., 2012). Currently, a lack of effective vaccine candidates is 
restricting the progression within this field, especially due to the multi-stage lifecycle 
of this pathogen. Stage specific parasite proteins limits protection and thus it is likely 
that an effective vaccine will have to be developed using a multi-antigenic approach 
(Liu et al., 2012). For these reasons, we must understand the host-pathogen interactions 
during invasion to identify key targets for the development of novel vaccines or 
therapeutics. 
1.10.2 Clonal Lineages of Toxoplasma gondii 
North American and European T. gondii strains can be defined as three clonal lineages; 
type I, II and III with direct association of genotype and disease pathogenicity (Howe 
et al., 1995). A distinct difference between these clonal strains is their migratory 
ability. In vitro type I strains show enhanced migration in comparison to type II and 
III strains. These type I parasites exhibit long-distance migration behaviour in the 
MDCK cell line as well as ex vivo. This is also reflected in vivo, where type I RH strain 
migrate more efficiently to the spleen compared to less virulent strains (Saeij et al., 
2005). This migration is associated with clonal pathology. Type I strains are generally 
highly virulent in mice (Fuentes et al., 2001; Howe et al., 1995). Type II strains are 
associated with clinical human infections and are thought to cause re-activation of 
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chronic disease in immunosuppressed or immunocompromised patients, and are also 
associated with congenital infections in Europe and North America (Carneiro et al., 
2013; Howe et al., 1995).  
Although these clonal lineages are widely accepted, regional differences in the 
dominant circulating genotype and presence of atypical genotypes are exception to 
these rules. Genotyping of isolated strains demonstrate a complex relationship of 
infection, with animal Toxoplasma strains being isolated from congenitally infected 
infants (Carneiro et al., 2013). The current source of these infections are not yet 
understood and further investigation into fully characterizing isolated parasites will 
help us to understand these interactions and parasite virulence.    
Ultimately, studying the phenotype of highly virulent strains comparatively with non-
virulent strains may help to identify key mechanisms in relation to the progression of 
parasitemia and pathogenicity to prevent disease transmission. 
1.10.3 Life Cycle of Toxoplasma gondii 
There are three extracellular infectious stages of T. gondii; tachyzoites, bradyzoites 
(found in undercooked meat) and sporozoites (found within oocysts that are shed into 
the environment) (Figure 12). Toxoplasma bradyzoites and sporozoites are acquired 
orally through the ingestion of contaminated food or water as tissue cysts or oocysts, 
respectively (Bonapaz et al., 2010; Cook et al., 2000; Dubey et al., 2002; Esteban-
Redondo and Innes, 1997; Guo et al., 2015; Limon et al., 2017). Following ingestion, 
in both definitive Felidae and intermediate hosts, pH changes within the digestive tract 
break down the walls of ingested oocysts or tissue cysts to release bradyzoites or 
sporozoites in the small intestinal lumen (Figure 12). Here, parasites invade the 
intestinal epithelial cells to infect host cells. 
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Figure 12) Toxoplasma life cycle 
The definitive host for Toxoplasma has 
been identified as the members of the 
Felidae family. Upon ingestion of 
tissue cysts in mice or birds, parasites 
are released to infect intestinal cells 
where they undergo schizogony and 
gamogeny forming oocysts. Shedding 
of oocysts results in environmental 
contamination which further infects 
intermediate hosts. In intermediate 
hosts, parasites invade intestinal cells, 
replicate, burst out of host cells and 
disseminate to other tissues. Here they 
form tissue cysts which are ingested in 
contaminated meat products. [Figure is 
modified and adapted from (Robert-
Gangneux and Dardé, 2012)]. 
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At this stage, the T. gondii life cycle differs in the definitive host and intermediate 
hosts (Black and Boothroyd, 2000; Robert-Gangneux and Dardé, 2012). Within the 
epithelial cells of the definitive host, invaded parasites undergo a series of processes 
called endopolygamy (schizogony followed by gamogeony) to produce gametocytes. 
Macro and micro-gametes fuse to form an oocyst (zygote). An oocyst wall forms 
around the parasite, and the infected cells burst to release oocysts into the small 
intestinal lumen which are later shed into feline faeces to contaminate the environment 
(Figure 12) (Black and Boothroyd, 2000; Robert-Gangneux and Dardé, 2012).  
Upon ingestion of bradyzoites or oocysts by the intermediate hosts, parasites invade 
the intestinal epithelial cells and undergo replication by endodyogeny until the host 
cell bursts to release highly invasive tachyzoites (Figure 12) (Black and Boothroyd, 
2000; Robert-Gangneux and Dardé, 2012). The tachyzoite stage parasites then re-
infect epithelial cells and monocytes. Within monocytes, the parasites exploit the 
systemic system to disseminate throughout the host and target the lymph node, brain 
and other tissues  (Figure 12) (Black and Boothroyd, 2000; Robert-Gangneux and 
Dardé, 2012). Within host tissues and in response to host immune responses, 
tachyzoites convert into slow growing bradyzoites to form tissue cysts, and so the cycle 
continues (Figure 12) (Black and Boothroyd, 2000; Robert-Gangneux and Dardé, 
2012). 
 
1.11 Toxoplasma Effector Molecules for Invasion 
Toxoplasma has a wide host range, and can infect virtually all mammalian and avian 
cells, a feature allowing for its biological success for invasion. Initial invasion events 
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occur within the small intestine following the release of free parasites from cysts or 
oocyst. Invasion of host cells is mediated by several proteins that act sequentially; 
SAGs, MICs, ROPs and GRAs (Figure 13). Invasion of host cells can be considered 
as multiple stages; attachment, formation of a moving junction, rhoptry discharge and 
finally invasion. 
The surface of Toxoplasma parasites contain GPI-anchored surface antigens (SAGs) 
and SAG-related sequence (SRS) proteins. Over 150 of these genes have been 
identified, however expression of these proteins appears to be life-stage specific. On 
invasive and proliferative tachyzoites, SAGs 1-3 and SRS 1-3 comprise the dominant 
phenotype and are thought to be involved with host cell attachment. The abundance of 
parasite SAGs positions has been theorised to allows for the parasite to glide along the 
target host cell to identify optimal binding sites during initial invasion (Carruthers and 
Boothroyd, 2007; Smith, 1995). 
After initial invasion, an adhesion event occurs specifically involving the apical pole 
of T. gondii. Due to the widespread distribution of SAG proteins, it was determined 
that they were not responsible for this apical attachment. Alternatively, this led to the 
study of MICs. There are approximately 15 MICs that have been identified, many of 
which are observed to be apically secreted during attachment. MIC2 and MIC3 have 
since been identified as a crucial secretory adhesion for host cell binding, and likely 
work synergistically to form a tight attachment to host cells (Carruthers and Sibley, 
1997; Garcia-Réguet et al., 2000; Huynh and Carruthers, 2006).  This process of 
attachment also involves another micronemal protein, apical membrane antigen 
(AMA1). Although the interaction of AMA1 is not fully understood, they are thought 
to interact with rhoptry neck (RON) proteins prior to the secretion of ROPs.  
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Figure 13) Invasion of Host Cells by Toxoplasma gondii 
Initial attachment involves the parasite surface receptor SAG proteins (blue), followed by a 
calcium-dependent deployment of MICs (green) during apical attachment. At this point, the 
moving junction is formed by the release of RONs (orange) associated with microneme-
derived AMA1 (red) forming a tight interface with a ring-like structure on the host cell surface. 
ROPs (yellow) are discharged at the invasion site into host cytoplasm. Parasites then invades 
host cells by pulling transmembrane MICs and the AMA1-RON ring to invaginate the plasma 
membrane for the creation of a parasitophorous vacuole. Parasites then traverse the host cell 
membrane in an unknown mechanism and undergo cell closure and separation. Modified from 
(Carruthers and Boothroyd, 2007). 
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As these secretory proteins reach the parasite surface, RONs form a stable connection 
with AMA1 to generate a moving junction (MJ) (Aikawa et al., 1978; Singh et al., 
2010). The MJ and apicomplexan gliding motility shares the same actin-myosin motor, 
which has allowed for the identification of relevant proteins in host cell attachment 
(Harding et al., 2016). RON2, RON4 and RON8 have been identified to play 
significant roles in firm attachment to the host cell, potentially in a two-step process 
(Lebrun et al., 2005; Straub et al., 2011). AMA1 depleted parasites exhibit 
compromised invasion with no effect on initial attachment, but with inhibition of ROP 
secretion (Mital et al., 2005). Complete removal of AMA1 suggest that this protein is 
critical for invasion, but not essential (Egarter et al., 2014). Thus, the complete role 
and function of AMA1 for host cell invasion is still not understood.  
As the invasion process continues, Toxoplasma hijacks the host organelles and 
cytoskeleton as the MJ migrates towards the posterior end of the parasite to form a 
parasitophorous vacuole (PV) border. T. gondii then utilises their actin-myosin motor 
supported by the IMC, to actively penetrate and become internalised within host cells.  
At this stage, ROPs are secreted into the PV including ROP1, ROP4, ROP16 and 
ROP18 which signals the end of early stage invasion (Butcher et al., 2011; Carey et 
al., 2004; Carruthers and Sibley, 1997; El Hajj et al., 2007).  
Within the PV, GRAs are secreted to modify the structural environment and the PV 
membrane acts as a sieve for the diffusion of host small molecules, regulated by GRAs 
17 and 23 (Gold et al., 2015). Within the PV, GRAs 2, 4 and 6 form the intervacuolar 
membrane (IVM) which is thought to provide a supporting scaffold for the PV and 
partake in nutrient trafficking (Labruyere et al., 1999; Mercier and Cesbron-Delauw, 
2015). GRA7 is reported to be phosphorylated upon invasion of host cells and 
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associates with ROPs 2 and 4, and is thought to stabilise the PV (Clough and Frickel, 
2017; Dunn et al., 2008). Other GRAs are reported within the PV and IVN however 
the role of these are not well understood. 
Under the protection of the PV, T. gondii replicate by a process of internal budding to 
create two daughter cells (Goldman et al., 1958). Here the IMC plays an additional 
role in cell division, and an enrichment of IMC3 can be observed in daughter 
complexes (Gubbels et al., 2004; Morrissette and Sibley, 2002). The expression of 
IMC genes is coordinated and coincides with T. gondii budding (IMC1, 3-6, 8-11, 13 
and 15) however IMC 7 and 12 have the opposite expression, and IMC14 exhibits a 1 
hour lag (Anderson-white et al., 2012). Consequentially, a subset of IMCs have been 
attributed to each stage of replication (Anderson-white et al., 2012). Repeated cycles 
of parasite division form clusters of rosettes within host cells that eventually become 
overloaded and burst to release parasites back into the intestinal lumen (Gregg et al., 
2013).  
1.12 Manipulation of Host Cell Responses by T. gondii 
As Toxoplasma is an obligate intracellular parasite, the success of host cell invasion is 
crucial for parasite survival and subsequent dissemination throughout the host. The 
successful infection of host immune cells poses a challenge to the parasite as these 
host cells possess antimicrobial machinery. To ensure survival, Toxoplasma must 
manipulate host cell signalling and immune response to evade immunity.  
Host immunity is stimulated by pathogen-associated molecular patterns (PAMPs) that 
stimulate host pattern receptors such as TLRs. The activation of TLR (except TLR3) 
initiates intracellular signalling cascades via the common adapter myeloid 
differentiation factor 88 (MyD88). During Toxoplasma infection in MyD88 deficient 
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mice, IL-12 and IFN-γ response is impaired, suggesting that TLRs are important for 
the correct recognition of Toxoplasma and initiation of host immune response.  
Our understanding of how the parasite manipulates host cells is still only partially 
understood, however a few processes have been described. Upon infection, 
Toxoplasma is known to block apoptotic processes, disrupt host cell transcription 
factors including signal transducer and activator of transcription 1 (STAT1) and NF-
κB, which in turn inhibits the production of IL-12 and TNF-α. 
STAT family proteins induce a broad range transcriptional program and are modulated 
differently according to the parasite clonal lineage. All strains appear to inhibit the 
dissociation of STAT1 from nuclear DNA to prevent future-reactivation of host cell 
response (Rosowski et al., 2014). During normal STAT1 activation, STAT1 undergoes 
nuclear cytoplasmic cycling. Following DNA binding and activation, STAT1 is 
dissociated with nuclear DNA, dephosphorylated and exported back into the 
cytoplasm where it can be re-activated to induce downstream responses to host cell 
infection. Other STAT members STAT3 and STAT6 must also undergo cycling of 
DNA to fulfil their full transcriptional functions. During infection, the ablation of a 
STAT1 response is thought to benefit parasite survival as STAT1-/- mice show 
enhanced susceptibility to infection (Rothfuchs et al., 2006).  
In contrast to STAT1 activation, host cell STAT3 and STAT6 activation is regulated 
by Toxoplasma ROP16 in a strain-specific manner. During host cell invasion, 
Toxoplasma ROP16 is injected into the host cell cytosol, and localises to the host cell 
nucleus where it can modulate host cell signalling pathways and suppress macrophage 
pro-inflammatory responses (IL-12 production). Types I and III strains of Toxoplasma 
are potent activators of STAT3, whereas type II strains are incapable of sustaining 
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activation. Deletion of ROP16 converts type I parasites into high inducers of IL-12p40 
and eliminates the parasite’s ability to block nitric oxide production. Interestingly, 
ROP16-/- parasites exhibited increased replicative behaviour both in vivo and in vitro, 
which is attributed to STAT6-mediated activation of arginase-1, an essential amino 
acid nutrient required for parasite survival and for host cell production of nitric oxide 
(Butcher et al., 2011; Laliberte and Carruthers, 2008; Ong et al., 2010).  
Toxoplasma ROP16 modulation of IL-12p40 is significant for parasite survival, as the 
IL-12 IFN-γ pathway has repeatedly been demonstrated to play a critical role in control 
of Toxoplasma infections. The recognition of parasite factors via TLRs activates the 
NF-κB pathway to induce IL-12 production by dendritic cells and macrophages 
(Dupont et al., 2013). IL-12 in turn activates the production of IFN-γ by T cells and 
natural killer (NK) cells (Dupont et al., 2013). Mice lacking IFN-γ, the IFN-γ receptor 
of IL-12p40 show enhanced susceptibility to infection (Jankovic et al., 2002; 
Rothfuchs et al., 2006).   
NF-κB is an important part of host response to T. gondii, and is one of the key pathways 
modulated following invasion. Again, there are differences in the way each clonal 
lineage of T. gondii manipulates the host response. Type II strains drive translocation 
of NF-κB to the nuclei of myeloid cells, resulting in the secretion of high levels of IL-
12, whereas type I strains inhibit NF-κB pathway translocation (Rosowski et al., 2011). 
In type II parasites, the dense granule protein 15 (GRA15) is responsible for driving 
NF-κB translocation (Rosowski et al., 2011), whereas the type I allele of the rhoptry 
protein (ROP18) inhibits the NF-κB pathway (Du et al., 2014). 
 Chapter 1 – General Introduction  P a g e  | 59 
Clearly, the modulation of host cell response to infection is variable across parasite 
lineages, and understanding these processes are critical to identifying mechanisms to 
tackle infections in the future.  
1.13. Interactions between Toxoplasma gondii and the Intestinal Epithelium 
Following oral ingestion, Toxoplasma traverses the intestinal epithelium to 
disseminate deep into host tissues reaching immunologically privileged sites to cause 
severe pathology. Several known interactions occur during invasion; disruption of 
tight junctions, host cell cytokine production, and release of Paneth cell defensins. 
However, our knowledge of the specific molecular pathways governing the interaction 
between T. gondii and the intestinal epithelium are still extremely limited. 
1.13.1 Disruption of Intercellular Tight Junctions 
During early stage invasion, Toxoplasma concentrate at intercellular junctions and 
potentially exploit a paracellular route of migration to traverse the intestinal 
epithelium. Further work dissecting the mechanisms underlying transepithelial 
migration have identified a crucial interaction of Toxoplasma MIC2 with host cell 
intercellular adhesion molecule 1 (ICAM-1) which is up-regulated during infection 
(Barragan et al., 2005). Infection of Madin Darby Canine Kidney monolayers by type 
I RH strain tachyzoites for 6 hours report that migration can occur without disrupting 
the epithelial barrier integrity (Barragan et al., 2005), however live cell imaging of 
YFP-expressing RH bradyzoite infection of rodent intestinal epithelial cells 
demonstrate a disruption to the tight junctional complex component, occludin (Weight 
et al., 2015). Here, infection altered the distribution of occludin which led to  fractured 
tight junctional complexes and observable occludin within the host cell cytosol 
(Weight et al., 2015). This finding is in agreement with a more recent study of CaCo2 
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monolayers infected by RH-derived 2F1 strain for 24 hours, which induced co-
localisation of tight junction proteins occludin and zonula-occludens 1 (ZO-1) which 
manifested as a discontinuous pattern and resulted in decrease transepithelial electrical 
resistance (TEER) (Briceño et al., 2016). Importantly, the parasite counterpart in this 
interaction is not yet known.  
In response to stimulation, the intestinal epithelium releases mediators to attract and 
activate immune cells. In vitro, enterocyte cell lines respond to Toxoplasma infection 
by release of CCL2 (MCP-1), CXCL2 (MIP-2) and CXCL10 (IP-10) (Mennechet et 
al., 2002). Co-incubation of enterocytes with primed intraepithelial lamina propria 
CD4+ T cells enhances this response by producing CCL5 (RANTES), CCL2, CCL7 
(MCP-3) and CXCL10 following Toxoplasma infection (Mennechet et al., 2002). In 
vivo, 8-day orally infected mice show significantly up-regulated expressed of CCL2, 
CCL3, CCL5, CXCL2, CXCL9 and CXCL10 in the small intestine (Gopal et al., 2011; 
Mennechet et al., 2002). Receptors for some of these chemokines (for example CCL2 
and CCL5) have been shown to play important host protective roles in T. gondii 
infection through induction of appropriate immune responses. Understanding what 
drives production of these chemokines in the intestinal epithelium following T. gondii 
infection, what other signals the epithelium may transmit to the immune system, and 
whether the parasite can manipulate these pathways, may allow for the design of novel 
adjuvants or therapeutics. 
1.13.2. TLR-9 Mediated Release of Paneth Cell Defensins 
Oral infection with T. gondii stimulates IFN-β production via TLR9, resulting in the 
release of α-defensins. In vitro studies have shown that both α- and β-defensins can 
reduce the infectivity of T. gondii, though the precise mechanism remains unclear. 
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Additionally, α-defensin production may be linked to the production of host-protective 
chemokines by the intestinal epithelium. Interestingly, Type I strains may be capable 
of down-modulating the production of host β-defensins to enhance invasion and 
survival, though the parasite effector proteins mediating these effects remain to be 
identified. 
Here, it is evident that many aspects of the intestinal epithelial response to T. gondii 
are poorly understood. The generation of a suitable model could facilitate the progress 
within this field of study by identifying key host-pathogen interactions. These findings 
also re-iterate the importance of generating a suitable model that retains an apically 
polarised phenotype to mimic the in vivo mechanisms of infection. 
 
1.14 The Need for Proteomic Studies of Host-Pathogen Interactions  
Generally, the observations reported about Toxoplasma invasion have been largely 
discovered using reductionist and hypothesis-driven experimental design. However 
recent developments in the field of genome sequencing, transcriptomic and proteomic 
approaches will be crucial for identifying the host-pathogen interactions during 
infection. Unlike traditional studies, systems biology gather experimental data in a 
hypothesis-generating approach through assessment of whole complex systems. 
Currently, Toxoplasma host-pathogen interactions has relied heavily on transcriptomic 
approaches, however the relationship between transcripts and their respective protein 
abundance is not clear. It has been estimated that only approximately half of transcripts 
detected by transcriptomic approaches correlate with a significant change in protein 
abundance (Ghazalpour et al., 2011). Unsurprisingly, studying the proteome changes 
during Toxoplasma infection has reported additional findings not observed using 
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transcriptomic, microarray or serial analysis of gene expression (SAGE) techniques 
(Xia et al., 2008). Thus the use of proteomic systems biology approaches may be 
favoured over microarray or transcriptomic technologies to identify key mechanisms 
for further study. 
Proteomic techniques have been used to compare parasites of different developmental 
stages (Z. X. Wang et al., 2017) and parasite strains of clonal lineages (Zhou et al., 
2017) to elucidate some of the underpinning parasite biology that is important for 
understanding the mechanisms of parasite growth and replication. However, one of the 
current limitations of utilizing proteomic approaches for the purposes of studying host 
cell responses to early stage infection is a lack of appropriate intestinal model. Existing 
cell line models, as discussed previously, can’t recapitulate the host cell responses of 
the in vivo epithelium which makes them an unsuitable model. Studies have utilised 
cell lines to study infections, but generally these experiments require almost 100% 
parasitisation to compensate for the signal-to-noise ratio of uninfected cells (Al-
Bajalan et al., 2017; Guiton et al., 2017). From a physiological standpoint, these 
models do not represent a natural infection where parasites form small, discrete foci 
of infection in relatively low abundance (Coombes et al., 2013). Thus the findings 
performed in cells lines in vitro with high parasitic loads are likely to be not 
comparable to the in vivo progression of infection. For these reasons, there is a demand 
for the establishment and optimisation of an in vitro alternative for study of these 
events in order to identify targets for the development of novel therapeutics. 
1.15 Research Aims and Objectives 
A lack of suitable in vitro model and the identification of LGR5+ stem cells has driven 
the establishment of stem-cell derived 3D intestinal models. However limitations with 
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accessing the luminal space in organoid cultures poses challenges for studying host-
pathogen interactions within this model. For this reason, this doctoral project aims to 
evaluate the use of organoid cultures as a model for intestinal biology, and to optimise 
organoid models specifically for the study of enteric pathogens using the successful 
protozoan parasite T. gondii to validate the model. The project can be separated into 
three separate aims as described below. 
Aim number 1: Generate organoid models enriched for particular epithelial cell types, 
and validate their use as a potential novel infection model using mass spectrometry-
based label-free quantitative proteomics 
Objectives:  
a) Demonstrate that organoids are amenable to manipulation to drug skewing to 
generate high purity cultures with a major dominating intestinal epithelial cell 
type and confirm changes with confocal and imaging 
b) Validate the changes observed via mass spectrometry by comparing proteomic 
profiles of each high purity culture with known markers of differentiated cell 
types within the intestinal epithelium 
c) Identify novel proteins belonging to specific differentiated intestinal epithelial 
cell types 
Aim number 2:  Modify existing organoid culture protocols to develop a semi-
monolayer model with an accessible luminal surface for the application of parasites 
Objectives: 
a) Establish a culture protocol to generate organoids with an open luminal surface  
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b) Characterise the differentiation status, polarisation and integrity of the semi-
monolayer model using confocal microscopy and proteomic approaches 
Aim number 3: Using T. gondii as a model pathogen, optimize methods for the 
infection of collagen-supported epithelial sheets, and study the host response to 
infection using mass spectrometry-based label-free quantitative proteomics 
Objectives: 
a) Perform pilot infections with T. gondii to provide proof-of-concept evidence 
to support the use of the modified model as a tool to study host-pathogen 
infections 
b) Quantify infection with T. gondii via confocal imaging and determine time 
points for proteomic experiments 
c) Evaluate host response to two strains of T. gondii at early stage invasion and 
during parasite replication via mass spectrometry-based label-free quantitative 
proteomics 
Together, these aims will examine the feasibility of utilising organoids for infection, 
and will explore the use of these models to study basic host-pathogen interactions 
within the small intestinal epithelium. 
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Chapter 2 – Materials and Methods 
2.1 Murine Small Intestinal Organoid Culture  
All mice used within this study were maintained in accordance with the Animals 
Scientific Procedures Act 1986 (ASPA) under the PPL of “cull for tissue”. 
Drug skew treatments of organoid cultures described in chapter 3 was performed by 
Zoe Matthews in University of East Anglia using PGK-Cre on C57/BL6 background 
with no Cre activation i.e. wild type C57/BL6 mice. 
With the exception of the work mentioned above, throughout this study unless 
otherwise stated, female specific-pathogen free, C57B1/6J strain, aged between 6-12 
weeks (Charles River, Margate, United Kingdom) were culled by cervical dislocation 
schedule 1 procedure. Dissections of mice were performed in the Biological 
Specimens Unit (BSU) of the University of Liverpool. Biological samples were 
transported to IC2 (Liverpool Science Park) for further processing in PBS on ice. 
2.1.1 Crypt Isolation and Murine Organoid Culture 
Cold PBS without Ca++ or Mg
++ (Sigma Aldrich, Dorset, United Kingdom) was used 
throughout the isolation process unless stated otherwise. Murine jejunum and ileum 
were transferred PBS where abdominal fat was carefully removed. Small intestinal 
(SI) tissues were cut longitudinally and washed thrice in PBS. SI tissues was cut into 
0.5cm2 sections and transferred to fresh PBS for transport.  
Tissue pieces were incubated in 15mL of 30mM EDTA dissociation buffer for 5 
minutes at room temperature (Table 3). SI were transferred to fresh PBS and shaken 
for approximately 15 seconds. PBS fraction was examined by light microscopy to 
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check for epithelial dissociation. Incubation in EDTA and PBS shaking was repeated 
a further 3 times to further dissociate villus to generate a crypt-rich solution (Figure 
14). Crypt solutions were filtered through a 70µm cell strainer into a falcon tube to 
remove remaining villus fragments. Crypt density was estimated by performing a 
rough count of 20µL of the filtered solution. Crypts were concentrated by 
centrifugation at 300xg for 10 minutes at 4 degrees, and re-suspended at a density of 
10 crypts/µL into Matrigel® (Corning). Matrigel® solution was plated onto pre-
warmed 48-well plates containing 9mm round coverslips in 30µL domes and allowed 
to polymerise for 30 minutes at 37oC and 5% CO2. 
 
Figure 14) Dissociation of small intestinal tissues remove mucus, villus and eventually crypt 
units 
During the first two cycles of 30mM EDTA incubation, the luminal debris, mucus contents 
and large villus structures are dissociated from small intestinal tissues. Within the third cycle 
of EDTA incubation, crypt columnar units begin to dissociate from the base of the villus as 
clumps that resemble a “crypt skirt”. Small intestinal crypts are identifiable by their elongated 
shape and the presence of granular Paneth cells. By the fourth round of dissociation, crypt 
columnar units are removed singularly to generate a crypt rich fraction which can be 
concentrated and embedded into Matrigel® for culture. Scale bars = 100µm 
 
Complete organoid media was prepared according to published protocol (Sato et al., 
2009), however the media was unusually yellow in colour and was unable to sustain 
organoid growth during initial attempts (Table 3).  To address this, I tested the addition 
of either NAC or HEPES to correct the pH of the medium. As a result, I found that the 
addition of HEPES to a final concentration of 0.1M was suitable for organoid culture 
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and was thus added to the media each time. Complete media changes were performed 
every 4 days (Sato et al., 2009). 
Table 3. Recipes of buffers and medium required for establishing murine 
organoids 
 
Volume 
Stock 
concentration 
Final 
concentration 
EDTA Dissociation Buffer 
0.5M EDTA (Corning, 
ThermoFisher) 
900µL 0.5M 30mM 
PBS 14.1mL - - 
Complete Organoid Media (per 1mL) 
Advanced Reduced Serum 
Dulbecco’s Modified Eagle 
Medium (Gibco™, 
ThermoFisher)  
 - - 
Human R-Spondin 1 
(PeproTech) 
5 or 10µL* 100µg/mL 
1µg/mL but 
reduced to 
500ng/mL after 
first passage* 
Murine Noggin (PeproTech) 10µL 10µg/mL 100ng/mL 
Human EGF (PeproTech) 10µL 5µg/mL 50ng/mL 
B27 Supplement (Gibco™, 
ThermoFisher) 
20µL 50X 1X 
N2 Supplement (Gibco™, 
ThermoFisher) 
10µL 100X 1X 
Penicillin/Streptomicin 
(Sigma) 
10µL - 1% 
N-Acetyl L-Cysteine (NAC)+ 
Included in the original recipe 
but was later replaced with 
HEPES+ 
10µL 100mM 1mM 
HEPES (Sigma) 10µL 1M 10mM 
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2.1.2 Organoid Passage 
At days 7-9 of culture, established organoids were routinely passaged by mechanical 
disruption. Organoid media was removed via pipetting and Matrigel® domes were 
washed gently with PBS to remove residual media. Matrigel® domes were disrupted 
by repeated pipetting with 500µL of cold PBS (using a P1000 pipette) and transferred 
to a fresh tube. Organoid solutions were syringed through a 27G needle into a 15mL 
conical tube, and the volume was topped to 10mL with cold PBS. Fragmented 
organoid cultures were concentrated down at 300xg for 10 min at 4oC, and re-plated 
in fresh Matrigel® as described above. Generally, organoids were passaged at a 1:3 or 
1:4 ratio dependent upon density.  
2.1.3 Drug Skew Treatments of Murine Small Intestinal Organoids 
Drug skew treatments in chapter 3 were performed by Zoe Matthews at the University 
of East Anglia. Organoids were established, as above, and overlaid with drug skew 
media consisting of Dulbecco’s Modified Eagle Media (DMEM) containing 500ng/ml 
R-spondin (R&D Systems), 50ng/ml EGF (Peprotech) and 100ng/ml noggin 
(Peprotech), as described by Sato et al, 2009. Media was replaced on days 2, 5 and 7 
post-isolation to introduce 3μM CHIR99021 (Tocris) and 10μM DAPT (Tocris) for 
Paneth cell; 2μM IWP-2 (Tocris) and 10μM DAPT for goblet and enteroendocrine 
cells (Yin et al., 2013). Drug skewed organoids were not passaged, but were fixed for 
confocal imaging or prepared for proteomics at day 8. 
2.2 Establishment of Epithelial Sheet Cultures on Collagen Gels 
For the development of organoid models on collagen gels, murine organoids were first 
established in Matrigel®. At day 7 organoids were fragmented and passaged onto 
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either bovine (type I) or rat tail (type I) collagen gel domes in 48-well tissue cultures 
plates containing sterile 9mm coverslips. Collagen gels were prepared as described 
below. 
2.2.1 Preparation of Collagen Gels 
Type 1 bovine collagen gels were prepared to a final concentration of 1.5mg and 
2mg/mL using a modified version of a previously described protocol (Sixt and 
Lämmermann, 2011) (Table 4). Briefly, 7.5% sodium bicarbonate solution (NaHCO3, 
sterile-filtered) (Sigma Aldrich, Dorset, United Kingdom) and sterile water were 
added to 10X Minimal Essential Medium (Eagle) (MEM) with Earle’s salts, without, 
L-glutamine and sodium bicarbonate (Sigma Aldrich) and thoroughly mixed. 
Purecol® (3mg/mL) (Advanced Biomatrix, San Diego, USA) was added to the 
MEM/sodium bicarbonate solution and pH strips were used to test pH levels of the gel 
solution. 
Table 4) Recipes for 10 wells of either 1.5mg/mL or 2mg/mL bovine type I 
collagen gels 
 
Final collagen 
concentration 1.5mg/mL  
Final collagen 
concentration 2mg/mL 
10x DMEM (µL) 40.00 40.00 
Water (µL) 137.6 70.94 
7.5% NaHCO3 (µL) 22.40 22.40 
Collagen (3mg/mL) 
(µL) 
200.00 266.66 
 
Type 1 rat-tail collagen gels (Life Technologies, Warrington, United Kingdom) were 
prepared following manufacturer’s instructions to a final concentration of 1.5mg/mL 
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and 2mg/mL using the volumes below (Table 5). NaOH and water was added to 10X 
MEM and pipetted carefully to ensure thorough mixing. Rat tail collagen (3mg/mL) 
was added to the MEM solution and pH strips were used to test pH levels. 
Table 5) Recipes for 10 wells of either 1.5mg/mL or 2mg/mL rat tail type I 
collagen gels 
 
Final collagen 
concentration 1.5mg/mL  
Final collagen 
concentration 2mg/mL 
10x DMEM (µL) 40.00 40.00 
Water (µL) 190.00 123.33 
1M NaOH (µL) 10.00 10.00 
Collagen (3mg/mL) 
(µL) 
200.00 266.66 
 
Both types of collagen gels were formed by pipetting 30µL of mixture into 48-well 
plates onto 9mm coverslips followed by incubation at 37oC and 5% CO2 for a 
minimum of 30 min to allow for gel polymerisation. 
2.2.2 Seeding Organoid Fragments onto Collagen Gels 
Day 7 murine organoid cultures were fragmented through pipetting and syringing, 
concentrated down and re-suspended in PBS. Fragment solutions were then overlaid 
onto polymerised collagen gels. Success in the initial attempts to culture monolayers 
were limited by the poor adherence of organoid fragments onto the collagen gels which 
were due to two reasons; the shape of the dome causing fragments to slip off resulting 
in a pool of fragments not adhered to the collagen, and the incubation time of fragments 
to allow adherence without drying the cells out which led to poor viability of cells.  
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To address this issue, subsequent collagen gels were pipetted as previously, however 
they were smoothed out using a P200 pipette tip in order to generate a flatter surface 
to prevent organoid fragments from sliding off the gel and pooling around the base of 
the dome. This in turn allowed for more organoid fragments to be associated with the 
collagen gels.  
To access the duration of incubation for adherence to the collagen gel, I aimed to 
identify a balance between feasibly applying the fragments in a small volume, without 
the samples drying out too quickly. Two volumes of PBS containing fragments were 
attempted and evaluated (5µL and 10µL) along with two types of pipette tips; small 
bore (1-10µL tip) and medium bore (10-200µL tips).  
Here, I determined that using 1-10µL tips were unsuitable for re-plating organoids as 
the bore of the tip was too narrow to allow the organoid fragments to be dispensed 
without touching/compromising the surface of the gel. Comparatively, using the larger 
tip, I could pipette the organoid fragments above the gel and allow gravity to pull the 
suspension downwards onto the collagen gel without damaging it. Similarly, using the 
larger volume of 10µL was beneficial as the large volume allowed for more coverage 
of the collagen gel, whereas re-plating using 5µL volume yielded fragments 
concentrated in one region of the gel. For this reason, subsequent monolayer 
establishment was performed using organoid fragments re-suspending in 10µL PBS, 
and pipetted using 10-200µL tips. 
Organoids incubated for 15 minutes in 37oC and 5% CO2 and complete media was 
added to cultures for 8 days, with a. complete media change on day 4. 
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2.3 Toxoplasma gondii Culture 
Two clonal strains of T. gondii are used within this thesis; RH strain (type I, virulent) 
and Veg strain (type III, avirulent). Both strains of T. gondii were cultured in 
immortalised adherent Vero cells derived from African green monkey kidney 
epithelial cells.  
Vero and T. gondii RH and Veg were cultured in T-25 vent-lidded flasks with basal 
media Dulbecco’s Modified Eagle’s Medium with high glucose supplemented with 
5% foetal bovine serum and 1% Penicillin/Streptomycin, and incubated at 37oC in a 
5% CO2 atmosphere. 
2.3.1 Vero Cell Culture 
Confluent Vero cells were sub-cultured every 7 days. Cell supernatant was discarded, 
and cell monolayer as rinsed thrice with 3mL PBS to remove residual serum that 
inhibits trypsin function. To detach cells from the flask, 1mL of Trypsin-EDTA 
(Gibco) was added and cells were incubated for 5 min at 37oC in a 5% CO2. Progression 
of detachment was examined by light microscopy and cells were re-incubated for a 
further 5 min if required. To neutralise trypsin activity, 4mL of complete media was 
added to cells and 10µL of cell suspension was added to 10µL of trypan blue 
(Thermofisher) for counting using a Neubauer chamber. New flasks were seeded at 4 
x 105 cells/flask. 
2.3.2 Toxoplasma gondii Culture 
Following an overnight incubation, culture medium was replaced on Vero cells, and a 
cryovial of frozen parasite tachyzoites were added. Infected Vero cell cultures were 
examined daily using an inverted light microscope to monitor parasite growth. Within 
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approximately 5-7 days, 75% of Vero cells were infected with regions of parasites 
egress observed. At this point, 10µL of supernatant was taken to count parasites within 
the culture. To maintain parasite cultures, T. gondii RH and Veg were passaged onto 
new flasks at 3 x 103 and 1 x 104 per flask respectively. Parasite passage was routinely 
performed every 7 days, onto 24 hour incubated 14 cells. 
2.3.3 Parasite Purification from Vero Cells 
For infection assays, parasites were grown until over 75% of Vero cells were infected 
and parasites were beginning to egress. Infected veros were removed from flasks using 
a cell scraper and transferred to a 50mL conical tube. Parasites were concentrated 
down at 400xg for 10 min and cell pellet was re-suspended in 10mL of PBS. The cell 
suspension was syringed thrice with a blunt ended needle to disrupt Vero cell structure 
and release intracellular tachyzoites. The cell and parasite suspension was 
concentrated down again at 400xg for 10 min and the cell pellet was re-suspended in 
5mL of PBS.  
A PD-10 desalting column (GE HealthCare Life Sciences, Buckinghamshire, United 
Kingdom) was equilibrated by releasing and discarding the storage fluid. The column 
was then washed twice with 5mL PBS, and the flow through discarded. The parasite 
cell suspension was added to the column, collecting the flow through. An additional 
5mL of PBS was added to flush the column. Parasite counts were then performed on 
10µL of PBS, the desired number of parasites were concentrated down by 
centrifugation and re-suspended in complete organoid media. 
 
 Chapter 2 – Materials and Methods  P a g e  | 74 
2.4 Toxoplasma gondii Infection Assay 
Media was removed from day 7 collagen-supported epithelial sheets, and media 
containing parasites was applied directly onto cultures, then incubated at 37oC and 5% 
CO2.  
For initial infections, epithelial sheets were allowed to incubate with parasites for set 
time periods and samples were fixed with 4% PFA (Life Technologies) in PBS for 60 
minutes at room temperature. 
For optimisation of the infection protocol, we introduced centrifugation following 
exposure to parasites. Infected monolayer cultures were either not centrifuged, or 
centrifuged (at 100xg for 1 min) prior to incubation. Cultures were fixed and stained 
for confocal imaging. 
To assess the role of mucus during the initial stages of infection, we introduced a pre-
treatment with a mucolytic N-Acetyl L-Cysteine (NAC) (Sigma Aldrich). At day 7, 
media was replaced with organoid media containing 0mM, 2mM, 5mM or 10mM 
NAC, and sheets were incubated for 60 minutes. Mucolytic media was removed after 
incubation and replaced with complete media containing T. gondii tachyzoites. 
Samples were fixed for confocal imaging. For each infection within this thesis, a non-
infected control was also prepared for comparison. 
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2.5 Antibody Staining and Confocal Imaging 
For chapters 4 and 5, all staining of organoid and epithelial sheet samples were 
performed on 9mm coverslips in 48-well plates. Organoids samples used in chapters 
4 and 5 were fixed with 4% paraformaldehyde (PFA) in PBS for 60 minutes at room 
temperature. All staining steps were performed on a rocker. 
To stain epithelial sheets, samples were washed thrice with washing buffer; PBS with 
1% donkey serum and 0.1% Triton X-100. Samples were incubated for 1 hour at room 
temperature in blocking buffer. Primary antibodies were made up in blocking buffer; 
PBS with 10% donkey serum and 1% Triton X-100, and incubated on epithelial sheets 
for 1 hour at room temperature. Epithelial sheets were then washed thrice with washing 
buffer. Secondary antibodies, epithelial stains and DAPI were made up in washing 
buffer, and incubated on epithelial sheets for 2 hours at room temperature. Epithelial 
sheets were washed thrice in PBS and extracted from 48-well plates on coverslips.  
To stain 3D organoids, samples were washed for 2 hours with washing buffer at room 
temperature, with buffer changed every 20 min. Organoid samples were incubated 
with blocking buffer for 4 hour, then primary antibodies were incubated in blocking 
buffer overnight at 4oC. Samples were washed thrice with washing buffer, and 
secondary antibodies, epithelial stains and DAPI were incubated for 2 hours at room 
temperature. Organoid samples were washed thrice in PBS and extracted from 48-well 
plates on coverslips. 
To prevent damaging epithelial sheets and organoid samples during mounting, 7mm 
diameter O-rings were attached to glass slides using rubber adhesive (Halfords). 
Hydromount (Scientific Laboratory Supplies, Nottingham, United Kingdom) was 
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pipetted into O-rings, and the sample was inverted onto the Hydromount solution for 
preservation. Stained samples were stored in the dark at 4oC until confocal imaging.  
For characterisation of collagen sheets, organoids and epithelial sheets were stained 
with phalloidin, and a combination of either lysozyme or mucin-2 (Table 6).  
To visualise tight junctions, epithelial sheets were stained with e-cadherin, CD326 
EpCam or ZO-1 (Table 6). For infections, epithelial sheets were stained with 
phalloidin and anti-SAG1 (Table 6).  
Secondary antibodies used were either donkey anti-mouse Alexa Fluor 488 (AbCam, 
Cambridge, United Kingdom), donkey anti-rabbit FITC (Stratech Scientific Ltd, 
Suffolk, United Kingdom), or donkey anti-rabbit TRITC (Stratech). All samples were 
stained with DAPI for nuclear visualisation.  
All images reported in chapters 4 and 5 were acquired in the Centre for Cell Imaging 
within the Institute of Integrative Biology, University of Liverpool. Confocal images 
were acquired using Zen Black software (Zeiss) on a Zeiss LSM880 upright confocal 
microscope with laser lines Diode (405), Argon (488), DPSS-5610 (561) and HeNe633 
(633) and W-Plan Apochromat 40x/1.0 Dic (water immersion) objective (Zeiss) or 
Plan-Apochromat 63x/1.0 oil DIC M27 (oil immersion) objective (Zeiss) lenses. 
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Table 6) Antibodies and stains used for confocal imaging in chapters 4 and 5. 
Product Host Manufacturer Target 
Stains 
Phalloidin conjugated to 
rhodamine 
N/A Life Technologies F-actin 
Phalloidin conjugated to 
AF647 
N/A Life Technologies F-actin 
DAPI N/A Life Technologies Nucleus 
Primary Antibody 
Chromogranin A 
 
Rabbit Insight Biotechnology 
Enteroendocrine 
Cells 
E-cadherin (24E10) Rabbit 
BD Transduction 
Laboratories 
Tight Junctions 
Epithelial Cell Adhesion 
Molecule (CD326 
EpCam) 
Mouse 
Affymetrix 
eBiosciences 
Tight Junctions 
GRA7 Rabbit 
Gift from David 
Sibley (Washington 
University) 
Dense Granule 7 of 
T. gondii 
Lysozyme 
(BGN/06/961) 
Mouse AbCam 
Lysozyme  
(Paneth cells) 
Mucin-2 (H-300) Rabbit Insight Biotechnology 
Mucin 2  
(goblet cells) 
SAG-1 (TP3) Mouse Abcam 
Surface antigen 
protein of T. gondii 
Zonular Occludens 1 
(ZO-1) 
Rabbit Abcam 
Tight junction 
Protein 
Secondary Antibody 
Anti-rabbit TRITC Donkey Stratech Scientific Ltd N/A 
Anti-rabbit FITC Donkey Stratech Scientific Ltd N/A 
Anti-mouse AF488 Donkey AbCam N/A 
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2.6 Quantification of Confocal Images using Imaris 
All images quantified for characterisation and infection were processed using Imaris 
x64 v9.0.1 image analysis software (BitPlane). In all cases, automated cell counting 
was manually checked for accuracy of quantification. 
In chapter 4, total cell numbers and numbers of differentiated cells were acquired using 
the “spots” function on Imaris (Figure 15). The “spots” function on Imaris detects 
fluorescent signals from any chosen source channel and assigns a spot which can be 
automatically quantified within the software. To calculate the total number of cells 
within an image, the spots function was used to quantify nuclear staining by detecting 
DAPI fluorescence. Using the default settings (minimum diameter: 4.15µm), followed 
by manually adjusting the detection threshold, it was possible to generate an overlay 
of “spots” that was representative of the cells within the image (Figure 15 B).  
The detection of differentiated cells was also quantified using the “spot” function by 
detection of mucin-2 (goblet cell marker) via FITC fluorescence (Figure 15 C) or 
lysozyme (Paneth cell marker) via AF488 fluorescence. All “spots” were manually 
checked for accuracy of the fluorescent detection and edited as appropriate. The 
number of goblet and Paneth cell populations within our monolayer culture was 
calculated as a proportion of the total number of cells available within the field of view.  
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Figure 15) Quantification of differentiated cell markers using “spots” on Imaris 
Confocal images acquired to check the differentiation status of epithelial sheets were quantified using Imaris image analysis software. (A) Whole 
epithelial sheets were overlaid with “spots” against DAPI fluorescence for total cell quantification (B), FITC for goblet cell quantification (C). 
Image C depicts the accuracy at which “spots” functions can identify fluorescence, and demonstrates the need for manual adjustment of “spots” to 
improve accuracy of quantification. Scale bars = 30µm.   
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Due to their 3D conformation, the “spots” function was not as easily applied to 
Matrigel®-grown organoids. For this reason, quantification of goblet and Paneth cells 
was performed on a single z-stack slices using the same methods as described above. 
Quartile and median slices of any given organoid were used for quantification, and an 
average of the three slices were taken. 
In chapter 5, infected samples were quantified using both “spots” and “surfaces” 
functions in Imaris. As described, total cell counts were obtained against DAPI 
fluorescent channel detection, and total Toxoplasma counts were obtained against 
AF488 fluorescent channel detection with a maximum diameter of 6µm (Figure 16 A-
C). Next, to distinguish between intra- and extra-cellular parasites within the image, 
the “surfaces” function was utilised to generate an iso-surface of the F-actin epithelial 
stain (Figure 16 D). Within this surface, it was possible to detect overlapping AF488 
fluorescence of intra-cellular parasites and generate a duplicated channel which was 
allocated the colour yellow (Figure 16 E). Using this newly generated channel, “spots” 
were then used to quantify the number of intracellular parasites.  
In all cases, the automated “spots” were manually checked for accuracy. In some 
circumstances, the duplicated channel of intra-cellular parasites was not 100% precise, 
and so the “ortho-slice” function was used to examine the distribution of parasites that 
were identified along the edges of the surface. Using the counts obtained for total cell 
number, total parasite number and intracellular parasite number, the infection and 
invasion rates were calculated. 
. 
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Figure 16) Quantification of parasite infection and invasion of epithelial sheets using "spots" and "surfaces" on Imaris 
(A) Confocal images of infected epithelial sheets were analysed via a combination of “spots” against (B) DAPI for total cell counts and (C) T. 
gondii by SAG-1 staining via AF488 fluorescence for parasite counts. (D) An “isosurface” was generated to match the F-actin staining, which was 
then used to mask intracellular parasites, and generate a duplicated channel of fluorescence (E) to identify parasites within the epithelial sheet. 
Scale bars = 30 µm
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2.7 Sample Preparation for Mass Spectrometry 
2.7.1 Matrigel®-Grown Organoid Sample Preparation for Proteomics  
In chapter 3, drug skewed organoids and non-treated controls were established as 
described in section 2.1.3.  At day 8, media was removed and Matrigel® domes were 
washed with PBS. Matrigel® was gently disrupted by pipetting with large bore tip. 
Samples were washed thrice with PBS by centrifugation at 300xg for 5 min. Samples 
were stored as a dry pellet at -80oC. For chapter 4, day 7 wild type organoid cultures 
were washed as described above, and stored as a dry pellet at -80oC. Three biological 
replicates of both drug skewed and wild type organoids were prepared for chapter 3 
by Zoe Matthews (UEA). 
In chapter 4, organoids were cultured until day 7 and dissociated from Matrigel® as 
described above. Three biological replicates of murine organoids were pelleted for 
proteomic comparison with collage grown epithelial sheets. 
2.7.2 Optimisation of Epithelial Sheet Purification from Collagen Gels 
In chapter 4, epithelial sheets were cultured for proteomics. Unlike Matrigel®, 
collagen gels are not easily dispersed through pipetting, so the separation of the 
epithelial sheet is more complex. Here, a protocol was established that uses 
collagenase to break the peptide bonds in the supporting collagen gel matrix, and 
release the epithelial sheets. 
Manufacturer protocols of collagenase enzymes suggest a working concentration of 
1mg/mL, however due to the sensitivity of intestinal epithelial cells several 
concentrations of collagenase were tested on collagen gels without epithelial cells first. 
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2mg/mL rat tail collagen gels were plated in 30µL domes onto coverslips, and allowed 
to polymerise for 60 min at 37oC and 5% CO2. Gels were transferred to Eppendorf 
tubes and submerged in an equal volume of either 0.1mg/mL, 0.2mg/mL, 0.5mg/mL 
or 1mg/mL type VIII collagenase from Clostridium histolytica (Sigma) and incubated 
for 30 min at 37oC.  After 15 min, the gels were gently pipetted with a large bore pipette. 
After a total incubation of 30 min, samples were checked by eye. At this point, if large 
pieces of gel were still visible by eye, then samples were re-incubated with pipetting 
every 10 min until fully dissolved. An equal volume of DMEM was added to neutralise 
collagenase enzyme activity. From this assay, it was determined that 0.1mg/mL of 
collagenase with 30 min incubation was sufficient to dissolve a 30µL dome of 2mg/mL 
rat tail collagen gel. This was then repeated with epithelial sheets to check whether the 
addition of PBS washes was sufficient to remove residual collagenase from the sample. 
Two biological replications of epithelial sheets, each with 5 wells, were grown on 
2mg/mL rat tail collagen. Media was removed and gels were washed with PBS to 
remove residual media. Gels were transferred to an Eppendorf tube and equal volumes 
of 0.1mg/mL of two different type VIII collagenases (Sigma) were added. Samples 
were incubated for 30 min at 37oC with pipetting at 15 min. Sample suspension was 
visualised by eye to confirm the dissolving of collagen gels, and media was added to 
neutralise collagenase activity. Samples were washed thrice with PBS by 
centrifugation at 300xg for 5 min each. Samples were stored at -80o and checked for 
sample degradation and thorough removal of collagenase by running on a 12% 1D gel.  
10µL of each sample were diluted in a 1:1 ratio with 2x laemmli buffer (Sigma) and 
denatured at 100oC for 10 min on a heat block. 5µL of CSL-BBL protein standard 
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(Geneflow Ltd) and 10µL of denatured samples were loaded into a 12% SDS gel 
(Table 7). 
Samples were run on the 1D gel for 50 min at 200V, 260mA and 100W using an 
electrophoresis power supply – EPS 601 (GE Healthcare). In addition to collagenase-
treated epithelial sheet samples, one aliquot of each collagenase was also included as 
controls. The gel was then stained with PageBlue Protein Staining Solution 
(ThermoFisher) to visualise protein bands.  
 
Table 7) 1D 12% mini-gel recipe for protein quality checks 
 Resolving Gel Stacking Gel 
Acrylamide/bisacrylamide 4mL 0.65mL 
4x Resolving gel buffer (1.5M Tris pH 8.8) 2.5mL --------- 
4x Stacking gel buffer (0.5M Tris pH 6.8) -------- 1.25mL 
10% SDS 50µL 50µL 
milliQH2O 3.4mL 3.025mL 
Mix first four ingredients and add the last two when ready to pipette the gel 
10% Ammonium Persulphate (100mg in 1mL) 75µL 25µL 
TEMED 7.5µL 2.5µL* 
*Increase to 5µL to reduce setting time 
 
Manufacturer product information sheets predict that the collagenase used contains at 
least 7 different proteases of varying sizes within a range of 68-130kDa. Epithelial 
sheet samples contained high molecular weight bands (Figure 17 – lanes 1 and 2) 
whereas collagenase only samples contained multiple protein bands at a variety of 
molecular weights ranging from ~30kDa to ~120kDa (Figure 17– lane 3 and 4).  
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Figure 17) Collagenase treatments at 30 min for 37oC and 5% CO2 successfully separates 
epithelial sheets from collagen gels and removal of collagenase is successful through PBS 
washing. 
Day 7 epithelial sheets were collagenase treated for 30 min at 37oC and 5% CO2. Samples were 
washed thrice in PBS and run on a 12% 1D gels. Epithelial sheet samples (lanes 1 and 2) 
contain heavy molecular weight bands, one of which is approximately 180kDa, whereas 
collagenase only samples contained multiple protein bands with varying weights. Bands found 
in collagenase only samples were absent from washed epithelial sheets, indicating the absence 
of collagenase remnants following PBS washes. 
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The absence of protein bands within the range of ~30kDa and ~120kDa in epithelial 
sheet samples indicates the successful removal of collagenase from samples during the 
PBS wash steps. Henceforth, epithelial sheet and collagen gel separation for mass 
spectrometry sample preparation was performed using 0.1mg/mL for 30 min at 37oC 
and 5% CO2, as successful removal was confirmed here. 
 
2.7.3 Protein Digest for Mass Spectrometry 
Samples in chapter 3 were prepared for proteomics by Stuart Armstrong using the 
following protocol. Buffer (50mM ammonium bicarbonate, 0.2% w/v Rapigest, 
Waters) was added to washed organoid samples before sonication using sonicating 
water-bath (Jencons) for 3 x 10 minutes on ice. Samples were then heated at 80⁰C for 
10 minutes. Protein content was determined using the Coomassie plus protein assay 
kit (Pierce) according the manufacturer’s instructions. Protein content was normalised 
between samples using 50mM ammonium bicarbonate. Protein were then reduced with 
3 mM dithiothreitol (Sigma) at 60⁰C for 10 minutes then alkylated with 9 mM 
iodoacetimde (Sigma) at room temperature for 30 minutes in the dark. Proteomic grade 
trypsin (Sigma) was added at a protein: trypsin ratio of 50:1 and samples incubated at 
37⁰C overnight. Rapigest was removed by adding TFA to a final concentration of 1% 
(v/v) and incubating at 37⁰C for 2 hours. Peptide samples were centrifuged at 12,000g 
for 60 min (4⁰C) to remove precipitated Rapigest.  
Samples used in chapters 4 and 5 were all digested using the same protocol as above 
by myself.  
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2.8 NanoLC MS ESI MS/MS Analysis 
All peptide mixtures within this thesis were run through the mass spectrometer by Dr 
Stuart Armstrong. Protein data for chapter 3 was generated using the following 
protocol. 
Peptide mixtures (2µl) were analyzed by on-line nanoflow liquid chromatography 
using the nanoACQUITY-nLC system (Waters MS technologies, Manchester, UK) 
coupled to an LTQ-Orbitrap Velos (ThermoFisher Scientific, Bremen, Germany) mass 
spectrometer equipped with the manufacturer’s nanospray ion source. The analytical 
column (nanoACQUITY UPLCTM BEH130 C18 15cm x 75µm, 1.7µm capillary 
column) was maintained at 35⁰C and a flow-rate of 300nl/min. The gradient consisted 
of 3-40% acetonitrile in 0.1% formic acid for 150 min then a ramp of 40-85% 
acetonitrile in 0.1% formic acid for 5min. Full scan MS spectra (m/z range 300-2000) 
were acquired by the Orbitrap at a resolution of 30,000. Analysis was performed in 
data dependant mode. The top 20 most intense ions from MS1 scan (full MS) were 
selected for tandem MS by collision induced dissociation (CID) and all product spectra 
were acquired in the LTQ ion trap.  
For chapters 4 and 5, peptides were analysed by on-line nanoflow LC using the 
Ultimate 3000 nano system (Dionex/Thermo Fisher Scientific). Samples were loaded 
onto a trap column (Acclaim PepMap 100, 2 cm × 75 μm inner diameter, C18, 3 μm, 
100 Å) at 5 μl min−1 with an aqueous solution containing 0.1 %( v/v) TFA and 2% 
(v/v) acetonitrile. After 3 min, the trap column was set in-line an analytical column 
(Easy-Spray PepMap® RSLC 50 cm × 75 μm inner diameter, C18, 2 μm, 100 Å) fused 
to a silica nano-electrospray emitter (Dionex).  The column was operated at a constant 
temperature of 35°C and the LC system coupled to a Q-Exactive mass spectrometer 
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(Thermo Fisher Scientific). Chromatography was performed with a buffer system 
consisting of 0.1 % formic acid (buffer A) and 80 % acetonitrile in 0.1 % formic acid 
(buffer B). The peptides were separated by a linear gradient of 3.8 – 50 % buffer B 
over 90 minutes at a flow rate of 300 nl/min. The Q-Exactive was operated in data-
dependent mode with survey scans acquired at a resolution of 70,000 at m/z 200. Up 
to the top 10 most abundant isotope patterns with charge states +2 to +5 from the 
survey scan were selected with an isolation window of 2.0Th and fragmented by higher 
energy collisional dissociation with normalized collision energies of 30. The 
maximum ion injection times for the survey scan and the MS/MS scans were 250 and 
50ms, respectively, and the ion target value was set to 1E6 for survey scans and 1E5 
for the MS/MS scans. MS/MS events were acquired at a resolution of 17,500. 
Repetitive sequencing of peptides was minimized through dynamic exclusion of the 
sequenced peptides for 20s. 
 
For all chapters, Thermo RAW files were imported into Progenesis LC–MS (version 
4.1, Nonlinear Dynamics). Runs were time aligned using default settings and using an 
auto selected run as reference. Peaks were picked by the software and filtered to 
include only peaks with a charge state of between +2 and +6. Peptide intensities were 
normalised against the reference run by Progenesis LC-MS and these intensities are 
used to highlight differences in protein expression between control and treated samples 
with supporting statistical analysis (ANOVA p-values) calculated by the Progenesis 
LC-MS software. Spectral data were transformed to .mgf files with Progenesis LC–
MS and exported for peptide identification using the Mascot (version 2.3.02, Matrix 
Science) search engine. Tandem MS data were searched against the bovine predicted 
proteome (Uniprot release 2013_09). Mascot search parameters were as follows; 
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precursor mass tolerance set to 10ppm and fragment mass tolerance set to 0.05 Da. 
One missed tryptic cleavage was permitted. Carbamidomethylation (cysteine) was set 
as a fixed modification and oxidation (methionine) set as a variable modification. 
Mascot search results were further processed using the machine learning algorithm 
Percolator. The false discovery rate was < 1%. Individual ion scores > 13 indicated 
identity or extensive homology (p < 0.05).  Protein identification results were imported 
into Progenesis LC–MS as .xml files. 
 
2.9 Protein Analysis 
2.9.1 Ingenuity Pathway Analysis® (IPA)  
Proteomics data from chapters 3 and 5 were analysed using Ingenuity Pathway 
Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity). Detected 
proteins were identified by matching mass spectrometry data against reviewed 
proteome sequences, which were downloaded from a publically accessible database 
(UniProt). Core analysis has multiple methods of putting proteomics data into context 
by summarising canonical pathways, diseases and functions, and networks of the input 
proteins.  
For chapter 3, core analysis of each dataset were performed on IPA, with the following 
exclusion criteria; minimum of one peptide used for quantification, log2 fold change > 
1 and q value < 0.05. For chapter 5, core analysis of each dataset were performed on 
IPA, with the following exclusion criteria; minimum of one peptide used for 
quantification, log2 fold change > 1 and p value < 0.05. The log2 fold change criteria 
was used here as it is widely considered as a representation of a biologically relevant 
change in terms of differential abundances in protein expression. 
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2.9.2 Protein Atlas 
In chapter 3, highly up-regulated proteins within drug skewed organoids were cross-
checked for cell distribution on The Human Protein Atlas (www.proteinatlas.org V13). 
The Human Protein Atlas is a free online database of immuno-histological and 
immunofluorescent confocal microscopy images showing the spatial distribution of 
proteins in normal and cancerous human tissues, as well as 46 different human cell 
lines. Protein localisation was investigated to identify any proteins highly up-regulated 
that were specific to one or more of the differentiated intestinal epithelial cell types.  
2.9.3 Venny 2.1 
In chapters 3 and 5, comparison of protein lists was performed on Venny 2.1 
(http://bioinfogp.cnb.csic.es/tools/venny/index.html) (Oliveros, 2007). Venny is a free 
online interactive resource that compares up to four lists and generates the appropriate 
venn diagrams for visualisation. Using this tool, the associated common and unique 
proteins found within and across samples were identified for further analysis. 
2.9.4 PANTHER GO Protein Classification 
In chapters 5, gene ontology of proteins detected in non-infected, 24 hour infected and 
deactivated parasite spiked samples were analysed using online gene classification 
system PANTHER (www.pantherdb.org) (Mi et al., 2013). Protein IDs were uploaded 
and functional classification analysis was performed. Associated molecular functions 
and biological processes data were exported and visualised graphically to compare the 
lists of proteins identified in each sample.  
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Chapter 3 – Proteomic Profiling of High Purity Drug Skewed Organoid Cultures 
 
3.1. Introduction 
The gastrointestinal tract is a major route of entry for pathogens. A lack of suitable 
intestinal models has led to the establishment of in vitro organoid models. “Mini-gut” 
organoid models recapitulate the complex 3D structure and cellular composition of the 
intestinal epithelium in vivo, and are promising tools for the study of host-pathogen 
interactions at the luminal surface. In particular, the presence of fully differentiated 
epithelial cell populations, such as Paneth or goblet cells, offers the opportunity to study 
the host-defensive properties of these particular cells. However, the natural occurrence of 
these cell types in organoid cultures are low, which when combined with the small size 
of organoid cultures, severely limits the volume of biologically relevant material for 
functional analysis. This is particularly relevant for global profiling or systems analysis, 
which require large volumes of starting material to generate sufficient depth of coverage. 
More recently, there has been growing interest in manipulating regulatory signalling 
pathways to generate “skewed” organoid cultures enriched for specific epithelial cell 
populations such as Paneth and goblet cells. Several compounds have been identified and 
tested for this purpose. Specifically DAPT, a γ-secretase inhibitor modulates Notch 
signalling to drive differentiation toward the secretory cell lineage, and in combination 
with either CHIR99021 (CHIR) or IWP-2 can drive differentiation towards Paneth cell 
or goblet/enteroendocrine phenotype respectively (Chen et al., 2009; Peignon et al., 2011; 
Yin et al., 2014).  
In terms of intestinal infection, generating organoids enriched for Paneth or goblet cells 
lends itself to investigating host defence mechanisms specific to these cell types. Paneth 
cells secrete antimicrobial peptides (AMPs) such as defensins, lysozyme and Reg3 
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proteins in response to microbial stimulation (Bevins and Salzman, 2011; Cadwell et al., 
2008; Clevers and Bevins, 2013; Elphick and Mahida, 2005; Farin et al., 2014; Fernandez 
et al., 2008; Peeters and Vantrappen, 1975; van Es and Clevers, 2014; Wilson, 1999), and 
goblet cells renew a mucus layer that physically separates invading pathogens and the 
underlying epithelial cells (Ermund et al., 2013a, 2013b; Rodriguez-Pineiro et al., 2013). 
Furthermore, goblet cells in particular have been shown to be important for the host 
immune response through the unique generation of goblet cell associated antigen 
passages (GAPs), which allow luminal antigens to be delivered to the underlying 
dendritic cells within the lamina propria (McDole et al., 20012). Disruption to the 
secreted products of either Paneth or goblet cell population alters microbial clearance, 
making both of these important for host cell defence (Ganz et al., 2003; Loonen et al., 
2014; Sommer et al., 2014). 
Disruption to Paneth cell AMPs alters host susceptibility to enteric infections. Deficiency 
of REG3γ-/- results in mucus re-distribution, increased bacterial contact with epithelial 
cells and elevated expression of inflammatory markers (Loonen et al., 2014). Deficiency 
of lysozyme-M-/- results in the development of severe pathology in response to non-
pathogenic bacterial infection in comparison to wild type mice (Ganz et al., 2003). These 
studies demonstrate the importance of AMPs for bacterial clearance. Disruption to the 
mucus barrier proteins also alters host susceptibility to enteric infections. For example, 
MUC2-/- mice are more susceptible to infection by Citrobacter rodentium (Bergstrom et 
al., 2010). The mucus barrier is highly glycosylated, and the disruption of this process in 
mice affects gut microbial ecology and alters the microbiome composition (Sommer et 
al., 2014).  
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In addition to their role in host defence, specific epithelial sub-populations are targeted 
during invasion. Salmonella enterica serovar Typhimurium inhibits Paneth cell AMP 
expression during infection (Salzman et al., 2003a). Listeria monocytogenes and 
Escherichia coli exploit goblet and microfold (M) cells (respectively) to establish 
infection (Nikitas et al., 2011; Roberts et al., 2010). Observations of colonic goblet cell 
depletion during Citrobacter rodentium infection have also been reported, indicating a 
bacterial advantage to the modulation of goblet cell function, however these mechanisms 
are not fully understood (Bergstrom et al., 2008). 
An in vitro model that contained a high proportion of a specific epithelial cell lineage 
would allow the molecular mechanisms underlying the preferential invasion or cell 
modulation of these cell types to be studied in more detail. Understanding host-pathogen 
interactions with specific cell types will allow us to identify key pathways to target for 
drug and vaccine development. 
Molecular approaches have been used to quantify changes in gene expression following 
drug-skewing of organoids, however proteomic approaches have not yet been exploited 
for this purpose (Farin et al., 2012; Koo et al., 2012; Milano et al., 2004; Vandussen et 
al., 2014; Yin et al., 2014). Due to poor correlation in mRNA levels and protein 
expression (de Sousa Abreu et al., 2009), it is vital to establish a proteome profile of these 
cultures to determine if we can detect canonical features of Paneth and goblet cells which 
can be used to study the host defence functions during infection. 
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The aim of this chapter is to establish drug skewed organoid cultures and demonstrate the 
ability to evaluate these organoids via quantitative label-free mass spectrometry. In 
collaboration with the University of East Anglia (UEA) and the Wileman Autophagy 
group, the objectives of this chapter are to:  
a) Demonstrate that organoids are amenable to manipulation with drugs to generate 
Paneth and goblet/enteroendocrine enriched cultures  
b) Identify changes in protein abundance of enriched organoid cultures via mass 
spectrometry 
c) Identify novel proteins belonging to specific differentiated intestinal epithelial cell 
types  
 
3.2 Materials and Methods 
Biological samples were cultured and imaged by Zoe Matthews (UEA), mass 
spectrometry was performed by Dr Stuart Armstrong as part of a core facility (Centre for 
Pathogen Proteomics, University of Liverpool). Analysis of mass spectrometry data using 
Ingenuity Pathway Analysis, mining of the Human Protein Atlas, and comparative 
analysis with in vivo datasets was performed by Lisa Luu (Figure 18). 
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Figure 18) Workflow for the establishment of murine drug-treated organoids 
 
To generate organoid cultures, crypt cells are isolated from the small intestine of mice and 
embedded into Matrigel®. Combinations of drugs are administered on days 2, 5 and 7 to divert 
organoids down specific differentiation pathways and generate high purity cultures. Following 
approximately 8 days, organoids are either fixed for staining and confocal imaging, or extracted 
from Matrigel®, pelleted and frozen down for mass spectrometry analysis. 
 
3.2.1 Murine Stem Cell-Derived Organoid Culture and Drug-Skew Treatment 
Murine organoids were established and drug treated by Zoe Matthews (UEA) described 
in Chapter 2.1.3. Organoids were treated with DAPT in combination with CHIR or IWP-
2, on days 2, 5 and 7 to drive differentiation toward Paneth or goblet cell lineages, 
respectively. On day 8, organoids were either fixed in ice cold methanol containing 9% 
formaldehyde at -20oC for 1 hour, or pelleted down and frozen for proteomic analysis. 
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3.2.2 Sample Preparation for Proteomics 
Organoids were stained and imaged by Zoe Matthews (UEA) to confirm the enrichment 
of drug skewed organoid cultures, and samples were then processed for mass 
spectrometry by Dr Stuart Armstrong (Core Pathogen Proteomics) as described in 
Chapter 2.7. The increased abundance of Paneth, goblet and enteroendocrine cell markers 
was not quantified via confocal microscopy, however a significant up-regulation of these 
targets were visually overwhelming and confirm an increased population of Paneth, 
goblet and enteroendocrine sub-populations within their respective enriched culture. The 
data collected via confocal microscopy is not presented here, as it forms a part of Zoe 
Matthew’s PhD thesis.  
Organoid pellets were sonicated to release proteins, protein content was determined using 
the Coomassie plus protein assay kit (Pierce). Protein content was normalised across 
samples and reduced with 3mM dithiothreitol (Sigma). Samples were alkylated with 
9mM iodoacetimide (Sigma) and then trypsinated at a ratio of 50:1 at 37⁰C overnight. 
Detergent was then removed by the addition of TFA to 1% (v/v) and peptide mixtures 
were centrifuged to remove precipitated detergent. 
3.2.3 NanoLC MS ESI MS/MS Analysis 
Peptide mixtures (2µl) were analyzed by on-line nanoflow liquid chromatography using 
the nanoACQUITY-nLC system (Waters MS technologies, Manchester, UK) coupled to 
an LTQ-Orbitrap Velos (ThermoFisher Scientific, Bremen, Germany) mass spectrometer 
equipped with the manufacturer’s nanospray ion source, and RAW data were analysed by 
Dr Stuart Armstrong as described in Chapter 2.8. 
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3.2.4 IPA® Protein Analysis 
Detected proteins were identified by matching mass spectrometry data against reviewed 
proteome sequences, which were downloaded from a publically accessible database 
(UniProt). Data were analysed through the use of QIAGEN’s Ingenuity® Pathway 
Analysis (IPA®, QIAGEN Redwood City). Core analysis of each dataset were performed 
on IPA, with the following exclusion criteria; minimum of one peptide used for 
quantification, log2 fold change < 1 and q value > 0.05, to identify enriched networks 
following treatment of each organoid culture. 
3.2.5 Functional Annotation Clustering  
Functional annotation clustering was performed on statistically significant proteins using 
online resource DAVID Bioinformatics (Da Huang et al., 2009) to determine the 
biological function of proteins found to be up- or down- regulated in goblet or Paneth 
skewed cultures. 
3.2.6 Protein Atlas  
Statistically significant differentially expressed proteins within each data set were cross-
checked for cellular location against human intestinal tissues using Protein Atlas 
(www.proteinatlas.org V13). Protein atlas is a free online database of immunohistological 
and immuno-fluorescent confocal microscopy images showing the spatial distribution of 
proteins in normal and cancerous human tissues, and 46 different human cell lines. Protein 
localisation of highly up-regulated proteins was investigated to identify cell-specific 
protein expression. Known markers of Paneth and goblet cells were used as anatomical 
references. 
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3.2.7 Comparison of Goblet Cell Proteomics with Published Mucus Component Study 
Proteomic profiles of our goblet and enteroendocrine organoid cultures were cross-
compared with a published database of mucus components to validate our findings and 
to examine whether the goblet cells within organoid cultures can correctly mimic what 
has previously been observed in mucus taken from small intestinal tissues. 
3.3 Results 
3.3.1 Mass Spectrometry Identified Unique Proteins within Each Treatment Group 
Organoids were treated with either DAPT/CHIR or DAPT/IWP-2 to generate enriched 
Paneth or goblet cell organoid cultures, respectively. Drug skew success was confirmed 
by Zoe Matthews (UEA) using confocal microscopy. Although the confocal images were 
not quantified or presented here, the confirmation of successful drug skew was observable 
in the images with a striking increased abundance of Paneth, goblet and enteroendocrine 
cell markers (from Zoe Matthews via personal communication). 
Within enriched, drug-skewed organoids, we detected 1574 proteins in Paneth-skewed 
cultures, and 1471 proteins in goblet/enteroendocrine-skewed organoid samples. To 
identify highly up- or down-regulated proteins in drug-skewed organoids relative to 
untreated controls, an exclusion criteria of; >2 unique peptides for quantification, log2 
fold change > +/- 1 and q value < 0.05 was used.  
Based on this criteria, we identified proteins with changed abundances following drug 
skew treatment. In Paneth-enriched organoids, 36 proteins had increased abundance and 
65 proteins had decreased abundance when compared to un-untreated controls (Figure 
19). In goblet/enteroendocrine-enriched cultures, 55 proteins had increased abundance 
and 153 proteins had decreased abundance compared to un-treated controls (Figure 19). 
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Figure 19) Quantitative label-free proteomics of drug-skewed organoid cultures reveals altered 
patterns of protein expression  
Organoids were treated with DAPT/CHIR or DAPT/IWP-2 to promote differentiation towards 
the Paneth and goblet cell lineages, respectively. (A) Volcano plot depicting changes in protein 
expression between control and Paneth-skewed organoids compared to non-infected controls (B) 
Top 10 proteins up- and down-regulated in Paneth-skewed organoids (C) Volcano plot depicting 
changes in protein expression between control and goblet/enteroendocrine-skewed organoids 
compared to non-infected controls. (D) Top 10 proteins up- and down-regulated in 
goblet/enteroendocrine-skewed organoids.  
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3.3.2. Proteomic Analysis of CHIR and DAPT Treated Cultures Show an Increased 
Abundance of Known Paneth Cell-Associated Protein, Matrilysin (MMP7) 
Drug skew with DAPT and CHIR skews intestinal epithelial cell differentiation along the 
Paneth cell lineage. Here, we determined if observed changes in protein abundance in 
DAPT/CHIR-treated organoids were biologically characteristic of Paneth cells.  
A known marker of Paneth cells, matrilysin (MMP7) required for the activation of Paneth 
cell defensins, was highly up-regulated in DAPT/CHIR organoids (log fold change = 
1.78, q value = 0.00093, Supplementary Table 1 Appendix A). Within these cultures, we 
also observed an increased abundance of several alpha-defensin proteins (DEFA); 
DEFA4, DEFA5, DEFA7, DEFA20, DEFA22 and DEFA24, although none of these were 
statistically significant (data not shown). 
Additionally, we observed an increased abundance of proteins associated with other 
secretory epithelial cell types including nucleobindin-2 (NUCB2 - also known as 
nesfatin-1) (log fold change = 2.43, q value = 0.00076, Supplementary Table 1 Appendix 
A), chromogranin-A (CHGA) (log fold change = 1.66, q value = 0.00000, Supplementary 
Table 1 Appendix A) and secretogranin-1 (CHGB) (log fold change = 1.35, q value = 
0.00013, Supplementary Table 1 Appendix A). MMP7 up-regulation was specific to 
DAPT/CHIR treatment (Supplementary Table 3 Appendix A), whereas NUCB2, CHGA 
and CHGB up-regulation was also observed in DAPT/IWP-2 treated organoids which is 
consistent with the shared secretory lineage of goblet, enteroendocrine and Paneth cells 
(Supplementary Table 7, Appendix A).  
In tandem with an increase in secretory proteins, a down-regulation of a known intestinal 
stem cell marker, olfactomedin-4 (OLFM4) was observed, suggesting a loss of stem cell 
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phenotype as epithelial cells are directed along the Paneth cell lineage (log fold change = 
-2.14, q value = 0.00004, Figure 19 B and D; Supplementary Table 1 Appendix A). 
Network analysis of all proteins detected indicate an enrichment of proteins associated 
with cellular development, cellular growth and proliferation (Figure 20). Of the 35 
proteins displayed in this network, 6 were significantly up-regulated (red), 7 were 
significantly down-regulated (green) and 4 were detected but changes in protein 
abundance were not statistically significant (Figure 20). Here, only MMP7 up-regulation 
was unique to DAPT/CHIR treatment, and multiple other proteins were commonly up- or 
down-regulated in DAPT/IWP-2 organoids (Supplementary Tables 7 and 8, Appendix 
A).   
To identify proteins within our dataset that may be specific to the Paneth cells lineage, 
we attempted to stain murine organoids and murine small intestinal tissues with 
antibodies against two of the highly up-regulated proteins; KIAA1324 and DNAJC3. 
However the antibodies tested were not fully validated for use against murine targets, and 
thus these attempts were unsuccessful. Due to the lack of availability of validated 
antibodies, we utilised the online tool, The Human Protein Atlas as an alternative method 
to examine protein localization within the small intestine. Here we identified Paneth cells 
as granular cells at the base of intestinal crypts, and used lysozyme (LYS) and alpha 
defensin 5 (DEFA5) staining patterns as a reference (Figure 21 A and B). Staining 
patterns of proteins increased in abundance after DAPT/CHIR drug skew was compared 
to the LYS and DEFA5 references to identify those that were restricted to, or enriched 
within Paneth cells. 
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Figure 20) Differentially-expressed proteins in DAPT/CHIR-treated samples are involved 
with cellular development, cellular growth and proliferation 
Network analysis of proteins exhibiting significant changes in protein abundance following 
treatment with DAPT/CHIR identified a protein network for cellular development, cellular 
growth and proliferation as highlighted on Ingenuity Protein Analysis software. Grey-shaded 
molecules indicate proteins that were detected within our dataset but not statistically significant, 
red-shaded molecules indicate up-regulated proteins and green-shaded molecules indicate down-
regulated proteins. This protein network displays an up-regulation in known secretory proteins 
CHGA and CHGB and an up-regulation in a Paneth cell associated protein MMP7, along with a 
down-regulation in a known intestinal stem cell marker, OLFM4. 
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Figure 21) Expression of a sub-set of up-regulated proteins in DAPT/CHIR treated organoids 
is enriched within Paneth cells of the small intestinal crypt  
Protein localisation was examined using online tool, The Human Protein Atlas. Known Paneth 
cell markers (A) DEFA5 and (B) LYS were used to identify granular Paneth cells at the base of 
small intestinal crypts as an anatomical reference. Protein expression patterns of up-regulated 
proteins (C) MMP7, (D) KIAA1324, (E) SLC25A45 and (F) DNAJC3 are localised within Paneth 
cells, identifying them as potential novel markers.  
 
Of the 36 proteins up-regulated, MMP7, KIAA1324, SLC25A45 and DNAJ3 expression 
was restricted to, or enriched within Paneth cells (Figure 21 C – F). With the exception 
of MMP7, the role of these proteins in Paneth cell development and function, if any, is 
not yet understood. Of these proteins, MMP7 and DNAJC3 were uniquely up-regulated 
by DAPT/CHIR treatment whereas KIAA1324 and SLC25A45 were also up-regulated in 
DAPT/IWP-2 treated organoids, revealing a potential role of DNAJC3 in Paneth cell 
development or function (Supplementary Tables 3 and 7, Appendix A). 
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3.3.3 Proteomic Analysis of IWP-2 and DAPT Treated Cultures Show an Increased 
Abundance of Known Goblet Cell and Enteroendocrine Cell Proteins 
Goblet cells secrete mucus components to regenerate a protective mucus layer that 
physically separates the host intestinal epithelium and invading pathogens. 
Enteroendocrine cells secrete hormones for digestion to aid in nutrient absorption across 
the epithelium. Drug skew with DAPT and IWP-2 skews intestinal epithelial cell 
differentiation along the goblet and enteroendocrine cell lineage. Here, we determined if 
observed changes in protein abundance in DAPT/IWP-2-treated organoids were 
biologically characteristic of goblet and enteroendocrine cell phenotype. 
Multiple major mucus components were up-regulated following DAPT/IWP-2 skew; 
calcium-activated chloride channel regulator (CLCA1) (log fold change = 3.328, q value 
= 0.00347, Supplementary Table 2 Appendix A), anterior gradient protein 2 (AGR2) (log 
fold change = 1.857, q value = 0.04257, Supplementary Table 2 Appendix A), trefoil 
factor 3 (TFF3) (log fold change = 2.383, q value = 0.04095, Supplementary Table 2 
Appendix A) and zymogen granule membrane protein 16 (ZG16) (log fold change = 
2.270, q value = 0.03616, Supplementary Table 2 Appendix A). Furthermore, several 
known enteroendocrine cell markers were up-regulated; alpha-fetoprotein (AFP) (log fold 
change = 2.939, q value = 0.00866, Supplementary Table 2 Appendix A), cholecystokinin 
(CCK) (log fold change = 2.828, q value = 0.01682, Supplementary Table 2 Appendix 
A), and gastric inhibitory polypeptide (GIP) (log fold change = 2.360, q value = 0.01173, 
Supplementary Table 2 Appendix A). In addition to an increase in proteins associated 
with secretory cell lineages, a down-regulation of stem cell markers was observed; 
OLFM4 (log fold change = -2.337, q value = 0.02152, Supplementary Table 2 Appendix 
A) and SPARC-related modular calcium-binding protein (SMOC2) (data not shown) 
which indicate a loss of stem cell phenotype as a result of driving goblet/enteroendocrine 
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cell differentiation.  Here, CLCA1, AGR2, TFF3, ZG16, AFP, CCK and GIP were all 
uniquely up-regulated in DAPT/IWP-2 treated organoids (Supplementary Table 5, 
Appendix A) and confirm the success of direct differentiation toward goblet and 
enteroendocrine phenotype. 
Network analysis of all proteins detected indicate an enrichment of proteins associated 
with enteroendocrine development and function network (Figure 22). Of the 35 proteins 
displayed within this network, 9 were significantly up-regulated (red), 8 were 
significantly down-regulated (green), and 3 were detected but changes in protein 
abundance was not statistically significant (grey) (Figure 22).  
Many of the known goblet cell markers that were uniquely up-regulated can also be 
observed within this network suggesting a dominant enrichment of goblet-associated 
proteins as well as enteroendocrine system-related proteins (Figure 22). However, some 
proteins here were also up-regulated in DAPT/CHIR treated organoids; CHGA, CHGB, 
KIAA1324 and 2-acylglycerol O-acyltransferase 2 (MOGAT2). 
To identify other proteins within our dataset that may be specific to goblet cell 
differentiation or function, we utilised the online tool, The Human Protein Atlas. Firstly 
using histochemical staining patterns of MUC2 as a reference, and the presence of apical 
mucin granules we identified goblet cells (Figure 23 A and B). We then used this 
anatomical location to examine the expression of proteins with higher abundances in 
DAPT/IWP-2 organoid samples. 
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Figure 22) Differentially-expressed proteins in DAPT/IWP2-treated samples are involved 
with enteroendocrine system development and function. 
Network analysis of proteins exhibiting significant changes in protein abundance following 
treatment with DAPT/IWP-2 identified a protein network for enteroendocrine system 
development and function as highlighted on Ingenuity Protein Analysis software. Grey-
shaded molecules indicate proteins that were detected within our dataset but not 
statistically significant, red-shaded molecules indicate up-regulated proteins and green-
shaded molecules indicate down-regulated proteins. This protein network displays an up-
regulation in known goblet cell and enteroendocrine associated proteins CLCA1, AGR2, 
GIP and CHGA. 
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Figure 23) Expression of a sub-set of up-regulated proteins in DAPT/IWP-2 treated organoids 
is localised within goblet cells of the villus tissues 
Protein localisation was examined using online tool, The Human Protein Atlas. Known goblet 
cell markers (A) MUC2 and (B) TFF3 were used to identify goblet cells containing apical mucin 
granules. Protein expression of up-regulated (C) CLCA1, (D) UGT2B17 and (E) ZG16 are 
localised within goblet cells. 
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Of these proteins found more abundantly in DAPT/IWP-2 organoids, TFF3, CLCA1, 
ZG16 were localised within goblet cells and UDP glucuronosyltransferase family 2 
member B17 (UGT2B17) was localised within a subset of goblet cells (Figure 23 B - E). 
All three of these proteins were uniquely up-regulated in DAPT/IWP-2 treated organoid 
cultures (Supplementary Table 5 Appendix A).  
To validate our findings and show that high purity goblet/enteroendocrine mixed cell 
cultures can mimic the in vivo environment, we compared up-regulated proteins with 
those detected within mucosal scrapings of murine gastrointestinal tracts in a study 
investigating the composition of gut mucus (Rodriguez-Pineiro et al., 2013).  
Of the 56 statistically significant up-regulated proteins within our goblet and 
enteroendocrine mixed cultures, 14 are reported to be found within murine in vivo 
gastrointestinal scrapings as detected by mass spectrometry (Rodriguez-Pineiro et al., 
2013) (Table 8). Of these common proteins, 10 were uniquely up-regulated in 
DAPT/IWP-2 and not in DAPT/CHIR treated organoids (highlighted with an asterix in 
Table 8), indicating that the changes in protein abundance in the former more closely 
represent murine gastrointestinal mucus scrapings than the latter. 
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Table 8) 14 proteins detected in DAPT/IWP-2 organoids, common to Rodriguez-Pineiro et al., 2013 studying murine gastrointestinal mucus 
composition 
Protein 
Identifier 
Description Q Value P Value 
Log Ratio 
Change 
Regions of small 
intestine previously 
detected 
      
Q9D7Z6* Calcium-Activated Chloride Channel Regulator 1 (CLCA1) 0.00347 0.00004 3.334 duodenum, ileum 
P20152* Vimentin (VIM) 0.01043 0.00053 2.48 all 
Q8K0C5* Zymogen Granule Membrane Protein 16 (ZG16) 0.03616 0.01062 2.27 all 
P16110* Galectin 3 (LGALS3) 0.04314 0.01623 2.20 all 
O88312* Anterior Gradient Protein 2 Homolog (AGR2) 0.04257 0.01533 1.86 all 
Q64133 Amine Oxidase [Flavin-Containing] A (MAOA) 0.00578 0.00009 1.75 all 
Q62425 NADH Hydrogenase [Ubiquinone] 1 Alpha Subcomplex Subunit 
4 (NDUFA4) 
0.01732 0.00175 
1.51 all 
P97742* Cartinine O-Palmitroyltransferase 1, Liver Isoform (CPT1A) 0.03385 0.00810 1.49 all 
Q9CQX2 Cytochrome B2 Type B (CYPB5B) 0.04134 0.01455 1.26 all 
Q61847* Meprin A Subunit Beta (MEP1B) 0.03891 0.01211 1.19 all 
Q64521* Glycerol-3-Phosphate Dehydrogenase, Mitochondrial (GPD2) 0.04085 0.01386 1.18 all 
Q64464* Cytochrome P450 3A13 (CYP3A13) 0.02908 0.00612 1.10 all 
P21447 Multidrug Resistant Protein 1A (ABCB1A) 0.00101 0.00000 1.07 all 
O88428* Bifunctional 3'-Phosphoadenosine 5'-Phosphosulfate Synthase 2 
(PAPSS2) 
0.03487 0.00896 
1.03 all 
* Proteins uniquely up-regulated in DAPT/IWP-2 treatment  
  
Chapter 3 – Validating Organoids for Intestinal Biology P a g e  | 110 
 
3.3.4 The Shared Secretory Lineage of Paneth and Goblet Cells is Reflected in the 
Proteome of Drug Skewed Organoids 
Having identified unique proteins in both Paneth and goblet/enteroendocrine skewed 
organoids, we also observed a subset of 18 up-regulated proteins that were shared in 
both treatment groups groups (Supplementary Tables 7 and 8, Appendix A).  
Within this group we report an increased abundance of proteins associated with 
secretory cell lineage; CHGB, SERPINH1, CHGA, NUCB2, MAOA, MOGAT2, 
several cytochromes; CYP2B19, CYPB10, CYP2C29, CYP3A11 and several solute 
carrier family proteins; SLC22A18, SLC25A45 and SLC27A4 (Supplementary Tables 
7 and 8, Appendix A). The shared increased abundance of secretory cell proteins is 
likely due to the shared secretory cell lineage of these populations. 
Using the same techniques as previously, we compared the staining pattern of these 
shared proteins with goblet and Paneth cell localisation on the Human Protein Atlas. 
Here we observed that, three of the proteins most changed in abundance were localized 
in enteroendocrine and Paneth cells; CHGA, CHGB and NUCB2 (Figure 24). The 
function of these shared proteins for secretory cell differentiation is currently 
unknown.  
  
Chapter 3 – Validating Organoids for Intestinal Biology P a g e  | 111 
 
 
 
Figure 24) Expression of a sub-set of up-regulated proteins in both DAPT/IWP-2 and 
DAPT/DHIR treated organoids is localised within Paneth and enteroendocrine cells of the 
small intestinal epithelium.  
Protein localisation was examined using online tool, The Human Protein Atlas. Using the same 
reference images as previously, we identified that (A) CHGA, (B), CHGB and (C) NUCB2 
are localized within enteroendocrine and Paneth cells. 
 
 
 
3.4 Discussion 
Organoids are promising tools for the study of infection. However, due to the limited 
volume of experimental material, the study of host defensive functions of Paneth cells 
and goblet cells is severely limited. 
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In this chapter, we validated drug-skewed organoids to be used to study Paneth and 
goblet cell functions in host-defence via quantitative label free mass spectrometry. 
Established murine organoid cultures were drug-skewed to drive differentiation along 
specific secretory cell lineages. Using confocal and proteomic approaches, we 
demonstrate that these in vitro organoid cultures share characteristics of Paneth and 
goblet cells in vivo and are amenable to mass spectrometry analysis. 
Previous studies have demonstrated that small molecule manipulation of cell 
signalling pathways can divert cellular differentiation toward specific cell lineages as 
determined by IHC and gene expression assays (transcriptomics) (Farin et al., 2012; 
Koo et al., 2012; Milano et al., 2004; Vandussen et al., 2014; Yin et al., 2014). To date, 
proteomic approaches have not been exploited to study organoid cultures, and as the 
correlation between mRNA expression and protein expression has been proven to be 
low in some instances, it is crucial to study the proteomic profile develop a better 
understanding of the underlying proteome in differentiated intestinal organoid cultures 
(Steiling et al., 2009). Furthermore, here we demonstrate that drug-skewed organoids 
provide sufficient material to apply mass spectrometry techniques for the analysis of 
Paneth and goblet cells in organoid cultures. 
Paneth-skewed organoids were produced by addition of DAPT/CHIR treatment to 
established murine organoids, and then analysed by label-free mass spectrometry for 
Paneth cell features. Paneth cells contain AMPs such as lysozyme and alpha-defensins. 
Alpha-defensin pre-cursors are constitutively produced, however are only activated 
through cleavage by MMP7 allowing for their secretion into the crypt lumen in 
response to antimicrobial stimulation (Weeks et al., 2006; Wilson, 1999). Here, mass 
spectrometry detected an increased abundance of several alpha-defensin proteins 
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although these were not statistically significant, and no observable change in the 
abundance of other AMPs were found. The production of other AMPs is not 
constitutive, and requires the sensing of commensal flora (Foureau et al., 2010; 
Menendez et al., 2013; Peeters and Vantrappen, 1975; Walker et al., 2013). A lack of 
microbial stimulation in this model could explain why other AMPs were not observed 
to be significantly increased in abundance here. Prediction of cleavage sites after 
trypsination (using Peptide Cutter - http://web.expasy.org/peptide_cutter/) on the 
alpha defensin protein sequence (taken from UniProt) indicate that trypsination may 
result in peptide sequences sizes that are not within the detectable range for this method 
of mass spectrometry (800Da – 3000Da), highlighting a limitation of the sole use of 
this method of protein detection. 
Further examination of all up-regulated proteins in Paneth-skewed versus control 
organoids reveal several potential novel markers of Paneth cells. Using online tool, 
The Human Protein Atlas, localisation of up-regulated proteins was compared to 
expression patterns of known Paneth cell markers. MMP7, KIAA1324, SLC25A45 
and DNAJC3 were identified to be specifically expressed or enriched within Paneth 
cells. KIAA1324 (also known as EIG121), up-regulates autophagy pathways (Deng et 
al., 2010). Murine knockout models of atg16l autophagy gene exhibit abnormal Paneth 
cell protein secretion, demonstrating that autophagy is essential for maintaining Paneth 
cell function (Bevins and Salzman, 2011). SLC25A45 is a fatty acid transport protein, 
however relatively little is known about this member of the SLC25 family. An up-
regulation of SLC25A45 mRNA is reported during hyperthyroidism, however the 
physiological role of this protein in the intestine is unknown. It’s localisation to Paneth 
cells may suggest a role in innate defence (Gutierrez-Aguillar and Baines, 2013; 
Ramadoss et al., 2014). DNAJC3 (also known as p58IPK) plays a role in the unfolded 
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protein response during endoplasmic reticulum stress (Roobol et al., 2015; Van Huizen 
et al., 2003) and is activated during viral infection, inducing cell death and 
inflammation as part of host cell response (Goodman et al., 2009). The up-regulation 
of these proteins in DAPT/CHIR treated organoids, and the evidence of Paneth cell-
specific localisation may suggest that these proteins play a role in Paneth cell function. 
Functional studies are required to further evaluate the role of these proteins in Paneth 
cell function, either for host immune defence or for maintenance of the intestinal stem 
cell population.  
Gastrointestinal goblet cells are responsible for mucus secretion onto the intestinal 
epithelia, generating a protective mucosal layer that acts as a physical barrier to 
regulate the exposure of the host immune system to antigenic material (Specian & 
Oliver, 1991; Zarepour et al., 2013). The composition of mucus varies throughout the 
gastrointestinal tract, and the major mucus protein component in the small intestine is 
mucin-2 (MUC2) (Zarepour et al., 2013). An increase in MUC2-positive cells was 
observed following DAPT/IWP-2 treatment by confocal imaging (reported by Zoe 
Matthews), however the changes in MUC2 protein abundance was not significant by 
q value (false discovery rate). Here we could report that an increased abundance of 
mucin-2 was observed if we base this observation on the reported p-value, however 
this method is less robust and does not take into account multiple testing.  
Proteins increased in abundance in DAPT/IWP-2 samples in relation to non-treated 
controls were compared with published murine gastrointestinal mucus scraping 
proteome data, to validate that DAPT/IWP-2 skewing results in an epithelial 
phenotype representative of in vivo mucus composition. A subset of proteins were 
commonly identified in murine gastrointestinal mucus samples and DAPT/IWP-2 
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treated organoid samples. These include several known mucus-related proteins 
CLCA1, ZG16, AGR2 and TFF3 that were within the top 20 up-regulated proteins 
(Pelaseyed et al., 2014; Rodriguez-Pineiro et al., 2013; Taupin & Podolsky, 2003).  
The similarities between the in vitro skewed organoids with in vivo mucus components 
proteome profile support the finding that DAPT/IWP-2 treated organoids can mimic 
in vivo mucus production.  
Further examination of up-regulated proteins in goblet/enteroendocrine samples 
compared to untreated controls reveals a potential marker of goblet cells. Using online 
tool, The Human Protein Atlas, localisation of up-regulated proteins was compared to 
expression patterns of known goblet cell markers. CLCA1 and UGT2B17 were 
identified to be specifically expressed within goblet cells. CLCA1 is a known mucus 
component and has previously been identified as a goblet-specific marker. More 
recently, studies of CLCA1 deficient mice suggest that the removal of this protein has 
no effect on mucus synthesis, structure or barrier function within the colon (Erickson 
et al., 2015). UGT2B17 is an enzyme associated with elimination of toxic xenobiotics 
(Wang et al., 2012). A down-regulation of ovine mucosal UTGB17 transcripts in 
response to nematode infection has been reported (Knight et al., 2011), however it’s 
exact role in the development of goblet cells and host response to infection is currently 
unknown. The physiological importance of this protein during infection requires 
further examination, however its localisation specifically within goblet cells may allow 
it to be used as a specific cell marker. 
Enteroendocrine cells constitute a small population of the intestinal epithelial cell 
layer, and are essential for regulating digestion, metabolism and gut motility through 
the secretion of various hormones such as serotonin, insulin and secretin 
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(Gunawardene et al., 2011; Herzig, 1998; Li et al., 2011; Nagatake et al., 2014). 
Currently, the inter-relationship between various enteroendocrine cell lineages is 
poorly understood and difficulties remain with identifying differentiated 
enteroendocrine cell types, however several markers have been established (Cirillo et 
al., 1995; Furness et al., 2013; Gunawardene et al., 2011; Liu et al., 2001; Nagatake 
et al., 2014; Roth et al., 1990). Amongst these known proteins associated with the 
endocrine phenotype, CHGA, AFP, CKK and GIP have all been shown to be highly 
up-regulated within our cultures. CHGA has previously been detected as up-regulated 
(by ~14 fold) following the same treatment in a study utilizing microarray technology 
performed by Yin et al., 2014. 
In addition to determining unique protein changes within each treatment group, a sub-
set of proteins were identified that were commonly up- or down-regulated in both 
enriched organoid cultures (Table 3, Appendix A). Of these proteins, CHGA, CHGB 
and NUCB2 were localised in enteroendocrine-like cells in both crypt and villus 
domains.   
These three proteins highlighted are known to be involved with enteroendocrine 
functions, and were therefore not expected to be differentially up-regulated in 
DAPT/CHIR Paneth skewed organoids. CHGA is an established enteroendocrine 
marker and a previous study has reported an increased in CHGA mRNA expression 
following DAPT/CHIR, which appears to be largely due to the addition of Notch 
signalling inhibitor DAPT (Yin et al., 2014). Our findings here obtained through 
proteomic approaches, agree with findings from qPCR and microarray experiments in 
a similar model. CHGB is often co-localised with CHGA, and is an important protein 
in secretory granule biogenesis (Huh et al., 2003; Portela-Gomes et al., 1997). It has 
  
Chapter 3 – Validating Organoids for Intestinal Biology P a g e  | 117 
 
been hypothesised that CHGB has a secondary function and can bind calcium, 
potentially playing a role in protein transport (Schmidt et al., 2011). In vivo studies 
show that CHGB-/- mice exhibit lower levels of hormone secretion by pancreatic islets 
(Obermuller et al., 2010). However the effect of knocking out this protein has not yet 
been extensively studied within the intestine (Portela-Gomes et al., 1997), and 
therefore its role in the gastrointestinal tract is not yet fully understood. Further studies 
investigating the role of CHGB in the secretory cells of the intestinal epithelium may 
help to further understand gut homeostasis and its role in the development of secretory 
epithelial cells. NUCB2 has recently been reported to be present within 
enteroendocrine cells and plays a role in the regulation of glucose homeostasis 
(Ramesh et al., 2015) 
In addition, several other proteins were identified as potentially important for the 
function of either goblet or Paneth cells as they were up-regulated in both treated 
organoid cultures when compared to untreated controls; sulhydryl oxidase 1 (QSOX1) 
and SLC family proteins, SLC22A18, SLC25A45 and SLC27A4 (Supplementary 
Table 3, Appendix A). QSOX1 has previously been detected within colonic mucus and 
functions to establish disulphide bonds which are important for the formation of 
fibronectin within extracellular matrix networks (Ilani et al., 2013; Williams et al., 
1983). Oxidation of disulphide bonds are important for the correct folding of secretory 
proteins, specifically the C- and N- terminus of MUC2 contain disulphide bonds (Godl 
et al., 2002). In rat tissues, QSOX1 protein expression has been specifically localised 
within epithelial secretory cell types (Tury et al., 2005). Thus this protein is likely to 
be important for the correct formation of a protective mucus barrier or function of 
secretory cells within the small intestine. The solute carrier (SLC) family proteins are 
important for absorption, distribution, metabolism and elimination processes 
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(Gutierrez-Aguillar and Baines, 2013; Palmieri, 2004). Broadly, within the intestine, 
these proteins regulate small molecule transport across the epithelium to facilitate 
communication between the host and the microbiome (Wu et al., 2013). The known 
functions of the SLC family member proteins up-regulated in secretory cell 
populations here is unknown, and further investigation is required to determine the 
role of these proteins during host immunity. 
Detection of common proteins in both Paneth and goblet cells may infer that the drug 
skew treatments were not successful in generating enriched organoid cultures, 
although this is not reflective of organoids as visualised by confocal imaging. More 
likely is that the similarities in up-regulated proteins observed in both treatment groups 
is due to the shared secretory cell lineage of Paneth, goblet and enteroendocrine cells. 
The determination of secretory cell fate is modulated by the Notch signalling pathway 
through suppressive action (Vandussen et al., 2014; VanDussen et al., 2012; Yin et al., 
2014). In both DAPT/CHIR and DAPT/IWP-2 treatments, the Notch signalling 
pathway is inhibited to allow cells to differentiate along the secretory cell lineage (Yin 
et al., 2014). It is possible that the proteins up-regulated in both treatment groups are 
regulated solely through this pathway, and so the inhibition of Notch signalling results 
in an increase of these secretory associated proteins. As mentioned above, an increased 
level of CHGA mRNA has previously been reported in DAPT/CHIR treated organoids 
(Yin et al., 2014), which suggests that the drug treatments have worked as previously 
described in the literature. Currently, very little is currently known about the 
relationship between the various secretory cell types within the small intestinal 
epithelium. Further profiling of these drug treated cultures at timed intervals may 
provide us with more information regarding the changes in protein expression 
throughout the process of terminal differentiation.  
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To summarise, the data here demonstrates that mass spectrometry can be applied to 
intestinal stem cell derived organoid to examine changes in protein abundance. 
Distinct profiles of known cell markers can be observed within treatment groups by 
mass spectrometry which agrees with previous studies utilising microarray and 
imaging techniques (Koo et al., 2011; Milano et al., 2004; Yin et al., 2013). 
Furthermore, in vitro goblet/enteroendocrine enriched organoid cultures are capable 
of generating proteins similar in composition to murine gastrointestinal mucus in vivo.  
The ability to detect markers Paneth and goblet cell markers via proteomic approaches 
demonstrate the suitability of this model to study the functional roles of these cell types 
in vitro. This model bypasses the limitations of existing models by inducing an 
enriched phenotype providing sufficient biological material to examine during enteric 
infection.
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Chapter 4 – Development of a Collagen-Supported Epithelial Sheet 
Model  
4.1 Introduction  
Due to the limitations of existing intestinal epithelial models for infection studies 
(Chapter 1), we are interested in adapting intestinal organoid models to study host-
pathogen interactions at the epithelial surface. These models are considered a 
promising tool to propel to field of intestinal infection biology forward, but have not 
yet been adequately optimized for this purpose. 
4.1.1 Establishment of Intestinal Organoids 
Identification of  LGR5+ stem cells within the small intestine (Barker et al., 2007), has 
allowed for the establishment of organoid cultures (Sato et al., 2009). Crypt columnar 
base units containing LGR5+ stem cells cultured in the presence of Wnt agonist R-
spondin 1, epidermal growth factor (EGF) and noggin produce a 3D model of the 
intestine (Sato et al., 2009). Following crypt isolation, LGR5+ stem cells of the crypts 
terminally differentiate into Paneth, goblet, enteroendocrine and tuft cells within 
distinct crypt-villus domains to form a fully differentiated in vitro model of the gut 
(Sato et al., 2009). Prior to the development of organoid cultures, there was never a 
long-term in vitro culture system that maintained the crypt-villus physiology observed 
in vivo, making organoid models an exciting prospect for the future of intestinal 
biology research.  
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4.1.2 Current Uses of Organoid Cultures 
To date, organoids have been exploited for regenerative medicine, nutrient transport 
and cancer studies (Neal and Kuo, 2016; Zachos et al., 2016; Zietek et al., 2015). With 
the exception of a few studies, there has been limited work on developing organoid 
cultures for the purposes of studying intestinal pathogens (Macartney et al., 2000; 
Saxena et al., 2016; Wilson et al., 2014; Zhang et al., 2014). Although small intestinal 
organoid cultures have been proposed as a useful tool for the study of intestinal 
infections, the organoid model still poses challenges and bears its own limitations.  
4.1.3 Organoids as Infection Models 
In order to accurately reflect in vivo physiology during an infection, it is important to 
study the host-pathogen interactions at the luminal interface where the pathogen would 
naturally be exposed to the host. Existing organoid culture methods yield 3D closed 
conformation structures with an enclosed lumen surrounded by multiple crypt-villus 
domains, making the luminal surface difficult to access without disrupting epithelial 
structure and integrity. The direct application of parasites is therefore impractical 
without specialised equipment such as a micro-injector (Wilson et al., 2014). 
The development of an organoid model specifically for the study of enteric pathogens 
would aid in the study of protozoan parasites, as our current ability to investigate 
enteric protozoan infection is severely limited. As stem cells can be isolated from the 
small intestine, large intestine or the colon, these new models will allow for protozoan 
infections to be studied at different anatomical locations within the gut to mimic the 
diverse infection strategies employed by a diverse group of parasites (Klotz et al., 
2012). 
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Protozoa have not yet been studied within organoid models and there is still a lack of 
understanding of the mechanism involved in early stage invasion of the intestinal 
epithelium. Unlike bacteria and viruses which have been successfully micro-injected 
into organoid models to establish infection (Wilson et al., 2014), due to their large size 
there are technical challenges involved with micro-injecting protozoan parasites onto 
the luminal interface within a 3D model.  
4.1.4 Modification of Organoid Culture 
An alternative method of utilising small intestinal stem cell-derived organoid cultures 
is to modify current culture conditions to generate a 2-dimensional (2D) semi-
monolayer culture grown either on transwell membranes or on an alternative gel matrix 
(Jabaji et al., 2013; Moon et al., 2013; Y. Wang et al., 2017). Unlike 3D organoids 
which are embedded in Matrigel®, these modified methods involve seeding 
established Matrigel®-grown organoids onto the surface of alternative matrices. The 
open conformation of semi-monolayer cultures exposes the luminal surface of the 
intestinal epithelium and would allow for direct overlay of gastrointestinal pathogens. 
However, unlike previously established organoids grown in Matrigel®, culture of 
murine organoids on collagen gels remains largely unexplored with only one research 
group briefly utilising this culture method, though not fully validating or optimising it 
for infection studies  (Jabaji et al., 2013).  
To act as a suitable in vitro intestinal model, two particular features of the intestinal 
epithelial must be retained; the presence of major epithelial cell types involved with 
immune defence, and the polarization of the epithelium for the recognition of 
pathogens. 
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Traditionally, in vitro monolayer cell line cultures are susceptible to de-differentiation 
with passage (Briske-Anderson et al., 1997; Sambuy et al., 2005). There is also 
evidence to suggest that cell densities are altered in transwell-supported monolayers 
making it a less reliable model than a collagen-based matrix model (Moon et al., 2013). 
However, the differentiation status of the cells within collagen grown semi-monolayer 
cultures and the functionality of this model are currently undefined. Whilst promising, 
the suitability of this monolayer model as an in vitro alternative to in vivo whole animal 
experimentation or 3D explant tissues for infections requires further validation.  
Ultimately the translation of these culture techniques will lead to the development of 
in vitro models for the study of early stage infection events, which are severely lacking 
at present. Organoid models have been demonstrated to be amenable to genetic 
manipulation, allowing for the role of specific molecular pathways in the response to 
infection to be studied (Andersson-Rolf et al., 2014; Powell and Behnke, 2017). 
4.1.4. Aim and Objectives 
The aim of this chapter is to modify existing organoid culture protocols to develop a 
novel model for the study of enteric infections.  
Objectives: 
a) Establish a culture protocol to generate collagen supported epithelial sheets, 
and extend the protocol to generate livestock models. 
b) Determine if collagen supported epithelial sheets contain major epithelial cell 
types with host defensive functions 
c) Determine if the epithelium is appropriately polarised in collagen supported 
epithelial sheets 
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4.2 Materials and Methods 
4.2.1. Collagen Gel Preparation 
Type 1 bovine and rat tail collagen gels were prepared to a final concentration of 
1.5mg/mL as described in Chapter 2.2.1. Collagen gels were pipetted in 30µL domes 
into 48-well plates containing 9mm coverslips, and incubated at 37oC and 5% CO2 for 
a minimum of 30 min to allow for gel polymerisation.  
The integrity of collagen gels were evaluated after 60 min of polymerisation, and after 
the removal of favourable conditions. A suitable density of collagen was then 
identified to be used as a scaffold for organoid fragments. This was then tested with 
the addition of organoid fragments, to assess structural integrity throughout the culture 
of epithelial sheets and collagen gel contraction. 
4.2.2 Matrigel Grown Murine Small Intestinal Culture 
Murine small intestinal organoids were established after crypt isolation and cultured 
in Matrigel® using a modified culture technique (Sato et al., 2009) as described in 2.1. 
Murine crypt units were isolated and embedded in Matrigel®. Matrigel preparations 
were polymerised for 30 min at 37oC and 5% CO2. Advanced Reduced Serum 
Dulbecco’s Modified Eagle Media (DMEM) containing 500ng/ml R-spondin 
(Peprotech), 50ng/ml EGF (Peprotech), 100ng/ml noggin (Peprotech), 1X B27 
supplement (Life Technologies, 1X N2 supplement (Life Technologies), 1% 
Penicillin/Streptomycin (Sigma) and 10µM HEPES (Sigma) was overlaid onto 
polymerised domes. Complete media changes were performed every 3-4 days (Sato et 
al., 2009). 
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4.2.3 Generation of a Monolayer Epithelial Model 
Day 7 Matrigel®-grown organoids were fragmented by pipetting with PBS and 
syringing through a 27G needle. Excess Matrigel® containing cellular debris was 
removed through centrifugation at 300xg for 10 min at 4oC.  
The organoid pellet was re-suspended in PBS and organoid fragments were pipetted 
directly onto polymerised collagen domes. Fragments were allowed to adhere to gels 
during 15 min incubation at 37oC and 5% CO2 atmosphere and complete media was 
added to cultures for 8 days, with a. complete media change on day 4.  
Light microscopy images were acquired using a Zeiss Axiovert inverted microscope 
(Carl Zeiss, Cambridge, United Kingdom) and processed using Zen Blue 2.0 software 
(Carl Zeiss). For confocal imaging, day 8 epithelial sheets were washed with PBS then 
fixed with 4% paraformaldehyde (PFA) (Life Technologies) (in PBS) for 20 min at 
room temperature and stored in PBS at 4oC until staining.  
Pilot studies were performed to demonstrate that monolayer culture protocols are 
translatable to other species of organoid cultures. Bovine organoids (grown by Dr 
Hayley Derricott) were fragmented via pipetting, and concentrated down with 
centrifugation at 50xg for 3 min 4oC. The organoid pellet was plated onto collagen gels 
as described above, and allowed to adhere for 15 min at 37oC and 5% CO2 atmosphere. 
Bovine organoid media consisting of 1:1 of IntestiCult® (StemCell Technologies, 
Cambridge, United Kingdom), and Wnt3a-conditioned media (HEK293 cell line was 
generously gifted from Dr Carrie Duckworth, University of Liverpool) containing 
1µg/mL R-spondin 1, 100ng/mL noggin, 100ng/mL EGF, 1.5µM CHIR99021 
(Tocris), 5µM Y27632 (Tocris), 5µM SB202190 (Tocris), 250nM A8301 (Tocris) and 
100µg/mL Primocin (InvivoGen, Toulouse, France) was overlaid onto cultures. Media 
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was changed every 3 days. Sheets were then fixed with PFA, and stained for intestinal 
epithelial cell markers. 
4.2.4 Antibody Staining and Confocal Imaging  
To confirm differentiation, epithelial sheets were stained as described in chapter 2.5 
with mouse monoclonal antibody to lysozyme (BGN/06/961, AbCam, Cambridge, 
United Kingdom) or rabbit polyclonal antibody tomucin-2 (H-300, Insight 
Biotechnology, Middlesex, United Kingdom) antibodies. Secondary antibodies used 
were either donkey anti-mouse Alexa Fluor 488 (AF488) (AbCam, Cambridge, United 
Kingdom), donkey anti-rabbit FITC (Stratech Scientific Ltd, Suffolk, United 
Kingdom), or donkey anti-rabbit TRITC (Stratech Scientific Ltd). Nuclei were stained 
with DAPI (Life Technologies). F-actin was labelled using phalloidin conjugated to 
Alexa Fluor 647 (AF647) or Rhodamine (Life Technologies). 
For evaluation of polarisation and cell-cell adhesions, epithelial sheets were stained 
with rabbit monoclonal antibody to e-cadherin (Clone 24E10, New England BioLabs, 
Hertfordshire, United Kingdom) or mouse anti-CD326 Epcam (Affymetrix 
eBiosciences, Altrincham, United Kingdom) and nuclei stained with DAPI. 
Confocal images were acquired using Zen Black software on a Zeiss LSM880 upright 
confocal microscope using laser lines Diode (405), Argon (488), DPSS-5610 (561) 
and HeNe633 (633) and W-Plan Apochromat 40x/1.0 Dic (water immersion) or Plan-
Apochromat 63x/1.0 oil DIC M27 (oil immersion) objective lens (all Zeiss). 
4.2.5. Quantification of Confocal Images for Cellular Differentiation 
All images for quantification were processed using Imaris x64 v8.0.1. Image analysis 
software (BitPlane, Oxford Instruments, Zurich, Switzerland).  
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Quantification of differentiated epithelial sub-populations in epithelial sheets and 3D 
organoids was performed as described in Chapter 2.6 and Figure 15 using the inbuilt 
“spots” function. For 3D organoids, the lower quartile, median and upper quartile z-
stack was used for quantification. 
4.2.6 Collagenase Treatments for Collagen Gel Separation 
For proteomics experiments, epithelial sheets were required to be separated from 
collagen gels. Optimisation of this process was performed as described in Chapter 
2.7.2 to obtain an optimal concentration of collagenase enzyme. During sample 
collection for proteomics, epithelial sheets were washed twice PBS and transferred to 
1.5mL Eppendorf tubes. Samples were submerged with 0.1mg/mL collagenase 
(Sigma) and incubated at 37oC and 5% CO2. At 15 min incubation, a P1000 was used 
to gently disrupt the collagen gels and the solutions were incubated for a further 15 
min.  
After 30 min incubation, an equal volume of complete media was added to collagenase 
solution to neutralize enzyme activity. Samples were washed three times with PBS by 
centrifugation at 300xg for 5 min each. Samples were stored as dry pellets at -80oC. 
Three biological replicates of day 7 collagen-grown epithelial sheets were prepared for 
proteomics experiments. 
4.2.7 Matrigel®-grown Organoid Preparation for Proteomics 
Murine organoids were established as described above, at day 7 media was removed 
and Matrigel® domes were washed with PBS. Matrigel® domes were gently disrupted 
by pipetting with a large bore tip (P1000). Samples were washed three times with PBS 
by centrifugation at 300xg for 5 min each. Samples were stored as dry pellets at -80oC. 
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Three biological replicates of day 7 Matrigel®-grown organoids were prepared for 
comparison to collagen-supported epithelial sheets. 
4.2.8 Peptide Digest and NanoLC MS ESI MS/MS Analysis 
Sample peptide digest was performed as described in Chapter 2.7. Organoid and 
epithelial samples were sonicated in 2mM ammonium bicarbonate, 0.1% w/v Rapigest 
(Waters, United Kingdom). Protein content was determined using the Coomassie Plus 
protein assay (Pierce, Thermofisher), and normalised as required. Samples were 
reduced with 3mM dithioreitol, alkylated with 0mM iodoacetimide and trypsinated at 
a ratio of 50:1. Samples were run on 12% mini-gel to confirm successful peptide digest 
and Rapigest was removed via the addition of 1% (v/v) trifluoroacetic acid (TFA). 
Peptide samples were centrifuged at 12,000xg for 60 min at 4oC to remove precipitated 
Rapigest, re-suspended in 0.1% TFA in 3% acetonitrile and stored at 4oC prior to 
loading. Peptide mixtures (2µl) were analyzed by Dr Stuart Armstrong as described in 
Chapter 2.8. Raw data files were processed in Progenesis LC-MS (Version 4.1, 
Nonlinear Dynamics) as described in Chapter 2.8. 
 
4.3 Results 
Due to limitations associated with existing in vitro and in vivo small intestinal infection 
models, there is a demand to generate a novel model incorporating differentiated 
epithelial cell types that is susceptible to infection at the luminal surface. Previous 
studies suggested that passage of established 3D organoid cultures onto an alternative 
collagen matrix could generate semi-monolayer epithelial sheets however, they have 
not yet been validated for infection studies. Within this chapter, we have described the 
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generation of collagen-supported epithelial sheets and demonstrated several desirable 
characteristics that make this model suitable for infection studies. 
4.3.1 Rat Tail Collagen Gels Successfully Sustain Epithelial Sheet Growth 
The first objective of this chapter was to optimise culture conditions for the generation 
of semi-monolayer epithelial sheets with an accessible lumen. We compared cultures 
grown on bovine type 1 collagen and rat tail type 1 collagen to identify a suitable 
substrate for the generation of these epithelial sheets. 
Firstly, we assessed the structural integrity and polymerisation of 1.5mg/mL and 
2mg/mL type 1 bovine and rat tail collagen gels. Collagen gels were prepared as 
described in Chapter 2.2 and allowed to polymerise for a minimum of 30 min at 37oC 
and 5% CO2, before being removed from the incubator and left at room temperature 
for 15 min (the approximate time taken to passage organoids onto the gels). Gels were 
re-incubated for a further 30 min and the structural integrity of the gels were examined. 
It was observed that gels at 1.5mg/mL were noticeably less stable than 2mg/mL gels, 
particularly, the bovine gels began to de-polymerise and lose their solid form. 
Therefore, further optimisation was carried out on rat tail collagen gels prepared to a 
final concentration of 2mg/mL  
Next we incorporated the organoids onto collagen gels as described in Chapter 2.2, to 
determine the ability of 2mg/mL collagen gels to sustain epithelial cell growth (Figure 
25). Briefly, 3D organoids were fragmented by syringing and re-plated onto 
polymerized 2mg/mL collagen gels and overlain with complete organoid media. 
  
Chapter 4 – Developing Epithelial Monolayers  P a g e  | 130 
 
 
 
Figure 25) Rat tail collagen gels successfully sustains semi-monolayer epithelial sheets. 
Organoid fragments were applied to collagen gels during passage, and cultured for 8 days. 
Light microscopy shows morphological differences between organoid fragments grown on (A-
D) bovine type 1 collagen gels and (E-I) rat tail type 1 collagen gels. Within 2 days of culture, 
organoid fragments begin to spread across the surface of both types of gel (A and E). 3D 
structures are retained on bovine gels (B) whereas this phenotype is lost on rat tail collagen 
gels by day 3 (F). Further growth is observed at day four on both types of gel (C and G), By 
day 6, fragments on bovine gels cease to develop further and remain in a 3D phenotype (D), 
whereas cultures on rat tail collagen develop to form an epithelial monolayer with cobblestone 
phenotype (H and I). At days 7 and 8 (H and I), areas of non-uniformity were evident 
(highlighted by red dashed lines) within the epithelial sheets. These were later identified by 
confocal imaging to contain Paneth cells. Scale bars = 100µm, except (I) where scale bar = 
50µm. 
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Within two days in culture, organoids began to undergo morphological changes on 
both bovine and rat-tail collagen gels (Figure 25, A and E). Unlike 3D organoid 
cultures embedded within Matrigel®, fragments grown on collagen gels began to 
spread outward across the surface of the gel forming a more flattened 2D phenotype 
(Figure 25, A and E).  
After three days in culture, organoids grown on bovine collagen gels appear to have 
retained more of their 3D structure (Figure 25 B) compared to those grown on rat tail 
collagen gels where the fragments were fully At day four, although there were signs 
that the organoids grown on bovine collagen gels were spreading, these cultures still 
retained 3D structures (as indicated by the arrow (as indicated by the arrow Figure 25 
C) whereas on rat tail collagen gels, the organoid fragments continued to spread further 
outwards forming a larger epithelial sheet (Figure 25 G). 
At day six, organoids grown on bovine collagen gels show no further changes (Figure 
25 D) whereas at days seven and 8, organoids passaged onto rat tail collagen gels 
formed a semi-monolayer large epithelial sheet with cobblestone phenotype that lack 
the 3D crypt-villus type structures seen on bovine gels (Figure 25 H and I).  
In the later stages of growth, organoids grown on rat tail collagen exhibited regions of 
non-uniformity with respect to cell size and density, as indicated by the red dashed 
circles in Figure 25 (H and I). These regions were visualised by confocal imaging and 
will be discussed in section 4.3.2.  
Comparison of bovine and rat tail collagen gels determined a suitable composition of 
collagen for the modification of close conformation organoid culture techniques to 
open conformation epithelial sheets suitable for infection studies. Structurally, bovine 
collagen gels were more susceptible to de-polymerisation following their removal 
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from incubation at 37oC and 5% CO2, whereas rat tail collagen gels retained their 
structural integrity even after removal from incubation. Furthermore, retention of 3D 
structures on bovine collagen gels is not desirable when considering a monolayer 
culture. Rat tail collagen grown organoid fragments generated large epithelial sheets 
with cobblestone phenotype, that were similar to previously published results by Jabaji 
et al., 2012. For these reasons, only organoid cultures on rat tail collagen gels were 
further evaluated for sustainability as an infection model. 
4.3.2 Epithelial Sheets Retain Differentiated Status In vitro  
The second aim of this chapter was to determine the differentiation status of collagen-
supported epithelial sheets via confocal imaging and proteomic approaches. 
Traditional in vitro cultures are susceptible to de-differentiation, and due to their 
importance during host immune response against invading enteric pathogens, the 
presence of Paneth and goblet cells is a desirable trait for intestinal epithelial models. 
Here, we characterised the epithelial sheet and evaluated the presence or absence of 
differentiated epithelial cell types within the culture via confocal imaging and mass 
spectrometry. Monolayer epithelial sheets were cultured for 7 days, and either fixed 
for confocal imaging or processed for mass spectrometry. Three replicates for confocal 
imaging were used for quantification, and three biological replicates of 5-well pooled 
samples of both collagen-supported epithelial sheets and Matrigel® grown organoids 
were prepared for mass spectrometry. 
Both Paneth and goblet cells were shown to be present in epithelial sheets after 8 days 
in culture (Figure 26 and Figure 27), confirming the retention of epithelial cell 
differentiation of this 2D monolayer culture in short term culture.  
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Figure 26) Characterisation of collagen epithelial cultures via confocal imaging confirms 
the presence of Paneth cells. 
Collagen-supported epithelial sheets and Matrigel® embedded organoids were fixed and 
processed for confocal imaging. Paneth cells are identified via anti-lysozyme (green) antibody 
staining, accompanied by nuclear stain DAPI (blue) and either anti-E-cadherin (red) antibody 
or F-actin (red) staining.  Paneth cells are present in both (A) collagen-supported epithelial 
sheets in clusters as highlighted by the dashed lines, and (B) Matrigel® controls some of which 
are highlighted by white arrows. Images are representative of three experimental replicates. 
Scale bars = 30µm, except for Ai where scale bar = 20µm. 
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Figure 27) Characterisation of collagen epithelial cultures via confocal imaging confirms 
the presence of goblet cells. 
Collagen-supported epithelial sheets and Matrigel® embedded organoids were fixed and 
processed for confocal imaging. Goblet cells are identified via anti-mucin-2 (green) antibody 
staining, accompanied by nuclear stain DAPI (blue) and F-actin (red) staining.  Goblet cells 
are present in both (A) collagen-supported epithelial sheets in clusters as highlighted by the 
dashed lines, and (B) Matrigel® controls, some of which are highlighted by white arrows. 
Images are representative of three experimental replicates. Scale bars = 30µm, except for Ai 
where scale bar = 20µm. 
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Paneth cells are present and arranged in micro-domain clusters within the central 
regions of the monolayer culture (as indicated by regions surrounded by dashed lines 
in Figure 26 A), whereas in Matrigel® grown organoids, Paneth cells are distributed 
within crypt domains although not often neighbouring one another (highlighted by 
arrows in Figure 26 B). This is reminiscent of their distribution in vivo where Paneth 
cells are found clustered at the base of crypt columnar base units. 
In contrast, goblet cells in monolayer cultures are more sporadically dispersed and 
appear to be distributed throughout the epithelial sheets (indicated by regions 
surrounded by dashed lines Figure 27 A). Similarly goblet cells in Matrigel® grown 
organoids are distributed throughout the whole organoid structure. These 
arrangements are comparable to in vivo goblet cell distribution, where goblet cells can 
be found throughout the transit amplifying region and within villus structures 
Automated cell quantification, using Imaris image analysis software, was used to 
estimate overall epithelial cell counts and generate a percentage of differentiated 
epithelial cell populations based on DAPI nuclear staining and differentiated cell 
staining. Based on three experimental replicates, we have determined that the Paneth 
and goblet cell populations constitute approximately 7.34% and 7.26% in Matrigel® 
grown organoids, and 3.31% and 1.89% in collagen grown sheets, respectively ( 
Figure 28).  The population differences are significant for both Paneth (p = 0.0355 and 
goblet cells (p = 0.0068) by an unpaired t-test. 
  
Chapter 4 – Developing Epithelial Monolayers  P a g e  | 136 
 
 
 
 
Figure 28) Paneth and goblet cell populations form a higher proportion of the whole cell 
population in Matrigel® grown organoids than collagen-supported epithelial sheets 
Confocal microscopy and Imaris analysis software was used to quantify the Paneth and goblet 
cell populations in Matrigel® grown organoids and collagen-supported epithelial sheets. 
Comparison of Paneth cell populations in Matrigel grown organoids vs collagen-supported 
epithelial sheets via students t-test show a significant difference (p = 0.0355) in the numbers 
of this cell type between the two cultures. Similarly, comparison of goblet cell populations in 
Matrigel grown organoids vs collagen-supported epithelial sheets via students t-test show a 
significant difference (p = 0.0068) in the numbers of this cell type between the two cultures. 
Together, these indicate that Matrigel® grown organoids contain a higher proportion of Paneth 
and goblet cells that collagen-supported epithelial monolayer cultures. Passage numbers of 
organoids used for quantification were 4, 10 and 16. Data is representative of three technical 
replicates. 
 
 
4.3.3. Mass Spectrometry Protein Detection in 3D Organoids vs Monolayer Epithelial 
Sheets 
To evaluate the presence of other epithelial cell types within our culture, we exploited 
label-free mass spectrometry to compare the proteins detected in epithelial sheets with 
Matrigel® grown organoids. Of the proteins detected in these samples, we searched 
for known intestinal epithelial markers and confirmed the expression of multiple 
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proteins associated with differentiated epithelial cell types of the small intestine. Our 
results indicate the presence of Paneth cells, goblet cells, enterocytes, stem cells and 
microvilli within the epithelial sheet model. 
Five Paneth cell products were detected; alpha-defensin 2, 5, 20, 24 and lysozyme C-
1 (Ayabe et al., 2002; Lisitsyn et al., 2012; Peeters and Vantrappen, 1975; Salzman et 
al., 2010, 2003a), however their presence was not uniform across both sample types 
(Table 9). Alpha-defensin 5, in particular, was not detected in Matrigel® grown 
organoids, but was detected in collagen-supported epithelial sheets (Table 9).  
Seven goblet cell markers and mucus components were detected; alpha-enolase, 
anterior gradient protein 2 homolog, chloride intracellular channel protein 1, mucin 2, 
mucin 13, trefoil factor 3 and zymogen granule membrane protein 16 (Lenaerts et al., 
2007; Rodriguez-Pineiro et al., 2013; Roussa et al., 2010; Taupin and Podolsky, 2003) 
(Table 9). The first three of these proteins were detected in all samples, whereas the 
latter 4 were not. In particular, trefoil factor 3 was detected in Matrigel® grown 
organoids, but not in collagen-supported epithelial sheets (Table 9). 
Two enterocyte markers were detected; intestinal fatty acid-binding protein and villin-
1 (Hodin et al., 1997; Kanda et al., 1996; Rusu et al., 2005; Sommer and Mostoslavsky, 
2014) (Table 9). The expression of both proteins was found across all samples (Table 
9). 
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Table 9) Intestinal epithelial differentiation marker proteins present in epithelial 
sheets and Matrigel® grown organoids detected by mass spectrometry, based on 
three biological replicates per group 
ID Protein Name Description Collagen Matrigel® 
P28309 Alpha-defensin 2 
Paneth cell markers 
(secreted anti-microbial 
peptides) 
 
✓✓✕ ✓✓✓ 
P28312 Alpha-defensin 5 ✓✓✓ ✕✕✕ 
Q45VN2 
Alpha-defensin 
20 
✓✓✕ ✓✓✓ 
Q5G865 
Alpha-defensin 
24 
✕✓✓ ✓✓✕ 
P17897 Lysozyme C-1 ✓✓✓ ✓✓✓ 
P17182 Alpha-enolase 
Goblet cell markers 
(components of mucus) 
 
✓✓✓ ✓✓✓ 
O88312 
Anterior gradient 
protein 2 
homolog 
✓✓✓ ✓✓✓ 
Q9Z1Q5 
Chloride 
intracellular 
channel 
✓✓✓ ✓✓✓ 
Q80Z19 
Mucin-2 
(Fragments) 
✓✕✕ ✕✓✓ 
P19467 Mucin-13 ✓✕✕ ✓✓✓ 
Q62395 Trefoil factor 3 ✕✕✕ ✓✕✓ 
Q8K0C5 
Zymogen granule 
membrane protein 
16 
✓✓✓ ✕✓✕ 
P55050 
Fatty acid-binding 
protein, intestinal 
Enterocyte markers 
✓✓✓ ✓✓✓ 
Q62468 Villin-1 ✓✓✓ ✓✓✓ 
Q3UZZ4 Olfactomedin-4 
Intestinal stem cell 
marker 
✓✓✓ ✓✓✓ 
P16014 Secretogranin-1 
Enteroendocrine cell 
marker 
✓✕✕ ✓✓✓ 
P26040 Ezrin 
Epithelial organisation 
and villus morphogenesis 
Intestine specific actin 
bundling protein of 
micro-villi 
✓✓✓ ✓✓✓ 
Q3V0K9 Plastin-1 ✓✓✓ ✓✓✓ 
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Additionally, stem cell protein olfactomedin-4 (Grover et al., 2010) was detected in all 
samples, indicating a presence of intestinal stem cells within the culture, and 
enteroendocrine cell marker secretogranin-1 (Wang et al., 2004) was present in all 
Matrigel® organoid samples, and one collagen grown epithelial sample. Two proteins 
associated with villus morphogenesis were detected in both sample types; ezrin and 
plastin-1 (Revenu et al., 2012; Shinomiya, 2012; Sumigray and Lechler, 2012; Wald 
et al., 2005) (Table 9). 
These subsets of proteins described above, indicate the presence of Paneth cells, goblet 
cells, enterocytes and stem cells within this epithelial model. 
 
4.3.3 Epithelial Sheets Exhibit Basolateral E-Cadherin and Strong Apical F-Actin 
staining 
Having confirmed the retention of epithelial cell differentiation after 8 days in vitro, 
next we evaluated the polarisation status of the epithelial sheets by confocal 
microscopy. As the intestinal epithelium in vivo is polarised and is the site of enteric 
pathogen invasion, in vitro models must also mimic this feature to accurately simulate 
early stage infection events which involves pathogen recognition on this surface. 
Here we evaluate polarization of the epithelial sheet by examining the distribution of 
a basolateral marker protein, e-cadherin and F-actin which is concentrated on apical 
surfaces (Figure 29).
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Figure 29) Collagen-supported epithelial 
sheets express specifically localised 
basolateral E-cadherin and enriched apical 
F-actin staining  
Epithelial sheets were cultured, fixed and 
processed for confocal microscopy. (A) 3D 
view of collagen-supported model stained for 
f-actin and e-cadherin. (B) Transverse view of 
collagen-supported model (0.264µm section). 
Collagen-supported model is polarized as 
demonstrated by apical enrichment of F-actin 
(C) and basolateral localization of e-cadherin 
(D). (E) 3D view of organoid stained for f-
actin and e-cadherin. (F) Transverse view of 
organoid model (0.470µm section). 3D 
organoid model is polarized as demonstrated 
by apical enrichment of f-actin (G) and 
basolateral localization of e-cadherin 
(H).Scale bars = 20µm. 
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Confocal microscopy was exploited to examine the localized expression of e-cadherin 
and f-actin staining in collagen grown epithelial (Figure 29). Here we report 
enrichment of f-actin expression upon the apical surface and basolateral localization 
of e-cadherin in both 3D organoids, and in collagen-supported epithelial sheets 
(Figure 29). This is further supported by the presence of integrin-beta 1, a protein 
involved in maintaining cell polarization (Yu et al., 2005) , which was detected in all 
three collagen grown epithelial samples by label free mass spectrometry. 
Having confirmed the polarisation status of this epithelial sheet model, next we 
evaluated the presence of cell-cell adhesions for the maintenance of epithelial barrier 
integrity.  
4.3.4. Staining for EpCam Demonstrates the Presence of Cell-Cell Adhesions 
Selective permeability across the intestinal epithelium in vivo regulates gut biological 
functions and protects against pathogen invasion. To determine the structural integrity 
of collagen-supported epithelial sheets, here we examined the localisation of epithelial 
adhesion molecule (EPCAM) and evaluated the presence of junction-associated 
proteins by label-free mass spectrometry. 
Confocal imaging confirmed the presence of cell-cell adhesions as denoted by 
EPCAM staining (Figure 30) and e-cadherin (Figure 25) staining on lateral surfaces. 
In vivo, epithelial sheet integrity is maintained by the presence of several complexes 
as described in Chapter 1.6; tight junctions, adherens junctions and desmosome. 
Particularly, EPCAM co-localises with tight junction protein claudin-7 to regulate cell-
cell adhesions (Ladwein et al., 2005), and its presence in collagen-supported models 
demonstrates the presence of cell-cell adhesions. 
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Figure 30) Collagen-
supported epithelial sheet 
staining for EpCam 
confirms the presence of 
cell-cell adhesions. 
Epithelial sheets were 
cultured, fixed and 
processed for confocal 
microscopy. Intercellular 
localisation of EpCam 
demonstrates the presence 
of cell-cell adhesion 
complexes within the 
collagen grown epithelial 
model. Scale bar = 30µm. 
 
  
Chapter 4 – Developing Monolayer Epithelial Sheets   P a g e  | 143 
4.3.5 Detection of Junctional Proteins by Label-Free Quantitative Proteomics 
Next, we evaluate the presence of the proteins involved in the formation of these 
complexes by label-free mass spectrometry. Proteins involved in the formation of tight 
junctions, adherens junctions and desmosomes were detected within collagen-
supported epithelial sheets. 
Five adherens junction proteins were detected; cadherin-1 (e-cadherin), cadherin-17, 
catenin alpha-1, catenin delta-1 and epithelial cell adhesion molecule (EpCam) in all 
samples with the exception of catenin alpha-1 which was detected in only one of the 
Matrigel® grown samples (Anderson and Van Itallie, 2009; Coopman and Djiane, 
2016; Su et al., 2008; Takeichi, 2014; van Roy and Berx, 2008) (Table 10).  
Six hemidesmosome/desmosome proteins were detected in collagen grown sheets, but 
not in Matrigel® grown organoids; desmoglein 2, desmocollin-2, desmoplakin,  
integrin alpha-6, integrin beta-4 and plectin (Coch and Leube, 2016; Giuffrida et al., 
2014; Ku et al., 1999; Mercurio et al., 2001; Stepp et al., 1990; van Roy and Berx, 
2008) (Table 10). 
Three tight junction proteins were detected, although not consistently in collagen-
supported epithelial sheets; junctional adhesion molecule A, tight junction protein ZO-
1 and tight junction protein ZO-2 (Arrieta et al., 2006; Citi and Cordenonsi, 1998; 
Giuffrida et al., 2014; Mandell and Parkos, 2005). These three proteins were all absent 
from Matrigel® grown organoid samples (Table 10). Here we also attempted to 
confirm the presence of tight junctions by staining for ZO-1. The antibody used was 
not reactive to the target protein in either epithelial sheets or Matrigel® control 
suggesting an antibody failure and not a lack of ZO-1 protein.  
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Table 10) Intestinal epithelial tight junction proteins present in epithelial sheets 
and Matrigel® grown organoids detected by mass spectrometry, based on three 
biological replicates per group. 
ID Protein Name Description Collagen Matrigel® 
P09803 
Cadherin-1 (E-
cadherin) 
Adherens Junction 
Proteins 
✓✓✓ ✓✓✓ 
Q9R100 Cadherin-17 ✓✓✓ ✓✓✓ 
P26231 Catenin alpha-1 ✓✓✓ ✕✕✓ 
P30999 Catenin delta-1 ✓✓✓ ✓✓✓ 
Q99JW5 
Epithelial cell 
adhesion molecule 
✓✓✓ ✓✓✓ 
O55111 Desmoglein-2 
Hemidesmosome/ 
desmosome proteins 
✓✓✕ ✕✕✕ 
P55292 Desmocollin-2 ✓✕✕ ✕✕✕ 
E9Q557 Desmoplakin ✓✓✓ ✕✕✕ 
Q61739 Integrin alpha-6 ✓✓✓ ✕✕✕ 
A2A863 Integrin beta-4 ✓✓✓ ✕✕✕ 
Q9QXS1 Plectin ✓✓✓ ✕✕✕ 
O88792 
Junctional adhesion 
molecule A 
Tight junction 
protein 
✕✓✕ ✕✕✕ 
P39447 
Tight junction protein 
ZO-1 
✓✕✕ ✕✕✕ 
Q9Z0U1 
Tight junction protein 
ZO-2 
✓✓✓ ✕✕✕ 
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In addition to detecting the presence of junctional associated proteins, we evaluated 
the presence of known structural proteins relevant to the in vivo small intestinal 
epithelium (Table 11).  Five intestinal epithelial cytoskeletal keratins were detected; 
7, 8, 18, 19 and 20 (Helenius et al., 2016; Ku et al., 1999). All of these were detected 
in all samples, with the exception of cytoskeletal keratin 20, which was detected in all 
but one Matrigel® sample (Table 11).  
 
 
The presence of these known intestinal structural proteins indicate that collagen-
supported epithelial sheets contain the same structural proteins as Matrigel® grown 
organoid cultures. 
4.3.6 Differentiated Bovine Epithelial Sheets Can Be Cultured On Collagen Gels 
The final aim of this chapter, was to demonstrate that the epithelial sheet protocol 
described above can be translated to generate models from other mammalian species. 
The availability of large mammal intestinal models is limited, particularly in food-
Table 11) Intestinal epithelial structural marker proteins present in epithelial sheets 
and Matrigel® grown organoids detected by mass spectrometry, based on three 
biological replicates per group. 
Q9DCV7 
Keratin, type II 
cytoskeletal 7 
Component of 
intermediate filament 
✓✓✓ ✓✓✓ 
P11679 
Keratin, type II 
cytoskeletal 8 
✓✓✓ ✓✓✓ 
P05784 
Keratin, type I 
cytoskeletal 18 
✓✓✓ ✓✓✓ 
P19001 
Keratin, type I 
cytoskeletal 19 
✓✓✓ ✓✓✓ 
Q9D312 
Keratin, type I 
cytoskeletal 20 
✓✓✓ ✓✓✕ 
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producing animals such as cows, pigs and sheep. To address this, Dr Hayley Derricott 
(Department of Infection Biology, University of Liverpool) has developed 3D 
organoid cultures derived from bovine and porcine small intestinal tissues. Here, using 
these 3D bovine organoids, I have demonstrated that the modified collagen-supported 
epithelial culture technique can be translated to generate bovine epithelial sheets. 
Collagen gels were prepared as previously, and bovine Matrigel®-grown organoids 
were harvested and re-plated on top. Bovine organoid media was added to collagen 
gels and cell adherence and growth was monitored. 
Two days post passage, bovine organoids begin to show signs of flattening and 
remodelling to accommodate the collagen gel (Figure 31 A). By day 4, the bovine 
organoid fragments begin to spread across the surface of the collagen gel (Figure 31 
B).  By day 7, larger epithelial sheets have formed, although these still retain some 3-
dimensionality (Figure 31 C). The bovine epithelial sheets here have spread to a size 
comparable to the murine epithelial sheets described in Figure 25. 
To determine the differentiation status of bovine epithelial sheets, samples were fixed 
and stained for markers associated with fully differentiated epithelial cell types. 
Confocal imaging confirms the presence of enteroendocrine cells (Figure 31 D). 
Attempts to stain for goblet cells and Paneth cells was also performed but were 
unsuccessful. This was limited by a lack of commercially available validated 
antibodies against bovine targets. Furthermore, the presence of bovine Paneth cells is 
disputed and has previously not been detected in bovine organoids (data not shown).  
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Figure 31) Bovine epithelial sheets can be cultured on rat tail collagen gels 
 
Matrigel® grown organoids were passaged onto 2mg/mL collagen gels (A) Bovine organoid 
fragments show signs of flattening on the surface of collagen gels at day 2. (B) Growth of cells 
is observed by day 4, where the culture is becoming more sheet-like. (C) By day 7, epithelial 
sheets are established that are comparable in size to murine epithelial sheets as described in 
Fig. 4.3.1.1. (D) Bovine epithelial sheets retain enteroendocrine cell populations (green) as 
well as some 3D-like structures (denoted by white arrows). Scale bars (A-C) = 100µm, D = 
20µm). Images are representative of two replicates. 
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Unlike murine epithelial monolayers that exhibit a flattened phenotype and 
cobblestoned f-actin staining pattern, bovine collagen-supported sheets do not appear 
uniformly flat. F-actin staining is generally enriched on the apical surface of polarized 
epithelia, and here we observed tubular structures with high F-actin expression which 
may be indicative of some luminal constructs retained within the bovine culture 
(Figure 31 D, white arrows).  
Differences between the growth cycles of murine and bovine intestinal stem cells may 
account for the discrepancies in re-modelling of organoid models between species. The 
bovine epithelial model requires further optimisation to develop the monolayer 
phenotype, however these pilot results indicate that the collagen culture method can 
sustain growth of other mammalian species in addition to murine cultures which is a 
potential tool for the study of host-pathogen interactions in food-producing animal 
species. Further optimisation of this technique for bovine intestinal stem cell derived 
cultures is required to modify the structural arrangement to monolayer phenotype.  
4.4 Discussion 
 
In vivo, the small intestinal epithelium acts as a physical barrier to protect the host 
from enteric pathogens. In order to study host-pathogen interactions in vitro, we aim 
to recapitulate the in vivo environment as closely as possible however current models 
of the intestinal epithelium are limited. For infection studies, several characteristics of 
the gut must be considered which are desirable for an intestinal model; the presence of 
differentiated epithelial cell populations and the selective permeability of the 
epithelium regulated by polarised cells and cell-cell adhesion complexes.  This chapter 
will discuss the development of a collagen-supported epithelial model, its ability to 
  
Chapter 4 – Developing Monolayer Epithelial Sheets   P a g e  | 149 
mimic the in vivo epithelium, and also its limitations for the study of host-pathogen 
interactions. 
Current models of the small intestine are limited, however the identification of LGR5+ 
intestinal stem cells has led to the development of 3D organoid cultures in vitro. Due 
to their ability to mimic the in vivo cellular diversity and structure, organoids are 
considered as promising tools for the study of enteric pathogens, but have not been 
fully optimized for this purpose. The enclosed conformation of organoid cultures 
restricts access to the relevant interface required to apply pathogens to study host-
pathogen interactions. Ideally, microinjection can be used to penetrate organoid 
cultures to deliver pathogens without disrupting epithelial integrity (Wilson et al., 
2014). However this technique requires specialised training and equipment, making it 
a less attractive and less accessible method for performing simple infection 
experiments. Moreover, microinjection of protozoan parasites has not yet been 
achieved in this model, which is likely due to difficulties with optimizing this method 
for large pathogens. Furthermore, microinjection is low throughput and laborious, 
yielding low volumes of biological material which limits the use of systems biology 
approaches. 
Modification of 3D organoid culture techniques has established a semi-monolayer 
epithelial sheet supported by a collagen scaffold for the purposes of studying drug 
metabolism however the presence of differentiated epithelial cell types and 
polarization status is unknown (Jabaji et al., 2013). This model differs from classical 
organoid cultures by forming “open” conformational sheets with an exposed luminal 
surface. As this model is developed primarily for studying drug metabolism and not 
infection, here we adapt and characterize this model to assess the suitability for 
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infection studies by evaluating cellular diversity, polarisation and integrity of the 
epithelial sheet. 
Two major epithelial cell types, Paneth cells and goblet cells, play important roles in 
supporting host immune defence against enteric pathogens. By confocal imaging, here 
we confirmed the presence of both Paneth and goblet cells within the collagen-
supported epithelial sheets, which is supported by the detection of Paneth and goblet-
associated proteins by label free mass spectrometry.  
We demonstrate that several Paneth cell secretory antimicrobial peptides are detected 
within this epithelial model including α-defensins 2, 5, 20 and 24 by label free-mass 
spectrometry. Paneth cells play a major role in host defence and are characterised by 
large apical granules that occupy their cytoplasm. These long-lived cells are rich in 
secretory anti-microbial peptides which modulate the gut microbiota (Ayabe et al., 
2000; Bevins and Salzman, 2011; Elphick and Mahida, 2005; Lisitsyn et al., 2012; 
Moal and Servin, 2006; van Es and Clevers, 2014). Importantly, intestinal defensins 
from Paneth cells confers resistance to enteric salmonellosis and Shigella infection 
(Fernandez et al., 2008; Salzman et al., 2003b). In addition to their role in immune 
defence, Paneth cells are important for the regulation of stem cell proliferation and 
Wnt signalling cascades in normal gut homeostasis which is important for epithelial 
cell turnover (Farin et al., 2012). In vivo Wnt signalling regulates the intestinal stem 
cell population by maintaining “stemness” and proliferative ability amongst these 
cells. Paneth cells provide essential signalling components such as Wnt3a and EGF to 
LGR5+ stem cells in vitro, and the removal of Paneth cells results in an ablation of the 
intestinal stem cell population (Toshiro Sato et al., 2011). For these reasons, the Paneth 
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cells play a major role in gut homeostasis and are an essential epithelial cell type 
required within an in vitro intestinal epithelial for self-regeneration. 
Multiple mucus components and goblet cell markers were also detected via label free 
mass spectrometry within epithelial sheet cultures. In addition to intracellular MUC2 
visualised by confocal imaging, we detected a variety of mucus components; alpha-
enolase, anterior gradient protein 2 homolog, chloride intracellular channel protein 1, 
mucin-13 (MUC13) and zymogen granule membrane protein 16 (ZG16) (Bergstrom 
et al., 2014; Birchenough et al., 2015; Lenaerts et al., 2007; Moal and Servin, 2006; 
Park et al., 2009; Pelaseyed et al., 2014; Rodriguez-Pineiro et al., 2013; Roussa et al., 
2010). Although multiple mucus components were detected here, within this thesis, 
the presence of a physical mucus layer has not yet been confirmed.  
Due to the hydrated state of mucus, PFA fixing collapses the mucus and therefore does 
not preserve this feature of the model. The evaluation of the mucus barrier layer 
therefore requires examination through alternative means that do not involve this 
fixation method. We have identified two potential methods of evaluating this feature; 
either by exploiting fixation by Carnoy’s fixation (reported to preserve mucus) or by 
two-photon imaging techniques (Coombes et al., 2013). Here, attempts to utilise 
Carnoy’s fixation of epithelial sheets were unsuccessful, likely due to poor antibody 
compatibility with this method of preservation. Therefore for future characterisation, 
we suggest the development of an epithelial sheet model derived from the intestinal 
stem cells of fluorescent reporter mice such as ROSAmT/mG (The Jackson Laboratory, 
Maine, USA), overlaid with fluorescent beads to be live cell imaged. A similar 
technique has been previously exploited to demonstrate the presence of mucus on 
intestinal tissue explants by Coombes et al., 2013.  
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The role of mucus for Toxoplasma invasion is currently unknown, however in related 
pathogens the mucus plays a significant role. In another apicomplexan 
Cryptosporidium spp, the parasite anchors onto the mucus layer to generate traction 
allowing it to penetrate host cells (Wilhelm and Yarovinsky, 2014; Yoshida et al., 
2011). When the presence of a mucus layer is confirmed, live imaging techniques can 
be used to visualize Toxoplasma interaction with the mucus layer during early invasion 
events which may identify parasite behaviours that exploit the mucus layer in a similar 
manner to Cryptosporidium spp. 
Several other important epithelial cell markers were also detected in our epithelial 
sheet model including enterocyte and microvilli markers; intestinal fatty-acid binding 
protein, villin-1, ezrin, plastin-1 and stem cell marker olfactomedin-4 (Coch and 
Leube, 2016; Grone et al., 1986; Hodin et al., 1997; Koo and Clevers, 2014; Saotome 
et al., 2004; Shinomiya, 2012; Yu et al., 2011). The detection of these markers within 
our cultures confirm the presence of a variety of differentiated epithelial cell types in 
culture that mimic the intestinal epithelium in vivo. 
By confocal imaging, we have examined the distribution pattern of Paneth and goblet 
cells in vitro. Within four days of culture, organoid fragments formed epithelial sheets 
with uniform patterning throughout, however after 7 days incubation we observed 
some heterogeneity throughout the sheet. The central regions of the epithelial sheets 
were generally composed of smaller, and more tightly packed cells whereas the outer 
regions were composed of larger cells. Confocal analysis of these areas reveal clusters 
of Paneth cells distributed within the central regions only and goblet cell distributed 
sporadically throughout. 
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This observation is suggestive that the peripheral regions of the epithelial sheets are 
enterocyte like, and the inner regions of the sheet are crypt-like, which potentially 
mimics the intestinal patterning in vivo, where Paneth cells are clustered in the crypt 
domains, and goblet cells are distributed sporadically throughout the transit amplifying 
region and the villi. To support this observation, visualising the distribution of LGR5+ 
stem cells could confirm the localisation of proliferating stem cells in relation to 
Paneth cells within these central micro-domains. Due to a lack of validated commercial 
LGR5+ antibody, this objective was not achieved within this chapter and requires 
further examination. However the self-renewal of Matrigel® organoids, and the 
observable growth of sheets suggest that cell proliferation is functional. 
Further to identifying the presence of differentiated epithelial cells, we quantified the 
populations of these cell types in the monolayer model and observed a lower 
proportion of Paneth and goblet cells when compared to Matrigel® grown 3D 
organoids. The 3D spatial arrangement and microenvironment is a unique feature of 
organoid cultures, and modification of this arrangement has evidently resulted in a 
diminished differentiated capacity. Recent work have demonstrated that the 
modification of static cell line cultures by the introduction of a microfluidic 
microenvironment can induce morphogenesis of 3D villus structures (Kim and Ingber, 
2013). Adaptation of this epithelial monolayer model onto a microfluidic chamber may 
recover a proportion of differentiated cells lost through the removal of a 3D organoid 
structure without re-forming an enclosed luminal space. This however is not a 
requirement for the use of this model for basic science infection studies as the 
epithelium still retains differentiated cell types. 
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Having confirmed the presence of the Paneth and goblet cells in vitro, we also 
evaluated the epithelial polarisation of this model via confocal microscopy. The 
basolateral localisation of e-cadherin, and the apical enrichment of F-actin confirms 
the polarisation status of this epithelial sheet model. During early stage invasion, the 
expression of pathogen recognition proteins localized to either to apical or basal 
surfaces, such as TLRs, regulates the recognition of pathogens invading the 
epithelium, allowing the host to mount an appropriate immune response. Polarisation 
of the epithelium is therefore an important requirement of intestinal infection models.  
In vivo, intercellular tight junctions maintain the separation of apical and basal 
domains, and also form a barrier to prevent excess transport of ions and molecules 
across the epithelium. The structural integrity of epithelial monolayers is maintained 
by the presence of these tight junctions, making this feature a desirable characteristic 
for intestinal infection models. Proteomic approaches were exploited to further 
examine the presence of absence of appropriate junctional proteins that make up the 
cell adhesion complexes; apical tight junctions, adherens junctions and desmosomes 
(Guttman and Finlay, 2009; Wells et al., 2014). 
Tight junctions of the intestinal epithelium are multi-protein complexes composed of 
four integral transmembrane proteins; occludin, claudin, junctional adhesion molecule 
(JAM) and tricelluin that all interact with ZO proteins to form tight junctional 
structures (Lee, 2015; Mandell and Parkos, 2005). Within our samples, we detected 
JAM-A protein in one of our collagen epithelial biological replicates, ZO-1 also in one 
collagen epithelial replicate and ZO-2 in all collagen epithelial samples. However, 
none of these three tight junction proteins were detected in Matrigel® grown 
organoids, which will be discussed later. 
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Adherens junctions are involved with remodelling tight junctions during 
morphogenetic and wound healing processes, and are composed of cadherin adhesion 
receptors and cytoplasmic proteins (catenins). Two cadherin proteins were detected 
within epithelial sheets; e-cad (cadherin-1) and cadherin-17, in addition to two catenin 
proteins; catenin delta-1 and catenin alpha-1. E-cadherin is a major component of the 
epithelial adherens junction and removal of this protein in mice results in death within 
24 hours of birth (Bondow et al., 2012). KO mice present with disrupted intestinal 
morphogenesis and the formation of abnormal adherens junctions leading to 
compromised intestinal barrier function (Bondow et al., 2012). Removal of e-cadherin 
also reduces the proportion of enterocytes within the small intestine, and increases the 
proportion of actively proliferating cells due to an inhibited level of nuclear activated 
β-catenin which as a result, alters Wnt signalling complexes. (Bondow et al., 2012). 
Thus e-cadherin is required for normal intestinal development. 
Both catenin delta-1, (p120 catenin) and catenin alpha-1 that were readily detected in 
all epithelial samples are directly involved in intestinal homeostasis. Removal of p120 
catenin in mice rapidly induces death within 21 days due to progressive mucosal 
erosion and intestinal bleeding (Smalley-Freed et al., 2010). Removal of p120 in 
immortalised cell lines generates low TEER monolayer cultures and amplifies immune 
cell engagement resulting in inflammation of the cells, thus this protein plays an 
essential role in barrier function and intestinal homeostasis (Smalley-Freed et al., 
2010).  P120 catenin binds and stabilises to cadherin proteins on the cell surface, and 
localises within the nucleus to activate transcription factors for gut homeostasis 
(Daugherty et al., 2014). Α-catenin also attenuates transcription via inhibition of the 
Wnt signalling pathway, although it has been more thoroughly studied in the context 
of cellular junctions. Α-catenin binds to filamentous actin to inhibit actin 
  
Chapter 4 – Developing Monolayer Epithelial Sheets   P a g e  | 156 
polymerisation in vitro to modulate f-actin remodelling (Daugherty et al., 2014). 
Removal of α-catenin in vitro results in enhanced transcription thus demonstrating its 
role in the inhibition of the Wnt signalling pathway and gut homeostasis (Daugherty 
et al., 2014).  
Hemidesmosome complexes facilitate adhesion of epithelial cells to basement 
membranes (Walko et al., 2015). Six hemidesmosome proteins were detected in 
collagen epithelial samples although not consistently; plectin, desmoglein-2, 
desmocollin, desmoplakin and two integrin subunits (α6 and β1) (Walko et al., 2015). 
(Walko et al., 2015). Integrin α6β4 and plectin form an essential component of the 
hemidesmosome complex to bind to extracellular laminin-332 and keratin 
intermediate filament network (Walko et al., 2015). Desmoplakin, has been shown to 
be essential for the formation of microvillus structures that compose the brush border 
of the intestinal epithelium and therefore its presence again indicates the correct 
homeostatic processes can be found within our model (Sumigray and Lechler, 2012). 
In addition, we also examined the presence of relevant intestinal cytoskeletal proteins 
within our samples. Cytokeratin proteins are intermediate filament proteins located 
within the cytoskeleton of epithelial cells that generate networks of rigid but flexible 
junctions to retain the biological requirements of those cells; in the case of the intestine 
they regulate epithelial polarity (Herrmann et al., 2007). The expression of 
cytokeratins is anatomically specific and intermediate filaments are considered to play 
an important role in determining the development and growth of specific tissues and 
organs. These intermediate filaments anchor the components of the intestinal 
epithelium via hemidesmosome complexes (Herrmann et al., 2007; Walko et al., 
2015). Murine intestinal epithelia express cytokeratins 7, 8, 18, 19 and 20 (Booth and 
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O’Shea, 2002; Gerbe et al., 2012; Helenius et al., 2016; Ku et al., 1999; Quinlan et al., 
2006; Ren et al., 2011; Zhou et al., 2003), all of which were detected within both 
epithelial sheets and Matrigel®-grown organoids demonstrating tissue-specificity 
within this model.  Furthermore, two other proteins of interest were detected; integrin 
β1 involved in maintaining cell polarisation (Beaulieu, 1992; Lee and Streuli, 2014; 
Yu et al., 2005) and intestinal-type alkaline phosphatase, a brush border enzyme which 
regulates intestinal homeostasis (Goldberg et al., 2008; Lallès, 2010). 
Together, with confocal and proteomic data we demonstrate the presence of the 
appropriate junction complex proteins and structural proteins within the epithelial 
model. Although the presence of these proteins alone does not constitute the presence 
of tight junctional complexes, tight junctions mark the boundary of apical and 
basolateral membrane domains and thus regulate epithelial polarisation. As 
polarisation has been demonstrated in this model by confocal imaging, we can presume 
that some tight junctions must also exist to maintain this segregation of domains. 
Attempts were made to confirm ZO-1 distribution throughout the epithelial sheet, 
however due to technical issues with the antibody purchased this was not successful. 
Due to time constraints, it was not possible to examine the distribution of other tight 
junction proteins, such as JAMs, occludens and claudins, although this was considered. 
Further examination of this feature would be preferential to confirm the presence of 
appropriate tight junction complexes and the regulation of epithelial molecule 
transport. 
The significance of developing this culture technique to generate differentiated and 
polarised epithelial sheets is hugely important for the study of zoonotic enteric 
pathogens, for which there are limited in vitro models. Only recently have we seen the 
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establishment of farm and companion animal organoid cultures of veterinary relevance 
which are still subject to restricted luminal access (Powell and Behnke, 2017) and our 
own unpublished data (manuscript in prep).  
To demonstrate the validity of this culture technique for the development of epithelial 
sheets infection models, we also performed pilot studies to provide evidence of bovine 
epithelial sheet growth from bovine organoids. Here we generated a similar model to 
the murine epithelial sheet by culturing organoid fragments on rat tail collagen for 7 
days. However, due to the poor availability of commercial bovine intestinal epithelial 
antibodies, this model has not yet been fully characterised at this time. Other 
characterisation methods such as qPCR could be used here to compare the expression 
of differentiated cell markers in these cultures to bypass a lack of validated bovine 
antibodies for imaging purposes. The findings here highlight two major characteristics 
of the epithelial sheet to support its use for infection studies, and demonstrate that this 
culture technique can be utilised in other mammalian species. However, several 
limitations of this model must also be considered. 
Due to the small volume of biological material of both organoids and epithelial sheets, 
the use of mass spectrometry highlighted several discrepancies within the proteome 
data. We observed an absence of several marker proteins in Matrigel® organoids 
which were present in collagen-supported epithelial sheets; alpha-defensin 5, integrin 
alpha-6, integrin beta-4, plectin and zonula-occludens protein 2 (ZO-2).  Zonula-
occludens proteins and other tight junctional proteins were detected within 3D 
organoids previously (data not shown), which suggests that the sensitivity of mass 
spectrometry was not compatible with the size of these samples.  
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We also observed variation in the number of detectable proteins and the robustness of 
detection of specific cell markers across biological replicates. In contrast to studies of 
cell biology in immortalised cell line models which are easy to culture uniformly, the 
smaller scale of collagen epithelial sheet models makes obtaining large volumes of 
biological material difficult. This is complicated by difficulties with standardising 
seeding density of organoid fragments onto collagen gels. Matrigel®-grown 3D 
organoid cultures contain varying numbers of intestinal stem cells in each organoid. 
When fragmented, these produce aggregations of differing sizes which are then plated 
onto collagen gels making uneven sized starting cultures. As proliferation of the 
epithelial sheet is determined by number of stem cells present within each organoid 
fragment plated onto collagen, smaller fragments are likely to generate smaller 
epithelial sheets.  
This natural variation within organoid cultures may account for some variability 
between protein returns of samples examined by mass spectrometry as several proteins 
were detected in some but not all replicates of either epithelial or 3D cultures 
including; alpha-defensin 2, alpha-defensin-24, mucin-2 fragments, mucin-13 and 
secretogranin-1. The sample size of these collagen sheets is therefore an important 
consideration for future work as detection of small protein changes are likely to be 
missed or not represented if the depth of analysis is shallow. For these reasons, future 
proteomic work involving epithelial sheets or organoid models should aim to increase 
the amount of biological material processed to maximise data gain.  
To conclude, here we have established a modified culture technique to generate a 
collagen-supported epithelial sheet model. Using confocal microscopy and proteomic 
approaches, we have characterised this model for Paneth and goblet cell features 
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including the presence of anti-microbial peptide and mucus components. We have also 
demonstrated the validity of this culture technique by generating an equivalent bovine 
model. This provides supporting evidence of the use of these models for the generation 
of in vitro animal models for infection.
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Chapter 5 – Optimisation of the Collagen-Supported Epithelial Sheet Model to 
Study Host Response to Toxoplasma gondii Infections  
5.1 Introduction  
Initial interactions between Toxoplasma gondii and host epithelial cells during early 
stage invasion are not well understood. The identification of Toxoplasma effector 
proteins has identified the mechanism of parasite internalization, however the host 
molecules involved in this process and mechanisms of epithelial transmigration have 
not been identified. Furthermore the host epithelial response to infection is poorly 
characterised.  
Enteric apicomplexa cause diseases globally in a wide host range including humans, 
companion animals and farm animals. Generally, these infections are acute and self-
limiting, however can become fatal if acquired by immunosuppressed patients. One of 
the most successful pathogens of economic importance is T. gondii. This parasite can 
infect virtually all mammalian cells and is thought to infect approximately 20% of the 
UK and US population, and between 50-80% in the Central and South American 
human population (Hill and Dubey, 2002; McAuley, 2014; NHS, 2015).   
Progress in this field has been limited by a lack of suitable models for the study of 
early invasion host-pathogen interactions. Using the novel collagen-supported 
epithelial cell model developed in Chapter 4, we optimize a protocol to establish 
infection. Using this method, we performed infection studies to examine changes in 
the host-proteome in response to virulent type I and avirulent type III Toxoplasma 
strains during parasite invasion and replication with a view to identify targets for the 
development of novel therapeutics. 
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The majority of infections are asymptomatic or cause only mild flu-like symptoms, 
however if an infected person becomes immunosuppressed they may experience 
reactivation of latent infection leading to neurological or ocular disorders, and death 
(Carruthers and Suzuki, 2007; Hill and Dubey, 2002). Infection of hosts during 
pregnancy has devastating consequences, including spontaneous abortions in sheep, or 
congenital toxoplasmosis in humans resulting in developmental delay, microcephaly, 
seizures or late onset chorioretinitis (Gilbert et al., 2006; Kravetz and Federman, 
2005). For these reasons, understanding the interactions during early stage invasion 
will help us to identify methods of disease prevention. 
European and North American strains of Toxoplasma are defined as three clonal 
lineages; type I, type II and type III. Type I strains exhibit higher virulence in mice, 
have a long distance migration (LDM) phenotype in vitro, and transmigrate across the 
intestinal epithelial barrier more readily than type II or III strains (Fuentes et al., 2001; 
Howe et al., 1995; Saeij et al., 2005). Traditionally, type II strains are less virulent, 
and have been associated with human infections and the development of congenital 
infections in Europe and North America, whereas type III strains are typically 
associated with infections in animals (Carneiro et al., 2013; Fuentes et al., 2001; Howe 
et al., 1995). However, more recently, atypical strains have been described that do not 
conform to these rules. The mechanisms that determine pathogenesis of Toxoplasma 
are unclear, and the comparative study of virulent and avirulent strains may identify 
key determinants of pathogenesis. 
To date, the invasion mechanisms of Toxoplasma have been studied both in vitro and 
in vivo. Several parasite effector proteins have been identified such as GPI-anchored 
surface antigens (SAGs), micronemal proteins (MICs) and rhoptry proteins (ROPs) 
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that interact with the host cell sequentially to regulate attachment and invasion 
(Grimwood et al., 1996; Grimwood & Smith, 1996; Mineo et al., 1993). However, the 
host-cell counterpart of many of these interactions is still unidentified. Furthermore, 
the mechanism by which Toxoplasma transmigrates across the intestinal epithelium is 
still not fully understood.  
Generally the host intestinal epithelial response to infection is not well understood, 
although some features have been described. During early stage invasion, Toxoplasma 
parasites are reported to disrupt host tight junction proteins and exploit a paracellular 
route of migration across the intestinal epithelium (Barragan et al., 2005; Weight and 
Carding, 2012). However, much of this data comes from in vitro cell line assays, and 
parasites can be observed residing within epithelial cells in vivo. While production of 
cytokines and chemokines has been studies in intestinal epithelial cells following 
infection, we still understand very little about how the host protects itself from 
invasion, and how the parasite can modulate the host epithelial response for its own 
benefit. 
Although T. gondii infections have been well studied using both murine in vivo and in 
vitro models, both methods have their limitations which has hindered our progress. In 
vitro models often rear simplistic results due to a lack of cell variation and thus a lack 
of complex host-pathogen physiology, and in vivo models pose technical challenges 
with maintaining the integrity of small intestinal tissues for procedures such as live 
cell imaging. Furthermore, due to the poor reproducibility and technical challenge of 
administering oral infections in vivo, often these invasions are established via 
intraperitoneal injections which do not mimic the natural route of infection. 
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Using our novel collagen-supported epithelial model, we will evaluate the use of label-
free mass spectrometry to study Toxoplasma within the epithelial sheet model during 
early and late stage infection. 
 
5.2 Materials and Methods 
 
 
Figure 32) Workflow schematic outlining the optimisation of infection studies for 
quantitative label-free mass spectrometry 
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5.2.1 Collagen-Supported Epithelial Sheet Culture 
Murine collagen-supported epithelial sheets were generated on rat tail collagen gels as 
described in Chapter 2. Day 7 Matrigel® grown organoid fragments were overlaid 
onto polymerised 2mg/mL rat tail collagen gels and allowed to adhere for 15 min at 
37oC and 5% CO2. Complete organoid media was overlaid onto organoid fragments 
and cultured for 7 days, with complete media changed on day 4. 
5.2.2 Culture of Toxoplasma gondii Parasites on Vero Cells 
Both Type I RH and Type III Veg strains of T. gondii were cultured and maintained in 
Vero cell cultures as described in Chapter 2.3. T. gondii culture supernatant containing 
tachyzoites was used to passage stocks, and parasites were purified from Vero cells 
for infections using PD-10 desalting columns as described in Chapter 2.3.3.  
For proteomics test run to determine the usefulness of including a “parasite-spiked” 
control, Toxoplasma were purified as above and pelleted by centrifugation. Parasites 
were de-activated by freezing at -20oC for a minimum of 24 hours.  
5.5.3. Infection of Epithelial Sheets with Toxoplasma gondii parasites 
Epithelial sheets were infected as described in Chapter 2.4. Media was removed from 
day 7 epithelial sheets, and replaced with media containing parasites. Cultures were 
fixed at multiple time points with 4% paraformaldehyde (in PBS) for 60 min at room 
temperature, washed thrice in PBS and stored in PBS at 4oC until staining.  
To assess the potential role of mucus during the initial stages of infection, the effect of 
a pre-treatment with a mucolytic N-Acetyl L-Cysteine (NAC) (Sigma Aldrich) was 
assessed. At day 7, media was replaced with organoid media containing 0mM, 2mM, 
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5mM or 10mM NAC, and sheets were incubated for 60 minutes. NAC media was 
removed after incubation and replaced with complete media containing T. gondii 
tachyzoites. Samples were fixed for confocal imaging. 
For optimisation of infection protocols, the effect of an additional centrifugation step 
following exposure to parasites was assessed. Infected epithelial sheets were either not 
centrifuged, or centrifuged at 100xg for 1 min prior to incubation. Cultures were fixed 
and stained for confocal imaging. 
5.5.4. Antibody Staining and Confocal Imaging 
Infected samples were stained and visualised by confocal imaging as described in 
Chapter 2.5. Epithelial sheets were stained with F-actin conjugated to Alexa Fluor 647 
or rhodamine (Molecular Probes), DAPI and a mouse monoclonal Toxoplasma gondii 
antibody to SAG-1 (TP3, Abcam), and donkey anti-mouse Alexa Fluor 488 secondary.  
Confocal images were acquired using Zen Black software on a Zeiss LSM880 upright 
confocal microscope using laser lines Diode (405), Argon (488), DPSS-5610 (561) 
and HeNe633 (633) and water immersion W-Plan Apochromat 40x/1.0 Dic objective 
or Plan-Apochromat 63x/1.0 oil DIC M27 (oil immersion) objective (all Zeiss) lens. 
5.5.5. Quantification of Infection  
Image analysis was performed in Imaris x64 v8.0.1 software as described in Chapter 
2.6. The Imaris “spots” function was used to quantify the number of cells and parasites 
within any given sample. The Imaris “surface” function was used to mask intracellular 
parasites, and give an estimated number of intracellularly invaded parasites. 
Automation of these counts were manually checked and edited to increase the accuracy 
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of quantification. A minimum of three fields of view were used to quantify invasion 
by T. gondii for all experiments.  
Quantification of images determined the rate of invasion at 24 hour, which we used to 
perform a test proteomic run with infected sheets, sheets spiked with deactivated 
parasites, and non-infected control. 
5.5.6. Extracellular Parasite Removal and Collagenase Treatment for Proteomics 
To minimise non-invading parasite proteins in infected samples, here a centrifugation 
step was evaluated for the proteomic sample preparation process. This optimisation 
was performed on 3D organoids as these were readily available.  
Day 7 organoids were removed from Matrigel® by centrifugation, and re-suspended 
in PBS. Purified parasites were added at a density of 2 x 105 per sample and incubated 
with organoids for 60 min. Samples were spun at either 50xg or 25xg for either 3 or 1 
min. A 10µL aliquot of the centrifuged supernatant, and cell pellet were taken for light 
microscopy where a parasite count was taken to determine the efficacy of 
centrifugation as a method of extracellular parasite removal (Figure 29 A and B). 
Parasite quantification in loose pellets and supernatant identified that 50xg and 25xg 
for 3 min removed 73% and 77% of parasites respectively (Figure 29 B). 
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Figure 33) Removal of extracellular Toxoplasma gondii from 3D organoids can be achieved 
through centrifugation. 
Organoid cultures were concentrated in four different conditions to remove Toxoplasma 
tachyzoites after incubating together for 1 hour. (A) Light microscopy images of cell pellets 
containing large organoid structures in centrifuged pellets, and parasites in supernatant. (B) 
Parasite count of supernatant and pellets determined the proportion of parasites removed 
through centrifugation at various speeds and time. This data is representative of a pilot 
experiment. Scale bars = 100µm. 
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Under these conditions, the removal of parasites was comparable. However due to the 
presence of organoid fragments in the supernatant of samples spun at 25xg for 3 min 
(Figure 33 A), this poses a risk of losing host cell material. For this reason, subsequent 
removal of parasites in samples for proteomics was performed via centrifugation at 
50xg for 3 min to minimise the risk of losing biological material.  
This spin out centrifugation was performed on infected epithelial sheets after 
collagenase treatment as described in Chapter 2.7.2. Isolated epithelial sheets were 
washed thrice with PBS and stored as a pellet for mass spectrometry peptide digest.  
For the proteomics test run, de-activated toxoplasma were added to an uninfected 
epithelial sheet as a “parasite spiked” control. For this test run, single replicates of each 
were prepared. For the main host-pathogen interaction experiment, three biological 
replicates of day 7 T. gondii infected epithelial sheets were prepared 
5.5.7 Peptide Digest and NanoLC MS ESI MS/MS Analysis  
Sample peptide digest was performed as described in Chapter 2.7. Peptide mixtures 
(2µl) were analyzed by on-line nanoflow liquid chromatography by Dr Stuart 
Armstrong as described in Chapter 2.8. Raw data files were processed in Progenesis 
LC-MS (Version 4.1, Nonlinear Dynamics) as described in Chapter 2.8. 
5.3 Results 
Here we utilise the collagen-supported epithelial sheet model developed in Chapter 4 
in a series of pilot infections to examine its biological capabilities to support protozoan 
parasite invasion and growth. Using confocal imaging and proteomic approaches, an 
infection protocol is optimised specifically for proteomic studies. Here this model is 
exploited to compare parasite-induced host protein response to Toxoplasma gondii RH 
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or Veg strain invasion and replication, against non-infected controls, with a view to 
identify targets for the development of novel therapeutics.  
5.3.1 Collagen-Supported Epithelial Sheets are Susceptible to T. gondii Invasion and 
Parasite Replication 
As the main objective of this thesis is to generate a novel model for the study of enteric 
pathogens, here we obtained evidence to support the use of our collagen-supported 
epithelial sheet model for infection studies by demonstrating susceptibility to invasion, 
and physiological compatibility with T. gondii replication.  
We firstly evaluated the susceptibility of epithelial sheets to pathogen-invasion by 
applying T. gondii onto the apical surface of the epithelial sheet. However, due to the 
novelty of this model, the infectious dose for optimal invasion was unknown.  The 
infectious dose chosen here was based on previous cell line infection studies performed 
by Mariwan Al-Bajalan (Al-Bajalan et al., 2017). During his doctoral studies, Mariwan 
infected 3-day post seeding HFF cells grown in T75 flasks with an infectious dose of 
1 x 107 tachyzoites. As the collagen-supported epithelial model is cultured in 48-well 
plates with a 0.95cm2 surface area, the infectious dose was scaled down to represent a 
similar host-to-parasite cell ratio as closely as possible. We therefore applied 1 x 105 
tachyzoites per well for the first pilot infection to determine whether the model was 
susceptible to invasion and parasite replication at 2, 6 and 72 hours infection. 
Preliminary results show that collagen-grown epithelial sheets are susceptible to 
invasion as early as 2 hours post infection (p.i) (Figure 34).  
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Figure 34) Collagen-supported epithelial sheets are susceptible to Toxoplasma gondii 
infection as early as 2 hours p.i 
Collagen-supported epithelial sheets were infected for 2 hours with 1 x 105 T. gondii RH, fixed 
and processed or confocal microscopy. Toxoplasma were visualised by detection of AF488 
fluorescence and parasite SAG-1 staining (green). Successful invasion was determined using 
Imaris (BitPlane) software. Images were analysed transversally to determine whether parasites 
were internalised based on F-actin staining (purple). Invasion was observed at 2 hours, as T. 
gondii parasites were embedded within the apical and basal surfaces of the epithelium as 
indicated by the arrows. Scale bars = 30µm.  
Infection was determined using Imaris software using the “orthoslice” function to view 
the epithelium transversally. Parasites were deemed to be intracellular based on 
localisation between the basal and apical surfaces of the sheet, as defined by F-actin 
staining (dashed lines Figure 34).  
T. gondii replicate within a PV formed upon successful invasion of host cells (Jacobs 
et al., 1998). To confirm successful invasion of the epithelial sheets by T. gondii, we 
stained for the Toxoplasma dense granule protein 7 (GRA7), which is secreted into 
PVs. The presence of GRA7 staining around individual tachyzoites confirmed the 
establishment of a PV following successful host cell invasion (Figure 35). 
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Figure 35) Toxoplasma dense granule (GRA7) is detectable on intracellular parasites at 4 
hours p.i 
Epithelial sheets were infected for 4 hours with 1 x 10
6
 T. gondii RH, fixed and processed for 
confocal microscopy. (A) SAG1 staining (green) identifies both intracellular and extracellular 
parasites within the field of view, whereas (B) GRA7 (red) identifies intracellular parasites 
that have formed a parasitophorous vacuole at 4 hours p.i. Scale bars = 20µm. 
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At 6 and 72 hours following infection with 1x105 parasites, we observed no signs of 
active replication (data not shown). However infection levels were in general very low. 
We therefore increased the infectious dose to 1 x 106 tachyzoites per well, and looked 
for evidence of parasite replication at 4 and 24 hours post infection. In vitro, 
Toxoplasma replication has been reported to occur as early as 4 hours post infection 
(Bommer, 1969). However, in our model, after 4 hours of incubation with Toxoplasma 
tachyzoites, parasite replication was not observed.  
Nevertheless, when the incubation time was increased to 24 hours in subsequent 
experiments, we were able to observe the formation of rosettes characteristic of 
parasite replication (Figure 36).  
 
 
 
Figure 36) Collagen-supported epithelial sheets are capable of supporting parasite 
replication. 
Collagen-supported epithelial sheets were infected for 24 hours with 1 x 10
6
 T. gondii RH, 
fixed and processed for confocal microscopy by detecting parasite SAG1 via AF488 
fluorescence. After 24 hours incubation with T. gondii tachyzoites, parasite replication was 
observed as denoted by the formation of intracellular rosettes. Scale bars = 20µm. 
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These results provide evidence to support the use of this novel model for the study of 
host-pathogen interactions as a) it is susceptible to infection, and b) can 
physiologically support pathogen growth and replication.  
5.3.2 Increased Infectious Dose Increases Proportion of Invaded Cells at Early Time 
Points 
To achieve the final objective of utilising the collagen-grown epithelial sheet model to 
study the host response to infection, we next performed a series of optimisation steps 
to maximise infection levels in our cultures, while minimising destruction of the 
monolayer. 
Based on the findings of the pilot infections, it appeared that the initial infectious dose 
of parasites determined whether robust parasite replication was observed, irrespective 
of the duration of infection. Therefore, we evaluated three infectious doses to 
determine the optimal parasite density to determine the highest infection index 
achievable without inducing host cell damage during early invasion events. 
Using Imaris image analysis software, the infections performed here were quantified 
as described in Chapter 2 to examine the proportion of host cells invaded, which will 
be referred to as the infection index. Unsurprisingly, increasing the infectious dose of 
parasites increases the infection index of collagen-supported epithelial sheets after 2 
hours infection (Figure 37). The lowest infection index observed was at 2.2% in 
samples infected with 1 x 106 tachyzoites, which increases to 3.96% when doubling 
the infectious dose to 2 x 106 tachyzoites (Figure 37).  At the highest infectious dose 
of 5 x 106 tachyzoites, an infection index of 5.47% was observed (Figure 37).  
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Figure 37) Increased infectious dose increases the proportion of cells invaded after 2 
hours incubation 
Epithelial sheets were infected for 2 hours with T. gondii RH, fixed and processed for confocal 
microscopy. Sheets were infected with either using 1 x 106, 2 x 106 or 5 x 106 T. gondii 
tachyzoites per well. Increasing parasite density increases the number of host cells infected 
after 2 hours of incubation with T. gondii RH. Bars represent standard error. The data presented 
here is representative of a single pilot experiment, with three confocal images quantified per 
density. 
It should be noted here that the surface area coverage of collagen gels by the epithelial 
cells was variable between wells making it technically challenging to standardise MOI. 
To address this, we evaluated the relationship between the proportion of collagen gel 
covered by host cells, and the infection index observed. However, we found no 
relationship between the proportion of gel covered with epithelial sheet, and the 
eventual infection index, suggesting that the data does not need to be normalised to 
account for variation in gel coverage (Figure 38). 
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Figure 38) The surface area of epithelial sheets does not affect infection indices 
Light microscopy images of infected gels were measured for surface area and percentage 
coverage of the collagen gel using ImageJ. The proportion of gel covered by the epithelial 
sheet does not affect the infection index as an outcome as determined by exponential 
regression analysis. Exponential regression analysis demonstrates a weak correlation between 
the percentage of collagen gel that the epithelial sheet occupies and the subsequent infection 
index (R2 = 0.03774), however this finding is not statistically significant (p = 0.91128) 
 
These findings suggest that a higher proportion of host cell infection can be achieved 
by increasing parasite density to 5x106 tachyzoites per well. However epithelial sheets 
exposed to a high infectious dose appear to exhibit some signs of distress. In non-
infected control samples, the epithelial F-actin appears robust with clearly defined 
intercellular and cell surface staining which is also observed at the lowest infectious 
dose of 1 x 106 tachyzoites per well (Figure 39 A and B). 
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Figure 39) Increasing infectious dose disrupts epithelial integrity after 2 hours incubation 
(A) Non-infected collagen-supported epithelial sheets show robust epithelial integrity, which 
is also reflected in (B) 1 x 106 tachyzoite infected sheets. (C) At a higher infectious dose of 5 
x 106 tachyzoites, the epithelial sheet shows some visual signs of integrity loss. White dashed 
lines indicate perimeter of epithelial sheet. Scale bars = 40µm.  
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However at the highest infectious dose, the epithelial regions exposed to tachyzoites 
exhibits disrupted F-actin staining suggesting loss of integrity (Figure 39 C). 
Moreover, there is evidence of excess epithelial sloughing when compared to the 
morphology of the model at a lower infectious dose (Figure 39 B and C). 
As the overall purpose of generating the collagen-supported epithelial model is to 
study host-pathogen interactions, it is crucial to generate high rates of host cell 
infection. For future infections, we hope to evaluate host-pathogen interactions during 
early invasion and during replication which we know takes place at around 24 hours. 
With these parameters in mind, although the highest infection index was observed by 
incubating collagen-supported epithelial sheets for 2 hours with 5 x 106 tachyzoites, 
the epithelial damage associated with this infectious dose makes it unsuitable for use 
in the future.  
Although the lowest infectious dose resulting in the lowest rate of infection, the 
difference was not significant. The collagen-supported epithelial sheet also appears be 
have maintained epithelial integrity at the lower dose which will allow it to support 
replication during longer durations of infection. For this reason, we determined that 1 
x 106 tachyzoites per well was a suitable infectious dose for future experimental work. 
5.3.3. Parasite Aggregation Along The Epithelial Sheet Perimeter 
While determining the optimal infectious dose, we noticed that large numbers of 
parasites aggregated along the epithelial sheet perimeter and uncovered surfaces of the 
collagen gel at 2 hours post infection (Figure 39 B and C). As the tachyzoites are 
applied directly to the collagen-supported epithelial sheet, it was assumed that 
parasites would be fairly uniformly distributed across the sample, even if they did not 
subsequently successfully invade the epithelial sheet.  
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Given that T. gondii can migrate across host cell surfaces using gliding motility, 
several non-exclusive explanations for this phenomenon were considered: 
(1) While parasites may initially have settled evenly in the wells, impaired 
migration on collagen compared to on the epithelial surface may result in the 
observed distribution over time. 
(2) Tachyzoites preferentially invade epithelial sheets at the perimeter, and are 
attracted to, or receive a “stop” signal, in these regions. 
(3)  The presence of a functional mucus layer is inhibiting parasite access to host 
cells.  
In order to optimise infection of the epithelial sheets, we set out to address which 
of these scenarios might be operating, and whether we could create a more uniform 
distribution of parasites across the well.  
5.3.4 The Perimeter-To-Surface Area Ratio Does Not Affect Infection Index 
We next determined if tachyzoites might preferentially invade epithelial sheets at the 
perimeter. If this were true, we hypothesised that wells with higher perimeter to surface 
area ratios (i.e. those containing several smaller epithelial sheets), would show a 
greater proportion of invaded cells. 
To evaluate this, light microscope images of infected collagen gels were acquired 
using GXCAM-Eclipse Camera (GT Vision, UK) and UCam Plus software. Light 
microscope images were analysed using ImageJ (NIH, USA) to generate 
measurements for length of perimeter and surface area of epithelial sheets on collagen 
gels. These measurements were used to generate an index of the perimeter-to-surface 
area, which was correlated with infection indices to evaluate the relationship between 
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the two measures. However, we found no relationship between the perimeter index 
and the eventual infection index, suggesting that the perimeter does not play a 
significant role in determining successful invasion, and is not the reason for the 
observed distribution in our cultures (Figure 40). 
 
Figure 40) The perimeter index does not affect the infection index 
Light microscopy images of infected gels were measured for epithelial sheet perimeter length 
using ImageJ. The perimeter-to-surface area index of epithelial sheets does not affect the 
infection index as an outcome as determined by linear regression analysis. Linear regression 
analysis demonstrates no correlation between the percentage of collagen gel that the epithelial 
sheet occupies and the subsequent infection index (R2 = 0.00045) which was not statistically 
significant (p = 0.91495). 
 
 
5.3.5 N-Acetyl L-Cysteine Treatment Does Not Increase Parasite Association to Host 
Cells 
Having evaluated both the perimeter length-to-surface area ratio, and the distribution 
of parasites during early invasion, here we aim to address the role of a mucus barrier 
layer during early invasion. 
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Currently, the role of mucus in Toxoplasma invasion is unknown, and the presence of 
an intact mucus layer within this model has not been investigated. Here, we evaluate 
the use of a mucolytic compound, N-acetyl L-cysteine (NAC) to break down the mucus 
component, and assess the changes to parasite association with host cells.  
Collagen-supported epithelial sheets were pre-treated with 0mM, 2mM, 5mM or 
10mM NAC for 60 min prior to infection for a further 2 hours. Here we hypothesised 
that the addition of NAC will increase the parasite to host cell contact, which will be 
evaluated by calculating the infection index and the number of parasites associated 
with the epithelial sheet.  
On first impressions, there were no visual changes to the distribution of tachyzoites 
after incorporating NAC pre-treatments prior to infections and parasites were still 
predominantly found at the perimeter of epithelial sheets (Figure 41). 
Generally, the infection index was higher in non-NAC treated samples at 16.72%, 
except samples treated with 2mM NAC which resulted in an infection index of 24.42% 
(Figure 42 A). We also calculated the density of parasites associated with the epithelial 
sheet to account for parasites that may be in contact with the epithelial sheet, but had 
not yet invaded. Here a similar trend was observed – the association of parasites within 
the epithelial sheet was slightly increased following incubation with 2mM NAC, but 
reduced following incubation with 5mM or 10mM NAC (Figure 42  B).
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Figure 41) NAC pre-treatment does not alter the distribution of parasites across monolayer cultures after 2 hours incubation. 
Epithelial sheets were pre-treated with 0mM, 2mmM, 5mM or 10mM NAC and infected with parasites for 2 hours. At 2 hour p.i, parasites (green) were still 
observed to be aggregating around the perimeter of epithelial sheets (purple) pre-treated with (A) 0mM, (B) 2mM, (C) 5mM and (D) 10mM. Images are 
representative of three fields of view in a single infection experiment. Dashed lines depict epithelial perimeters. Scale bars = 30µm
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Figure 42) Pre-treatment with NAC does not increase the association of parasites to host 
cells 
Epithelial sheets were pre-treated with either 0mM, 2mM, 5mM or 10mM NAC and infected 
with T. gondii tachyzoites for 2 hours. (A) Infection index was highest and lowest in 2mM and 
10mM NAC pre-treatment respectively.  (B) The number of parasites associated with 
epithelial sheets followed the same trend as the number of cells infected. The highest 
association was observed in 2mM NAC pre-treated sheets, and the lowest was in 5mM NAC 
pre-treated sheets. The bars represent standard error. The data presented here is representative 
of two experimental replicates.  
 
The findings here suggest that either the mucus component does not play a significant 
role in determining the outcome of epithelial cell infection, or that an intact mucus 
barrier is absent within this model. Since we observed no dramatic improvement in the 
infection index with the use of NAC, and the biological impacts of introducing a 
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mucolytic treatment on parasite behavior and the host cell response is unknown, we 
decided not to incorporate this additional step into our protocol.  
5.3.6 Centrifugation Does Not Affect Infection Index During Early Stage Invasion 
Despite the absence of a clear explanation for the aggregative behaviour of tachyzoites 
around the epithelial sheets, and having found no clear evidence that a barrier exists to 
prevent invasion, we attempted to create a more uniform distribution of parasites in 
our cultures, with the hope to increase the infection index. 
Established infection protocols of cell line cultures in vitro often exploit centrifugation 
to increase the contact of host cells and pathogen to encourage host cell invasion and 
synchronise infections. Within this model, tachyzoites are purified and re-suspended 
in organoid media which is then overlaid onto collagen-supported epithelial sheets. 
Here, we introduced an additional centrifugation at 100xg for 1 min after tachyzoites 
were added to epithelial sheets to promote direct contact with host cells and evaluate 
how parasites were settling onto the cultures. During this experiment samples were 
either spun, or not spun, and incubated for 30, 45 and 60 minutes before fixing.  
Here, we examined the infection index and density of parasites associated with the 
epithelial sheet to evaluate the effect of centrifugation. At 30 and 45 minutes post 
infection, the infection index was higher in centrifuged samples, suggesting an 
improvement in the invasion rate with the addition of centrifugation (Figure 43, A 
and B). 
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Figure 43) Centrifugation increases infection index and infectious potential at 30 and 45 
min, but not at 60 min 
Epithelial sheets were infected with T. gondii tachyzoites, and either centrifuged for 100xg for 
1 min, or not. (A) Centrifugation increases the infection index at 30 and 45 min, but not at 60 
min. (B) Centrifugation decreases the association index at 30 and 45 min, but not at 60 min. 
The bars represent standard error. The data represents a single pilot infection. 
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However, at 60 minutes post infection, this effect was lost, and the infection index in 
centrifuged samples was lower than in non-centrifuged samples (Figure 43, A and B). 
A similar pattern was observed when we calculated the density of parasites associated 
with the epithelial sheet (either invaded or attached to the apical surface). This data 
suggests that centrifugation initially brings more parasites in contact with the apical 
surface of the epithelial sheet, allowing invasion to occur more rapidly, but this does 
not result in higher infection rates at later time points (Figure 43, A and B). 
For future study of host-pathogen interactions, it is unlikely that we will collect 
experimental data earlier than a 60 minute time point, and so the addition of 
centrifugation to our infection protocol will not improve the infection index and will 
not be incorporated.  
Having determined that these optimisation steps described here do not increase the 
association of tachyzoites to host cells, we exploit this protocol to determine suitable 
parameters for proteomic studies. 
Specifically, defining suitable time points to recapitulate biological events during early 
host cell invasion and parasite replication, and determining the minimal threshold of 
biological material required to generate enough proteome signal are crucial to the study 
design. 
5.3.7 Selection of Time Points for Proteomic Studies 
Preliminary data confirm that collagen-supported epithelial sheets are susceptible to 
invasion by, and support the replication of, T. gondii. Therefore our model provides 
an excellent tool to investigate the host epithelial cell response to infection at two key 
stages: early invasion and replication. However, unlike traditional cell line cultures 
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where infection protocols are established, the exact timing of these events in our model 
remain unknown. Here we performed a more detailed time-course to select appropriate 
time points for proteomics based analysis of the host response. For these experiments 
we utilised two parasite strains; virulent type I (RH) and avirulent type III (Veg) strain. 
To select an early time-point, we first looked at infections following 1 and 4 hour 
incubation. Although infection was observed as early as 30 min in this model, the 
frequency of infection was low. Due to the asynchronous nature of parasite invasion, 
we decided to choose 1 hour as our early time point to maximise the observable number 
of invasion events for analysis. The four hour time-point was selected as previous work 
performed in cell lines by Xia et al. demonstrated that host cells exhibit large proteome 
changes at 4 hours post infection, indicating that the host response to infection is 
readily detectable at this time point (Xia et al., 2008) 
Unsurprisingly, the infection index was lower in the avirulent Veg strain at both time 
points (Figure 44). At 1 hour incubation, the infection rate is low and the difference 
between the two strains is negligible, however differences becomes more evident by 4 
hours resulting in 6.47% infection by Veg, and 8.20% infection by RH.  
From these findings, we have tangible evidence that infection rates are lower at 1 hour 
p.i. than at 4 hour. p.i.. As previously observed, there was a marked lack of parasite 
replication at the 4 hour time-point, which suggests that the increase in infection index 
between 1 and 4 hours is attributable to new infection events occurring in an 
asynchronous manner. The occurrence of these new infection events make the 4 hour 
time-point suitable for the study of early invasion of host cells by T. gondii, while 
increasing the likelihood that parasite material and the host cell response will be 
detectable by mass spectrometry 
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Figure 44) Infection after 1 Hour incubation with both RH and Veg is poor 
After 1 hour incubation, infection rates in both Veg and RH infected samples is low. The 
infection rate increased following 4 hours infection, with RH exhibiting a higher infection 
index in these experiments. The bars represent standard error. Data representative of two 
biological replicates. 
 
5.3.8 Replication Is Not Observed After 16 Hours Incubation with T. gondii RH or 
Veg Strains 
Having identified a suitable time point to represent early stage invasion, next we 
proceeded to perform a time-course experiments to identify a suitable incubation 
period to assess parasite replication. Based on pilot studies, we had identified parasite 
replication within this model at 24 hours post infection, however have not yet 
determined if parasite replication occurs any earlier. Although replication is observed 
as early as 4 hours in vitro, previous infections of HFF cell lines report replication 
most commonly at approximately 16 hours. To assess whether the same interaction 
occurs within this model, here we performed a time-course experiment to quantify the 
presence of replication at 16, 24 and 40 hours post infection (Figure 45). 
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Figure 45) Replication does not after 16 hours infection with either T. gondii RH or Veg 
Epithelial sheets were infected for 16, 24 and 40 hours, fixed and processed for confocal 
microscopy. Infection of epithelial model produces (A and B) no replication at 16 hours p.i., 
(C and D) some infection at 24 hours although with some regions of non-infected cells, and 
(E and F) more widespread infection throughout the sheet. Scale bars = 30µm except for (D) 
where scale bar = 40µm. Data representative of two biological replicates. 
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Initial observations based on confocal imaging suggest replication in RH but not Veg 
infected samples at 16 hours p.i. However, replication at this time point was limited to 
regions close to the perimeter of the sheet, whereas at 40 hours parasite replication was 
found to be more widespread. 
To compare the differences in infection and replication between RH and Veg strains, 
we evaluated the infection index, and calculated the proportion of host cells that 
contain replicating parasites based on the presence of a minimum of three or more 
parasites clustered in an early rosette formation. 
After incubation with RH and Veg tachyzoites for 16 hours, the proportion of infected 
cells is fairly low at 4.02% and 5.15% respectively (Figure 46 A). After 24 hours, this 
doubles in Veg infected samples, and triples in RH infected samples (Figure 46 A). 
By 40 hours, 18% and 41% of host cells become infected with Veg and RH 
respectively (Figure 46 A). 
Confocal imaging identified no replication after 16 hours of incubation with either Veg 
or RH strains, and low level replication at 24 hours (Figure 46 B). By 40 hours post 
infection, almost 5% of Veg-infected cells, and 8% of RH infected cells contained 
replicating parasites (Figure 46 B). 
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Figure 46) Parasite replication is not observed after 16 hours incubation 
Epithelial sheets were infected for 16, 24 and 40 hours, fixed and processed for confocal 
microscopy. Analysis of images quantified these infections. (A) Infection of host cells 
increased with duration of time between 16 and 40 hours. (B) No replication events were 
observed at 16 hours. Replication was observed at 24 hours but at low levels in Veg-infected 
samples. By 40 hours, the proportion of cells containing replicating parasites had doubled from 
24 hours. The bars represent standard error. Data representative of two biological replicates. 
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5.3.9 Label-Free Mass Spectrometry Detection of Parasite Proteins at 24 Hours Post-
Infection 
As T. gondii replication was not observed at 16 hour p.i., but was present after 24 hour 
infection, we performed a pilot infection to assess the sensitivity of label-free mass 
spectrometry for the detection of parasite proteins within the collagen-supported 
epithelial cell model.  
The purpose of this pilot study was to evaluate the potential use of a parasite “spiked” 
control sample. Due to the complexity of parasite and host proteins present within 
infected samples, the incorporation of spiked controls into the experiment could 
potentially identify subsets of proteins modulated in response to host cell exposure to 
parasites, rather than simply just host cell proteins modulated in response to active 
infection. However, due to the small sample size of collagen-supported epithelial 
sheets, the sensitivity of mass spectrometry for protein detection in the model may be 
low. This pilot infection will assess the benefit of incorporating the parasite spiked 
control into the experimental design for future infection studies. 
In chapter 4, we determined that 5 pooled-wells of collagen-supported epithelial sheets 
contained detectable host proteins, however the sensitivity of parasite protein detection 
in this model is not yet characterised. Moreover, due to the natural variability of cell 
numbers within this model observed in Chapter 4, here we decided to pool together 
10-wells to increase the depth of protein detection for this pilot study. 
 
797 total proteins were detected in the non-infected epithelial sheet sample, 1179 total 
proteins in the 24 hour RH-infected sample, and 1446 total proteins in the parasite 
spiked sample, with 667 proteins common in all three samples (Figure 47). 
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Figure 47) Venn diagram shows numbers of proteins detected in non-infected, 24 hour 
infected and spiked epithelial sheets 
797 proteins in the non-infected sample (blue), 1179 proteins in the infected sample (yellow) 
and 1446 proteins in the spiked sample (green) were identified. 
 
 
Non-infected and infected samples share 52.8% of proteins detected (Figure 48 A). 
The lowest number of proteins shared was between non-infected and parasite spiked 
samples at 50.1% (Figure 48 B), and the highest proportion of samples shared was 
between infected and spiked samples at 61.1% (Figure 48 C). 
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Figure 48) Venn diagram showing proteins detected by label-free mass spectrometry in 
non-infected, 24 hour RH infected and parasite spiked epithelial sheets 
After removing single-peptide hits, we detected 797 proteins in non-infected, 1179 proteins in 
infected and 1446 proteins in parasite-spiked samples. (A) 683 (52.8%) proteins shared 
between non-infected and infected samples. (B) 749 (50.1%) proteins shared between non-
infected and spiked samples. (C) 996 (61.1%) proteins shared between the infected and spiked 
samples. Results suggest that infected and spiked samples were most similar to one another, 
and non-infected and spiked samples were most different to one another. 
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Host proteins detected in each sample were analysed for similarities in molecular 
function and biological processes by gene ontology using Pantherdb 
(http://www.pantherdb.org/) (Mi et al., 2013). 22 proteins were excluded from the 
spiked control sample, 39 from the infected samples, and 3 proteins from the non-
infected sample data set as they were either uncharacterised or not recognised by 
Pantherdb. Nine molecular function terms were associated with the proteins detected 
in all three samples (Figure 49). The proportion of proteins detected in each molecular 
function group was similar across samples. However some small differences were 
observed in the proportion of “catalytic activity” proteins which were slightly lower in 
non-infected samples, and “structural molecule activity” proteins which were slightly 
higher in non-infected samples (Figure 49 purple bars). 
Twelve biological processes were associated with proteins detected in the spiked 
(green bars) and non-infected (purple) sample, and thirteen biological processes were 
detected in the infected sample (orange) (Figure 50). The proportion of proteins 
detected in each of the biological processes groups was also similar across samples, 
with the exception of “cellular component organisation or biogenesis” in the non-
infected sample, which had 1.2% and 1.4% more protein hits than spiked (green bars) 
and infected samples (orange bars) (Figure 50 purple bars). 
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Figure 49) Comparison of molecular functions associated with proteins detected in pooled 
non-infected, 24 hour infected and spiked samples. 
Single peptide proteins were removed from the data set and significant proteins were analysed 
in Panther DB Classification Tool (online; http://www.pantherdb.org/).  1446 proteins were 
input for the spiked control sample, with 22 unmapped ID’s excluded. 1179 proteins were 
input for the infected sample, with 39 unmapped ID’s excluded. 797 proteins were input for 
the non-infected sample, with 3 unmapped ID’s excluded. Nine molecular functions were 
associated with spiked (green bars), infected (orange bars) and non-infected control (purple 
bars). The proportion of proteins associated with molecular function was similar across all 
three samples, with the exception of structural molecule activity which was slightly higher in 
non-infected samples, and catalytic activity which was slightly lower in non-infected samples. 
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Figure 50) Comparison of biological processes associated with proteins detected in pooled 
non-infected, 24 hour infected and spiked samples 
Single peptide proteins were removed from the data set and significant proteins were analysed 
in Panther DB Classification Tool (online; http://www.pantherdb.org1446 proteins were input 
for the spiked control sample, with 22 unmapped ID’s excluded. 1179 proteins were input for 
the infected sample, with 39 unmapped ID’s excluded. 797 proteins were input for the non-
infected sample, with 3 unmapped ID’s excluded.  Twelve molecular functions were 
associated with spiked (green bars), and non-infected control (purple bars); and thirteen 
molecular functions were associated with the 24 hour infected (orange bars) sample. The 
proportion of proteins associated with biological processes were similar across all three 
samples, with the exception of cellular component organisation or biogenesis which was 
slightly higher in non-infected samples. 
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In the parasite-containing samples, 47 proteins were identified as parasite proteins in 
the 24 hour infected sample, and 24 in the parasite spiked sample, with 14 parasite 
proteins shared in both samples (Table 12 - Table 14).  
Within infected epithelial sheets, multiple proteins involved with the actin-myosin 
complex involved in active invasion of host cells were detected (Boucher and Bosch, 
2015).; TGME49_209030 actin (ACT1), TGME49_231630 alveolin containing 
intermediate filament (IMC4), TGME49_231640 alveolin containing intermediate 
filament (IMC1), TGME49_236040 fructose-1, 6-bisphosphate aldolase (F16BP/ FBP 
ALD), TGME49_2619190 glyceraldehyde-3-phosphate dehydrogenase (GAPDH2), 
TGME49_289690 glyceraldehyde-3-phopshate dehydrogenase (GAPDH1) and 
TGME49_293690 profilin (PRF) (Table 12).  
Tachyzoite-stage specific parasite proteins were also identified within infected 
epithelial sheet samples (Hehl et al., 2015; Holmes et al., 2010; Lyons et al., 2002); 
TGME49_232350 lactate dehydrogenase (LDH1), TGME49_268850 enolase 2 
(ENO2), TGME49_316400 alpha tubulin (TUBA1) and TGME49_318230 
phosphoglycerate kinase (PGKI) (Highlighted in Table 12).  
Interestingly, we also detected 14-3-3 in infected samples, which has been reported as 
a mediator of DC hypermotility phenotype (Weidner et al., 2016).  
In samples spiked with de-activated T. gondii, with the exception of ACT1, the 
proteins involved in maintaining the actin-myosin complex for cell invasion, and the 
tachyzoite specific proteins are absent (Table 13).  
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Table 12) 47 parasite proteins detected in 24 hour T. gondii RH infected epithelial 
sheets 
  
TGME49_204400 ATPase synthase subunit alpha, putative 
TGME49_209030 actin ACT1* 
TGME49_210690 ribosomal protein RPS6 
TGME49_211680 protein disulfide isomerase 
TGME49_216880 guanine nucleotide-binding protein  
TGME49_217890 
alkyl hydroperoxide reductase/ Thiol specific antioxidant/ 
Mal allergen, putative 
TGME49_219540 cytosolic tRNA-Ala synthetase 
TGME49_221620 beta-tubulin, putative 
TGME49_225930 triose-phosphate isomerase TPI-I 
TGME49_226250 DEAD (Asp-Glu-Ala-Asp) box polypeptide DDX3X 
TGME49_226960 phosphofructokinase PFKII 
TGME49_231630 alveolin domain containing intermediate filament IMC4*  
TGME49_231640 alveolin domain containing intermediate filament IMC1* 
TGME49_232250 catalase 
TGME49_232350 lactate dehydrogenase LDH1+ 
TGME49_232940 heat shock protein HSP20 
TGME49_233460 SAG-related sequence SRS29B 
TGME49_235470 myosin A 
TGME49_236040 fructose-1,6-bisphosphate aldolase* 
TGME49_247350 thioredoxin domain-containing protein  
TGME49_247550 heat shock protein HSP60  
TGME49_248340 GTP-binding nuclear protein ran/tc4 
TGME49_250770 eukaryotic initiation factor-4A, putative 
TGME49_251810 translation initiation factor eIF-5A, putative 
TGME49_259240 ribosomal protein RPS21 
TGME49_261010 tat-binding family protein, putative 
TGME49_261950 ATP synthase beta subunit ATP-B 
* These proteins form part of, or interact with the parasite actin-myosin complex 
required for the successful invasion of host cells 
+ These are fast-multiplying tachyzoite specific 
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Table 8 Continued) 47 parasite proteins detected in 24 hour T. gondii RH infected 
epithelial sheets 
  
TGME49_263090 14-3-3 protein 
TGME49_266960 beta tubulin 
TGME49_268850 enolase 2+ 
TGME49_269190 glyceraldehyde-3-phosphate dehydrogenase GAPDH2* 
TGME49_270510 asparaginyl-tRNA synthetase (NOB+tRNA synthase 
TGME49_273090 cell division protein CDC48CY 
TGME49_273760 heat shock protein HSP70 
TGME49_286420 elongation factor 1-alpha (EF-1-ALPHA), putative 
TGME49_288360 tryptophanyl-tRNA synthetase (TrpRS2) 
TGME49_288380 heat shock protein HSP90 
TGME49_289690 glyceraldehyde-3-phosphate dehydrogenase GAPDH1* 
TGME49_293690 profilin PRF* 
TGME49_295125 rhoptry protein ROP4 
TGME49_308090 rhoptry protein ROP5 
TGME49_310700 serine/threonine phosophatase PP1 
TGME49_311720 chaperonin protein BiP 
TGME49_313190 Rab18/RabC-family small GTPase 
TGME49_316400 alpha tubulin TUBA1+ 
TGME49_318230 phosphoglycerate kinase PGKI+ 
TGME49_320050 ribosomal protein RPL5 
* These proteins form part of, or interact with the parasite actin-myosin complex 
required for the successful invasion of host cells 
+ These are fast-multiplying tachyzoite specific 
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Table 13) 24 parasite proteins detected in epithelial sheets spiked with de-activated 
T. gondii RH 
  
TGME49_204400 ATPase synthase subunit alpha, putative 
TGME49_209030 actin ACT1 
TGME49_211680 protein disulfide isomerase 
TGME49_218260 histone H3.3 
TGME49_221620 beta-tubulin, putative 
TGME49_228210 26S proteasome regulatory subunit 
TGME49_231970 pre-mRNA processing splicing factor PRP8 
TGME49_233460 SAG-related sequence SRS29B 
TGME49_242330 ribosomal protein RPS5 
TGME49_248880 GTPase RAB7 
TGME49_258130 Rab1 protein 
TGME49_261010 tat-binding family protein, putative 
TGME49_261950 ATP synthase beta subunit ATP-B 
TGME49_266760 isocitrate dehydrogenase 
TGME49_271050 SAG-related sequence SRS34A 
TGME49_273090 cell division protein CDC48CY 
TGME49_273760 heat shock protein HSP70 
TGME49_276140 ADP ribosylation factor ARF1 
TGME49_286420 elongation factor 1-alpha (EF-1-ALPHA), putative 
TGME49_288380 heat shock protein HSP90 
TGME49_289680 Ras-related protein Rab11 
TGME49_308090 rhoptry protein ROP5 
TGME49_311720 chaperonin protein BiP 
TGME49_313190 Rab18/RabC-family small GTPase 
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Table 14)  14 parasite proteins shared in infected and spiked epithelial sheets 
  
TGME49_204400 ATPase synthase subunit alpha, putative 
TGME49_209030 actin ACT1 
TGME49_211680 protein disulfide isomerase 
TGME49_221620 beta-tubulin, putative 
TGME49_233460 SAG-related sequence SRS29B 
TGME49_261010 tat-binding family protein, putative 
TGME49_261950 ATP synthase beta subunit ATP-B 
TGME49_273090 cell division protein CDC48CY 
TGME49_273760 heat shock protein HSP70 
TGME49_286420 elongation factor 1-alpha (EF-1-ALPHA), putative 
TGME49_288380 heat shock protein HSP90 
TGME49_308090 rhoptry protein ROP5 
TGME49_311720 chaperonin protein BiP 
TGME49_313190 Rab18/RabC-family small GTPase 
 
 
Although relevant proteins for invasion were detected within 24 hour infected samples, 
the general number of parasite protein returns was low. Only 3.9% and 1.7% of 
proteins detected from infected and spiked controls were from T. gondii. Furthermore, 
there was variation in the number of host proteins identified across infected, spiked 
and non-infected control sample.  
Although the 24 hour time point would be preferable as this represents early 
replication, the number parasite proteins detected in this pilot study indicate that the 
parasite load may be too low for detection and therefore will be unsuitable for 
proteomic studies. 
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Comparably, the 40 hour time point has a higher load of replicating parasites, and 
generally a higher rate of invasion than the 24 hour. For this reason, the larger 
proteomic study will incorporate 40 hours as a time point to study host cell responses 
during parasite replication. 
5.3.10 Proteomic Analysis of Infections at 4 and 40 Hours with T. gondii RH and 
Veg 
Following the optimisation of an infection protocol to study host-pathogen interactions 
via mass spectrometry, we determined the optimal time points for the study of T. gondii 
early stage invasion. Here, using quantitative label-free mass spectrometry, we 
evaluate the protein abundance changes of T. gondii infected epithelial sheets at 4 and 
40 hours post-infection. 
Three biological replicates of epithelial monolayer cultures were infected for 4 and 40 
hours and either fixed for confocal imaging or stored for proteomics. Confocal imaging 
was used to confirm parasite invasion, and sample preparation was then performed for 
label-free mass spectrometry. 
After removal of single peptides hits, 1909 proteins were identified. Of these proteins, 
67 (3.5%) detected were T. gondii proteins.  Using exclusion criteria of p < 0.05 and 
log2 fold change > 1.0, significantly up- and down-regulated proteins at 4 and 40 hours 
were identified (Supplementary Tables 1-6, Appendix B).  
Comparison against non-infected control samples at each respective time point 
identified several differentially expressed proteins. After 4 hours incubation, of the 
detected host proteins, only 2 were down- and 3 were up-regulated by Veg infection 
(Supplementary Table 1, Appendix B), and 6 were down- and 1 was up-regulated by 
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RH infection compared to non-infected epithelial sheets (Supplementary Table 2, 
Appendix B).  
After 40 hours incubation, of the host proteins, 22 were down- and 8 were up-regulated 
with Veg infection (Supplementary Tables 3 and 4, Appendix B), and 14 were down- 
and 11 proteins were up-regulated by RH infections compared to non-infected 
epithelial sheets (Supplementary Tables 5 and 6, Appendix B). 
Comparison of Veg and RH parasite proteins at 4 and 40 hours identified very few 
differentially proteins between these time points (Table 15). A singular protein was 
significantly up-regulated from 4 to 40 hours by Veg infection; ribosomal protein 
RSP15 (TGME49_213350) (Table 15). Two proteins were significantly up-regulated 
from 4 to 40 hours by RH infection; ribosomal proteins RSP23 and RSP21 
(TGME49_229670 and TGME_252240, respectively) (Table 15). 
 
Table 15) Identification of significantly changed proteins between 4 and 40 hour 
infections of T. gondii Veg and RH Strain infections 
Accession Description P Value 
Log2 Fold 
Change 
Highest 
Condition 
TGME49_213350 
ribosomal protein 
RPS15 (RPS15) 
0.04348 4.98828 VEG 40 
TGME49_229670 
ribosomal protein 
RPS23 (RPS23) 
0.01938 14.32570 RH 40 
TGME49_259240 
ribosomal protein 
RPS21 (RPS21) 
0.01564 Infinity RH 40 
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5.3.11 A Subset of Host Proteins Was Similarly Modulated During RH and Veg 
Infections 
3 host proteins were each up- or down-regulated by both Veg and RH strains after 40 
hours incubation. Across both strains, there was an observable increase in the 
expression of host apolipoprotein A1 (APOA1), apolipoprotein A4 (APOA4) and 
chitinase-like protein 4 (CHIL4), and a downregulation in host ATP-binding cassette 
sub-family F member 2 (ABCF2), canalicular multispecific organic anion transporter 
2 (ABCC3) and pleoptropic regulator 1 (PLRG1) (Figure 51 and Supplementary Table 
7, Appendix B). 
 
 
Figure 51) A sub-set of 6 proteins were similarly modulated after 40 hour incubation with 
T. gondii RH or Veg 
Among the differentially expressed proteins, a sub-set of 6 proteins were commonly 
modulated at 40 hours infection with Toxoplasma RH and Veg parasites; APOA1, APOA4, 
CHIL4, ABCF2, ABCC3 and PLRG1. 
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CHIL4 is involved with neutrophil activity against helminth infections and the 
apolipoproteins are involved with lipid metabolism, PLRG1 is a regulator of cell 
proliferation and apoptosis, ABCC3 is involved with intracellular re-arrangement and 
ABCF2 is a cell protection factor. 
5.3.12 Modulation of Host Cell Immune Responses by T. gondii Veg Strain 
Here we examined the host-cell response to avirulent T. gondii Veg infection during 
invasion and replication at 4 and 40 hours respectively via quantitative label-free mass 
spectrometry. 
At 4 hours post infection very few changes in protein abundance were detected, 
however we observed that in particular, mitochondrial single-stranded DNA-binding 
protein (SSBP1), host dual specificity mitogen-activated protein kinase 3 (MAP2K3) 
and PDZ and LIM domain protein 1 (PDLIM1) were up-regulated (Supplementary 
Table 1 Appendix B) following 4 hour incubation with parasites. Interestingly, at 4 
hours we also detected a downregulation of apoa1 protein, involved with lipid 
biosynthesis which may act as a nutrient source during parasite scavenging.  
After 40 hours incubation, 22 proteins were down- and 8 proteins were up-regulated 
with Veg infection compared to non-infected samples (Supplementary Tables 3 and 4, 
Appendix B).  
Within the down-regulated proteins, in addition to the shared proteins described in 
chapter 5.3.11, modulation of host cell proliferation proteins was detected; 
serine/threonine-protein kinase vrk1 (VRK1), histone H1.1 (HIST1H1A) and PLRG1 
(Table 3 Appendix B). A down-regulation of four mitochondrial proteins; 28S 
ribosomal protein S30 (MRPS30), ATP-dependent Clp protease proteolytic subunit 
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(CLPP), 39S ribosomal protein L55 (MRPL55) and acyl-coA synthetase family 
member 2 (ACSF2) was also observed (Supplementary Table 3 Appendix B).  
Of the 8 up-regulated host proteins after 40 hours of Veg infection (compared to non-
infected controls), in addition to the shared proteins described in chapter 5.3.11, 
kunitz-type protease inhibitor 2 (SPINT2) which plays a role in inhibition of apoptosis 
and serine palmitoyltransferase 1 (SPTLC1) involved with sphingolipid metabolism 
were up-regulated (Supplementary Table 4, Appendix B).  
Here we also performed network analysis of detected proteins after both 4 and 40 hour 
infections to identify potential enriched functions within the data (Figure 52 and 
Figure 53).  
Network analysis of 4 hour Veg infections highlighted a change in small molecule 
biochemistry however the number of proteins identified within this network was low 
and many relationships were hypothetical, as denoted by dashed lines (Figure 52).  
Network analysis of detected proteins using IPA software identified a general down-
regulation of host cell signalling and cell-mediated immune responses after 40 hours 
(Figure 53). Here, this network also suggests a down-regulation of cytosolic host 
proteins by Veg tachyzoites after 40 hours incubation (Figure 53). 
To conclude, we have identified a general down-regulation of host cell signalling and 
cell mediated immune responses during replication of Veg parasites at 40 hours post 
infection.  
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Figure 52) Host proteins with significant changes in abundance following 4 hour infections 
with Toxoplasma gondii Veg strain parasites map to a small molecular biochemistry and 
lipid metabolism network as determined by IPA software. 
Within our dataset, 1 host protein was down-regulated (green), 2 host proteins were up-
regulated (red) and 2 were detected but not significantly differentially expressed (grey).  
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Figure 53) Host proteins with significant changes in abundance following 40 hour 
infections with Toxoplasma gondii Veg strain parasites map to a cell-cell signalling and 
cell-mediated immune response network as determined by IPA software. 
Within our dataset, 9 host proteins were down-regulated (green) and 2 host proteins were up-
regulated (red). Of the down-regulated proteins, 6 are localised within the host cell cytoplasm.   
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5.3.13 Modulation of Host Cell Lipid Metabolism by T. gondii RH Strain 
Here we examined the host-cell response to virulent T. gondii RH infection during 
invasion and replication at 4 and 40 hours respectively via proteomic approaches. 
Surprisingly, although RH is more virulent than Veg, infection induced the modulation 
of fewer host cell proteins at both 4 and 40 hours incubation. 
After 4 hours infection, we observed a down-regulation in sulfhydryl oxidase 1 
(QSOX1) which plays a role in morphogenesis and tissue remodelling, and signal 
transducer and activator of transcription 1 (STAT1) (Supplementary Table 2 Appendix 
B) which is an important component of the IFN-γ pathway. 
After 40 hours infection, 14 proteins were down- and 11 proteins were up-regulated 
by RH infections (Supplementary Tables 5 and 6, Appendix B).  
Here, in addition to the shared proteins described in chapter 5.3.11, we observed a 
down-regulation of 2 salvage pathway proteins; l-fucose kinase (FUK) and sodium 
bicarbonate cotransporter 3 (SLC4A7), a barrier function protein cornifin a (SPRR1A) 
and 3 cell proliferation proteins; polyribonucleotide nucleotidyltransferase 1 (PNPT1), 
MMS19 nucleotide excision repair protein homolog (MMS19) and U6 snRNA-
associated sm-like protein LSm7 (LSM7). 
Of the up-regulated proteins, in addition to the shared proteins described in chapter 
5.3.11, an anti-microbial peptide, alpha-defensin 22 (DEFA22), an isoprenoid 
biosynthesis protein, mevalonate kinase (MVK) and two intermicrovillar adhesion 
complex proteins; ankyrin repeat and SAM domain-containing protein 4B (ANKS4B) 
and cadherin-related family member 2 (CDHR2) were up-regulated (Supplementary 
Table 6, Appendix B). 
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Here we also performed network analysis of detected proteins after both 4 and 40 hour 
infections to identify potential enriched functions within the data.  
Analysis of 4 hour RH infections highlight a change in tissue morphology network and 
stat1 signalling, however the number of proteins identified belonging to this network 
was low (Figure 54 and Figure 55). 
 
Figure 54) Host proteins with significant changes in abundance following 4 hour infection 
with Toxoplasma gondii RH strain map to a tissue morphology network as determined by 
IPA software. 
Within our dataset, 3 host proteins were down- (green), 1 host protein was up-regulated (red) 
and 6 were detected but not significantly differentially expressed (grey).  
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Network analysis of detected proteins using IPA software identified an up-regulation 
in host cell lipid metabolism after 40 hour incubations with RH tachyzoites. Here this 
network identified 11 up-regulated proteins with a shared function involving lipid 
metabolism (Figure 55). 
 
Figure 55) Host proteins with significant changes in abundance following 40 hour 
infection with Toxoplasma gondii RH strain map to a lipid metabolism network as 
determined by IPA software. 
Within our dataset, 1 host protein was down-regulated (green), 11 host proteins were 
up-regulated (red) and 8 proteins were detected but not significantly differentially 
expressed.  
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To conclude, we have identified a lower number of host-proteins significantly 
differentially modulated by infection with RH than with Veg tachyzoites. However RH 
infection appears to modulate lipid metabolism to a higher extent than during Veg 
infections. 
5.4.4 Discussion 
Existing models of the small intestine are limited for the study of host responses to 
early stage invasion. Using the collagen-supported epithelial sheet model developed 
in chapter 4, we optimised an infection protocol to analyse changes in host proteome 
during active invasion and parasite replication by T. gondii RH and Veg strains.  
T. gondii is widely considered to be capable of infecting almost all nucleated cells of 
warm-blooded vertebrates, and is easily maintained in cell culture. It was therefore 
surprising that very low infection rates were observed in our collagen-supported 
epithelial model. 
During pilot infections, we observed that parasites were concentrated on uncovered 
regions of the collagen gel, at the perimeter of the epithelial sheets. We evaluated 
several optimization steps to create a more uniform distribution of parasites with the 
aim to increase invasion of host cells, however success was modest. 
Complex in vitro models such as collagen-supported epithelial sheets may be 
comparatively more challenging than cell lines to infect due to the presence of Paneth 
and goblet cells that are known to play a role in host defence against pathogens. As the 
inner layer of colonic mucus is devoid of bacteria, and the composition of small 
intestinal mucus shares some similar proteins, the presence of these secreted mucus 
components in the collagen-supported epithelial model may contribute to the 
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inhibition of invasion here. However, this is not confirmed here as we only observed 
an increased invasion with one NAC treatment. Further work would be required to 
assess the presence of a mucus layer. Finally, type I T. gondii exhibit LDM phenotype 
and are thought to utilize a paracellular route of transmigration across the intestinal 
epithelium. However, we did not observe large numbers of parasites accumulating 
beneath epithelial sheets, which suggests that this is not responsible for the low levels 
of invasion reported here. 
In vivo, T. gondii is thought to infect the tip of the villus (Coombes et al., 2013). 
However, it is currently unknown whether parasites preferentially invade enterocytes 
at the villus tip, or whether they are simply more accessible. In this collagen-supported 
epithelial model, we have not yet analysed whether T. gondii preferentially targets a 
specific epithelial cell type. However, the confirmed presence of a variety of fully 
differentiated epithelial cells makes this possible. Examining this aspect of invasion 
may uncover some interesting parasite biology to explain the discrepancies observed 
between this collagen-supported epithelial model and cell line models. Live cell 
imaging of parasite behavior using collagen-supported epithelial sheets generated from 
Cre-reported mice may also help us to understand these early stage interactions (Koshy 
et al., 2010). 
Having determined suitable time points to represent early host cell invasion and 
parasite replication, we exploited quantitative label-free mass spectrometry to study 
the host cell response. During early stage invasion, very few significant changes in 
protein abundance were observed. Of note, STAT1 was decreased in abundance 
following infection with T. gondii RH strain. Previous studies have shown that all three 
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clonal lineages of T. gondii can block STAT1-mediated transcription when cells are 
infected prior to exposure to IFN-γ (Rosowski et al., 2014).  
Although few changes were observed after 4 hour infection, at 40 hour post infection 
with both T. gondii strains we report changes in abundance of proteins involved with 
lipid metabolism and cell proliferation. T. gondii relies on scavenged host molecules 
for survival. The parasite is unable to synthesis its own cholesterol, and instead uses 
host cell cholesterol for survival. Moreover, despite being capable of synthesizing 
parasite lipoic acid, Toxoplasma are also reported to scavenge host lipoic acid and 
growth inhibition has been observed in lipoate-deficient conditions (Crawford et al., 
2006). 
In both RH and Veg strain infections, we report an increased abundance of APOA1 
and APOA4 which are major components of high density lipoproteins and are involved 
in host cell lipid metabolism pathways (Schaefer et al., 1982). Furthermore, we show 
that a large proportion of the host cell proteins with significant changes in abundance 
after 40 hour infection with RH belong to a lipid metabolism network. For example, 
we also observed an increase in an isoprenoid biosynthesis protein, MVK, which 
agrees with previous transcriptomic studies that have reported increased transcription 
of glycolytic and mevalonate enzymes (Blader et al., 2001). Isoprenoids are organic 
compounds required in cell signalling and survival.  Although apicomplexa can 
synthesis precursors within their apicoplast, Toxoplasma are still reliant on importing 
host cell isoprenoids for survival and so targeting of both host and parasite mevalonate 
pathways may be an appropriate therapy against apicomplexan infections (Li et al., 
2013). 
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The observation of increased abundance of proteins involved in host lipid metabolism 
is consistent with nutrient scavenging required for parasite replication and survival, 
and may represent active modulation of host cell machinery by the parasite to aid its 
survival. Interestingly, although less proteins were changed in abundance in response 
to RH strain infection, more proteins involved with lipid metabolism were altered than 
in Veg infected cells. This finding indicates that the two lineages examined here differ 
in their ability to modulate host proteome response and deploy different strategies of 
parasite survival. 
At 40 hours infection with Veg, we also observed an increased abundance of host 
SPINT2, involved with the inhibition of apoptosis. Along with the changes induced in 
host cell metabolism, the changes in the abundance of these proteins are characteristic 
of pro-parasite responses that are induced by T. gondii to ensure parasite survival 
(Spear et al., 2006). A number of studies have demonstrated that T. gondii modulates 
host apoptosis through multiple mechanisms, such as; blocking upstream signaling, 
interfering with caspase 8 processing and function and affecting the balance of pro-
and anti-apoptotic BCL-2 family member proteins (Molestina, 2003; Nelson et al., 
2008; Shapira et al., 2002; Vutova et al., 2007). This modulation of apoptotic processes 
is thought to enhance parasite survival. 
Furthermore, we observed a modulation of host cell proliferation proteins (VRK1, 
HIST1H1A and PLRG1) by 40 hours in Veg but not RH infected samples 
(Kleinridders et al., 2009; Molitor and Traktman, 2013; Schober et al., 2011). Host 
cell cycle arrest has been previously reported in T. gondii infection (Brunet et al., 2008; 
Molestina et al., 2008; Nelson et al., 2008), however the roles of these three particular 
proteins in determining the outcome of infection are not yet known. 
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In addition to these pro-parasite infection induced changes in protein abundance, we 
also observed an increase in pro-host proteins as a result of infection. These are 
described as genes or proteins required by the host cell to defend against parasite 
invasion (Spear et al., 2006). Very few of these proteins were observed to have 
significant changes in abundance however after 40 hours RH infection we detected an 
increased abundance of host protection factor DEFA22. Mammalian alpha-defensins 
are antimicrobial peptides produced by intestinal Paneth cells and play a significant 
role in innate host defence. In vivo, the secretion of alpha-defensins in response to 
Toxoplasma is regulated in a TLR9 dependent manner (Foureau et al., 2010; Menendez 
et al., 2013). Generally, the alpha-defensins are significant in the tolerance of bacterial 
invasions (Salzman, 2010; Salzman et al., 2003a), and the modulation of related host 
cell β-defensin-2 is thought to be a host-evasion mechanism exploited by Type I 
Toxoplasma (Morampudi et al., 2011). However, the role of DEFA22 during 
Toxoplasma infection is not yet understood. Additional studies are required to 
determine the role of defa22 during Toxoplasma invasion events. 
Clearly, evaluating host response in this epithelial sheet model by proteomic 
approaches demonstrates the ability to detect known characteristics of T. gondii 
infection including modulation of host cell lipid metabolism and an inhibition of host 
cell proliferation. However as discussed previously, the small volume of biological 
material and variability across wells limits the use of this model to study change in the 
parasite proteome. As a consequence, almost no changes in parasite protein abundance 
between the 4 and 40 hour infection time points were detected, making this model in 
its current form unsuitable for the study of parasite changes during infection. The 
inclusion of parasite spiked controls are generally included in cell line studies, 
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however due to the low expected number of protein hits based on pilot studies, this 
control was not used here.  
For this model to produce enough parasite proteins for detection, it is recommended 
that this technique is up-scaled to larger sized wells from 30µL collagen domes in 48-
well plates, to 24- or 12- well plates, and the number of replicates increased to generate 
a larger volume of experimental material for analysis. Due to time constraints this was 
not performed within this doctoral project, however the up-scaling of this technique is 
achievable with some minor adjustments to the culture and infection protocols. 
To conclude, this chapter demonstrates the capabilities of this novel model to be used 
for infection studies, and highlights some improvements that can be implemented to 
improve this model. We have identified strain specific host proteome modifications, 
with Veg strain inducing host cell cycle arrest, whereas RH strain up-regulates host 
cell lipid metabolism. Furthermore, we have identified changes in abundance of 
DEFA22 that currently has an unknown role during Toxoplasma infection. 
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Chapter 6 – Summary and Forward Perspectives 
The understanding of invasion mechanisms of enteric pathogens has primarily been 
elucidated via the use of in vitro and in vivo models of infection. However the early 
stage invasion events exploited by enteric pathogens is poorly understood due to a lack 
of suitable models. Since the identification of the intestinal stem cell marker, LGR5, 
3D organoid models have been successfully established (Barker et al., 2012; Sato et 
al., 2009). These “mini-gut” models promise to be useful tools to study enteric 
pathogens. 
Several areas of interest would benefit from the use of organoids; the study of Paneth 
and goblet cell for host defence and the study of early stage enteric protozoal invasion.  
Paneth cells and goblet cells play significant roles in gut homeostasis and the 
regulation of gut microbiota (Farin et al., 2014; Fernandez et al., 2008; Salzman et al., 
2010; Schulz and Pabst, 2013), however their specific interactions with enteric 
pathogens are largely still poorly understood. Due to their naturally low occurrence of 
these cell types in vivo and a lack of in vitro alternatives, the directed differentiation 
of organoid cultures to produce enriched Paneth and goblet cell populations has gained 
interest (Yin et al., 2014). These enriched organoid cultures have been characterised 
via molecular and transcriptomic approaches (Yin et al., 2014), however due to 
reported discrepancies between the transcript level and protein abundance in vitro, 
proteome analysis must also be performed to validate their use for infection studies 
(Xia et al., 2008).  
Although these organoids are attractive tools for the study of host-pathogen 
interaction, a limiting characteristic of organoid cultures is their restricted luminal 
access which can only be bypassed via microinjection (Wilson et al., 2014; Zhang et 
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al., 2014). However, microinjection is not suitable for the establishment of protozoal 
infections due to challenges with optimizing this technique for larger protozoan 
parasites. The work presented in this doctoral thesis addresses these current limitations 
of organoids by demonstrating the amenability of enriched organoid cultures to 
proteomic analysis, presenting a novel modified protocol for the culture of 
differentiated and polarized epithelial monolayers, and, demonstrating the suitability 
of the model for the study of parasite induced host proteome changes via label free 
mass spectrometry and confocal microscopy.  
In chapter 3, the establishment of 3D organoid cultures followed by modulation of 
differentiation pathways with the use of DAPT in combination of CHIR or IWP-2 
drives epithelial cells toward the Paneth cell or goblet cell lineages. Quantitative label-
free mass spectrometry was used for the comparative study of Paneth and goblet-
enriched organoid proteome compared to non-treated controls. The main challenge 
concerned with the combination of these techniques was low volume of organoid 
material for mass spectrometry. By pooling multiple wells of organoid samples, the 
number of proteins detected were sufficient to perform comparative analysis. 
Evaluation of enriched Paneth and goblet cell organoid proteomes via label free mass 
spectrometry has demonstrated the ability to successfully combine these two 
technologies. These enriched organoids contained an increased abundance of proteins 
associated with secretory cells, mucus components (in goblet enriched) and MMP7 (in 
Paneth enriched). We also identified a protein, DNAJC3, that had not previously been 
described in Paneth cells, but that was increased in abundance in Paneth-skewed 
cultures, and enriched within Paneth cells by IHC. A potential role for DNAJC3 in 
Paneth cell differentiation or function deserves further exploration. 
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The findings here demonstrate the success of using proteomic approaches to study 
organoid cultures, specifically to investigate the host defence functions of Paneth and 
goblet cells in vitro. The enriched organoid cultures in this 3D conformation are still 
limited for infection studies due to their restricted luminal access, leading to the work 
performed in chapter 4. 
In chapter 4, the modification of organoid cultures led to the establishment of 
differentiated and polarized intestinal epithelial monolayers in vitro as a method to 
bypass restricted luminal access of 3D organoid cultures. The effect of organoid 
modification on cell arrangement, cell differentiation and sheet polarization was 
addressed. The distribution of Paneth and goblet cells suggest a presence of 
differentiated micro-domains within the inner regions of the epithelial sheets which 
may mimic the crypt like domains in vivo. Quantification of these cells in epithelial 
sheets confirms the retention of these populations in the novel model after 8 days in 
culture, albeit at a lower rate than 3D organoids. The collagen-supported epithelial 
sheets also showed features consistent with polarization, which is important for the 
correct localization and function of pathogen recognition receptors in vivo, and thus is 
an important feature of intestinal infection models in vitro. 
Analysis of organoid models by mass spectrometry revealed a variability in the 
numbers of proteins detected across different pooled epithelial sheet and 3D organoid 
samples. The disruption of organoids during passage is non-uniform and the number 
of crypt buds re-embedded in this process is difficult to standardize. As a result, we 
faced challenges with seeding the same number of intestinal stem cells per well 
resulting in discrepancies in the size of epithelial sheets between samples. This in turn 
impacts the robustness of using mass spectrometry on small samples, as the availability 
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of biological material is low. Moving forward, the experimental design of infection 
studies must be carefully considered to ensure sufficient biological material is 
available for detection of large numbers of proteins by mass spectrometry.  
The development of this model benefits the field of infection biology by providing an 
alternative model to the use of immortalized cell line cultures to study enteric 
infections. These findings led to the use of this epithelial model to study early stage 
invasion of murine intestinal epithelial cells by Toxoplasma gondii. 
In chapter 5, the collagen-supported epithelial model was exploited to study the host 
response to early invasion and Toxoplasma gondii replication. Confocal microscopy 
was used to examine the progression of infection over time, revealing a lag in host cell 
invasion and parasite proliferation in comparison to reported observations in cell line 
infections, likely due to the presence of Paneth and goblet cells that have important 
roles in host defence. Generally during pilot infection assays, invasion of host cells 
was low during early stage invasion, resulting in poor detection of parasite proteins 
during mass spectrometry test runs. Consequently, observations of significant parasite 
proteome changes were limited within this system without up-scaling the volume of 
experimental material, however this was not achievable within the time frame of this 
project. The time and labour required to generate additional experimental replicates 
and a larger number of wells was a major drawback in this investigation but could be 
incorporated into future studies.  Regardless of this challenge, this study demonstrated 
that proteins involved in host cell cycling, apoptosis, cell mediated immune response 
and lipid metabolism were modulated in response to Toxoplasma infections. These 
findings agree with current literature of T. gondii invasion (Al-Bajalan et al., 2017; 
Blader et al., 2001; Butcher et al., 2001; Guiton et al., 2017; Nelson et al., 2008), to 
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provide supporting evidence for use of label free mass spectrometry with this model 
to study parasite-induced host proteome changes, even during short term infections. 
Within this chapter we also show that Veg and RH strain infections elicit distinct 
modifications in the abundance of host cell proteins. 
This doctoral thesis has addressed some of the structural limitations of current 
intestinal models for the study of enteric pathogens. The development of an in vitro 
epithelial monolayer model widens the scope for future study of host-pathogen 
interactions by providing an alternative in vitro model to cell lines. Moving forward, 
several lines of investigation could be considered based on the findings reported here. 
Firstly, the transmigration of parasites across the host epithelium has not yet been fully 
described in vivo although some mechanisms have been described (Barragan and 
Sibley, 2002; Weight et al., 2015). The poor suitability of existing models limited the 
ability to study these early stage events, however, the establishment of the novel 
epithelial model provides the means to apply live imaging techniques in vitro to 
visualize the parasite invasion of a fully differentiation and polarized epithelial 
monolayer in real time.  
Secondly, during natural infections, bradyzoite and sporozoite forms of Toxoplasma 
are ingested to infect the intestinal epithelium. Due to difficulties obtaining bradyzoite 
and sporozoite stages of Toxoplasma, infections in this thesis were performed with 
tachyzoite stages that can be cultured in vitro. Although current literature has 
demonstrated that sporozoites and tachyzoites have some shared characteristics and 
express a core set of proteins for host cell invasion, these proteins are expressed at 
different abundancies (Guiton et al., 2017), and stage specific parasite proteins have 
also been identified (Dubey et al., 1998; Schwarz et al., 2005). Therefore expanding 
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the model to the study of other parasite stages would provide insights into the host-
pathogen communication mechanisms during early stage invasion and potentially 
identify relevant parasite molecular signaling pathways that could be exploited for the 
development of novel therapeutics. 
Thirdly, having determined that 3D organoids can be successfully characterised by 
mass spectrometry following drug-skewing, this technology could be adapted to 
generate Paneth or goblet-enriched epithelial sheets with the view to study defence 
functions in response to microbial stimulation.   
Lastly, the development of this model to generate a co-culture model which integrates 
intraepithelial lymphocytes, or other immune cell populations, would be beneficial for 
the study of more complex interactions. To date, the development of organoid co-
cultures has been limited. A recently study utilized organoid cultures for the expansion 
of intraepithelial lymphocytes, however an infection model has yet to be developed 
(Nozaki et al., 2016). 
The development of a collagen-supported epithelial sheet in this doctoral thesis has 
established a novel in vitro tool to study T. gondii host-pathogen interactions via 
quantitative label-free mass spectrometry and confocal microscopy, and can be 
extrapolated to include other enteric pathogens. This thesis has also highlighted several 
routes of investigation in which further work is required to elucidate the complexities 
of host-pathogen interaction for the identification of appropriate vaccine targets or 
signaling pathways for the development of therapeutics. 
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Supplementary Table 1) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P54869 3-hydroxy-3-methylglutaryl-
CoA synthase 2 (mitochondrial) 
(HMGCS2) 
Condenses acetyl-CoA with 
acetoacetyl-CoA to form HMG-CoA, 
which is the substrate for HMG-CoA 
reductase. 
Cytoplasm 0.00953 0.00032 ▲2.436 
P81117 Nucleobindin-2 (NUCB2) Calcium-binding protein. May have a 
role in calcium homeostasis. 
Nucleus 0.01100 0.00076 ▲2.432 
Q64459 Cytochrome P450 3A11 
(CYP3A11); CYP3A5  
Catalyzes erythromycin N-
demethylation, nifedipine oxidation and 
testosterone 6 beta-hydroxylation. 
Cytoplasm 0.00972 0.00027 ▲2.103 
Q64458 Cytochrome P450 2C29 
(CYP2C29); CYP2C8 
Metabolizes arachidonic acid to produce 
14,15-cis-epoxyeicosatrienoic acid 
(EET). 
Cytoplasm 0.00464 0.00008 ▲2.069 
Q9D816 Cytochrome P450 2C55 
(CYP2C55); CYP2C18 
Metabolizes arachidonic acid mainly to 
19-hydroxyeicosatetraenoic acid 
(HETE).  
Cytoplasm 0.00980 0.00041 ▲1.896 
Q10738 *Matrilysin (MMP7) Degrades casein, gelatins of types I, III, 
IV, and V, and fibronectin.  
Extracellular 
Space 
0.01169 0.00093 ▲1.785 
* Differentiated cell marker of Paneth cells 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P19324 Serpin H1 (SERPINH1) Binds specifically to collagen. Could be 
involved as a chaperone in the 
biosynthetic pathway of collagen. 
Extracellular 
Space 
0.04760 0.01640 ▲1.737 
O55071 Cytochrome P450 2B19 
(CYP2B19) 
In liver microsomes, this enzyme is 
involved in an NADPH-dependent 
electron transport pathway. It oxidizes a 
variety of structurally unrelated 
compounds, including steroids, fatty 
acids, and xenobiotics. 
Cytoplasm 0.00942 0.00026 ▲1.685 
P02088 Hemoglobin, Beta Adult Major 
Chain (HBB-B1) 
Involved in oxygen transport from the 
lung to the various peripheral tissues. 
Extracellular 
Space 
0.01660 0.01820 ▲1.683 
P26339 Chromogranin-A (CHGA) Secretory protein Cytoplasm 0.00049 <0.00001 ▲1.665 
       
P35441 Thrombospondin 1 (THBS1) Adhesive glycoprotein that mediates 
cell-to-cell and cell-to-matrix 
interactions. 
Extracellular 
Space 
0.00944 0.00031 ▲1.561 
P12791 Cytochrome P450 2B10 
(CYP2B10); CYP2B6 
In liver microsomes, this enzyme is 
involved in an NADPH-dependent 
electron transport pathway. It oxidizes a 
variety of structurally unrelated 
compounds, including steroids, fatty 
acids, and xenobiotics. 
Cytoplasm 0.00560 0.00011 ▲1.523 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P52825 Cartinine (CPT2) Catalytic activity; Palmitoyl-CoA + L-
carnitine = CoA + L-palmitoylcarnitine. 
Cytoplasm 0.02090 0.00302 ▲1.509 
Q05421 Cytochrome P450 2E1 
(CYP2E1) 
Metabolizes several precarcinogens, 
drugs, and solvents to reactive 
metabolites. 
Cytoplasm 0.02870 0.00593 ▲1.499 
O88310 Intelectin-1 (ITLN1) May play a role in the defense system 
against microorganisms. May 
specifically recognize carbohydrate 
chains of pathogens and bacterial 
components containing galactofuranosyl 
residues, in a calcium-dependent 
manner. 
Plasma 
Membrane 
0.00470 0.00008 ▲1.490 
Q78KK3 Solute Carrier Family 22 
Member 18 (SLC22A18) 
May act as a transporter of organic 
cations based on a proton efflux antiport 
mechanism. 
Plasma 
Membrane 
0.01150 0.00087 ▲1.463 
Q91VE0 Solute Carrier Family 27 
Member 4 (SLC27A4) 
Involved in translocation of long-chain 
fatty acids (LFCA) across the plasma 
membrane. Appears to be the principal 
fatty acid transporter in small intestinal 
enterocytes. Plays a role in the 
formation of the epidermal barrier.  
 
Plasma 
Membrane 
0.03860 0.00109 ▲1.407 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
Q80W94 2-Acylglycerol O-
Acyltransferase (MOGAT2) 
Catalyzes the formation of 
diacylglycerol from 2- 
monoacylglycerol and fatty acyl-CoA. 
Cytoplasm 0.01150 0.00856 ▲1.406 
A2AFS3 Protein KIAA1324 (KIAA1324) May protect cells from cell death by 
inducing cytosolic vacuolization and 
upregulating the autophagy pathway. 
 
Plasma 
Membrane; 
Endosome; 
Golgi 
Apparatus; 
Lyosome 
0.01060 0.00588 ▲1.361 
P16014 Chromogranin B/Secretogranin 
(CHGB) 
Neuroendocrine secretory granule 
protein, which may be the precursor for 
other biologically active peptides. 
Extracellular 
Space 
0.01050 0.00048 ▲1.347 
       
       
Q3UW53 Protein Niban (FAM129A) Regulates phosphorylation of a number 
of proteins involved in translation 
regulation including EIF2A, EIF4EBP1 
and RPS6KB1. 
Cytoplasm 0.00942 0.00030 ▼4.544 
Q8K2Z4 Condensin Complex Subunit 1 
(NCAPD2) 
RIKEN cDNA 5330417C22 gene. Nucleus 0.02830 0.00566 ▼2.296 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
Q8BHB9 Chloride Intracellular Channel 
Protein 6 (CLIC6) 
May insert into membranes and form 
chloride ion channels. May play a 
critical role in water-secreting cells, 
possibly through the regulation of 
chloride ion transport. 
Plasma 
Membrane 
 
0.00464 0.00006 ▼2.221 
O70310 N-Myristoyltransferase 1 
(NMT1) 
Adds a myristoyl group to the N-
terminal glycine residue of certain 
cellular proteins. 
Cytoplasm 0.00250 0.00423 ▼2.185 
Q3UZZ4 ^Olfactomedin-4 (OLFM4) Facilitates cell adhesion, most probably 
through interaction with cell surface 
lectins and cadherin. May promote 
proliferation of pancreatic cancer cells 
by favoring the transition from the S to 
G2/M phase.  
Extracellular 
Space 
0.00391 0.00004 ▼2.138 
P45377 Aldose Reductase-Related 
Protein 2 (AKR1B10) 
Catalytic activity; Alditol + NAD(P)+ = 
aldose + NAD(P)H. 
Cytoplasm 0.02050 0.00284 ▼1.997 
^ Stem cell marker of Lgr5+ intestinal stem cells 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P02798 Metallothionein-2 (MT2) Metallothioneins have a high content of 
cysteine residues that bind various 
heavy metals; these proteins are 
transcriptionally regulated by both 
heavy metals and glucocorticoids. 
Other 0.03757 0.01050 ▼1.890 
       
Q62189 U1 Small Nuclear 
Ribonucleoprotein A (SNRPA) 
Component of the spliceosomal U1 
snRNP, which is essential for 
recognition of the pre-mRNA 5' splice-
site and the subsequent assembly of the 
spliceosome.  
Nucleus 0.03413 0.009180 ▼1.681 
P51432 Phospholipase C, Beta 3 
(Phosphatidylinositol-specific) 
(PLCB3) 
The production of the second messenger 
molecules diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3) is 
mediated by activated 
phosphatidylinositol-specific 
phospholipase C enzymes. 
Cytoplasm 0.00782 0.00182 ▼1.631 
 Appendix A – Chapter 3 Supplementary Data    P a g e  | 258 
Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
Q4VAA2 Protein CDV3 (CDV3) Uncharacterised Cytoplasm 0.01145 0.00081 ▼1.616 
P62960 Y Box Binding Protein 1 
(YBX1) 
Mediates pre-mRNA alternative 
splicing regulation. The secreted form 
acts as an extracellular mitogen and 
stimulates cell migration and 
proliferation. 
Nucleus 0.00980 0.00413 ▼1.608 
P61290 Proteasome Activator Complex 
Subunit 3 (PSME3) 
Subunit of the 11S REG-gamma (also 
called PA28-gamma) proteasome 
regulator, a doughnut-shaped 
homoheptamer which associates with 
the proteasome.  
Cytoplasm 0.03230 0.00510 ▼1.544 
Q8VCN5 Cystathionine (CTH) Catalyzes the last step in the trans-
sulfuration pathway from methionine to 
cysteine. 
Cytoplasm 0.00955 0.00033 ▼1.519 
Q61753 D-3-Phosphoglycerate 
Dehydrogenase (PHGDH) 
Catalytic activity associated with 
amino-acid biosynthesis and L-serine 
biosynthesis 
Cytoplasm 0.00392 0.00042 ▼1.510 
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Supplementary Table 1 Continued) Top 20 proteins up- and down-regulated in DAPT/CHIR (Paneth Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
Q8CAY6 Acetyl-CoA Acetyltransferase 
(ACAT2) 
Catalytic activity; 2 acetyl-CoA = CoA 
+ acetoacetyl-CoA. 
Cytoplasm 0.01380 0.00142 ▼1.501 
Q61166 Microtubule-Associated Protein 
RP/EB Family Member 1 
(MAPRE1) 
Binds to the plus end of microtubules 
and regulates the dynamics of the 
microtubule cytoskeleton. Promotes 
cytoplasmic microtubule nucleation and 
elongation. May be involved in spindle 
function by stabilizing microtubules and 
anchoring them at centrosomes. 
Cytoplasm 0.02110 0.00319 ▼1.354 
Q9CQM9 Glutaredoxin 3 (GLRX3)  Has an essential function in 
embryogenesis. 
Cytoplasm 0.01380 0.00142 ▼1.334 
Q9ER72 Cysteine-tRNA Ligase, 
Cytoplasmic (CARS) 
Catalytic activity; ATP + L-cysteine + 
tRNA(Cys) = AMP + diphosphate + L-
cysteinyl-tRNA(Cys). 
Cytoplasm 0.02060 0.00291 ▼1.330 
P17918 Proliferating Cell Nuclear 
Antigen (PCNA) 
Auxiliary protein of DNA polymerase 
delta and is involved in the control of 
eukaryotic DNA replication by 
increasing the polymerase's 
processibility during elongation of the 
leading strand.  
Nucleus 0.01170 0.00093 ▼1.326 
Q62433  Protein NDRG1 (NDRG1) Stress-responsive protein involved in 
hormone responses, cell growth, and 
differentiation.  
Nucleus 0.03220 0.00772 ▼1.287 
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Supplementary Table 2) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids  
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
Q9D7Z6 *Calcium-Activated Chloride 
Channel Regulator 1 (CLCA1) 
Known component of small intestinal 
mucus. May be involved in the 
regulation of mucus production and/or 
secretion by goblet cells.  
Plasma 
Membrane 
0.00347 0.00044 ▲3.328 
P02772 *Alpha-fetoprotein (AFP)  Binds estrogens, fatty acids and metals. Extracellular 
Space 
0.00866 0.00366 ▲2.939 
P26339 *Chromogranin-A (CHGA)  Pancreastatin strongly inhibits glucose 
induced insulin release from the 
pancreas. 
Cytoplasm 0.01349 0.00103 ▲2.859 
P19324 Serpin H1 (SERPINH1) Binds specifically to collagen. Could be 
involved as a chaperone in the 
biosynthetic pathway of collagen. 
Extracellular 
Space 
0.04147 0.01470 ▲2.846 
P09240 *Cholecystokinin (CCK)  Induces gall bladder contraction and the 
release of pancreatic enzymes in the 
gut. 
Extracellular 
Space 
0.01682 0.00158 ▲2.828 
Q64459 Cytochrome P450 3A11 
(CYP3A11); CYP3A5 
Catalyzes erythromycin N-
demethylation, nifedipine oxidation and 
testosterone 6 beta-hydroxylation. 
Cytoplasm 0.00867 0.00035 ▲2.810 
P20152 Vimentin (VIM) Class-III intermediate filaments found 
in various non-epithelial cells. 
Cytoplasm 0.01043 0.00053 ▲2.481 
Q62395 *Trefoil Factor 3 (TFF3)  Involved in the maintenance and repair 
of the intestinal mucosa. 
Extracellular 
Space 
0.04095 0.01430 ▲2.383 
* Differentiated cell markers of goblet/enteroendocrine cells 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P48756 Gastric inhibitory polypeptide 
(GIP) 
*Potent stimulator of insulin secretion 
and relatively poor inhibitor of gastric 
acid secretion. 
Extracellular 
Space 
0.01174 0.00066 ▲2.360 
Q8K0C5 Zymogen granule membrane 
protein 16 (ZG16) 
May play a role in protein trafficking Extracellular 
Matrix; 
Extracellular 
Matrix 
0.03616 0.01062 ▲2.266 
P16110 Galectin-3 (LGALS3) Together with DMBT1, required for 
terminal differentiation of columnar 
epithelial cells during early 
embryogenesis.  
Extracellular 
Space 
0.00431 0.01620 ▲2.199 
Q99P58 + Ras-Related Protein Rab-27B 
(RAB27B) 
May be involved in targeting uroplakins 
to urothelial apical membranes. 
Cytoplasm 0.04033 0.01320 ▲2.139 
       
Q8BND5 Sulfhydryl oxidase 1 (QSox1) Catalyzes the oxidation of sulfhydryl 
groups in peptide and protein thiols to 
disulfides with the reduction of oxygen 
to hydrogen peroxide. May contribute to 
disulfide bond formation in a variety of 
secreted proteins 
Extracellular 
Space;Golgi 
Apparatus; 
Endoplasmic 
Reticulum; 
Extracellular 
Vesicular 
Exosome 
0.03340 0.00794 ▲2.095 
* Differentiated cell markers of goblet/enteroendocrine cells 
+ Proteins associated with secretion in other organs 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
P16014 * Chromogranin-B (CHGB); 
Secretogranin-1  
Neuroendocrine secretory granule 
protein, which may be the precursor for 
other biologically active peptides. 
Extracellular 
Space 
0.02089 0.00235 ▲2.039 
Q78KK3 Solute Carrier Family 22 
Member 18 (SLC22A18) 
May act as a transporter of organic 
cations based on a proton efflux antiport 
mechanism. 
Plasma 
Membrane 
0.00866 0.00031 ▲1.902 
O88312 *Anterior Gradient Protein 2 
(AGR2) 
Required for MUC2 post-transcriptional 
synthesis and secretion. 
Extracellular 
Space 
0.04257 0.00153 ▲1.857 
P52624 Uridine Phopshorylase 1 (UPP1) Catalyzes the reversible phosphorylytic 
cleavage of uridine and deoxyuridine to 
uracil and ribose- or deoxyribose-1-
phosphate.  
Cytoplasm 0.02203 0.00333 ▲1.825 
Q9JJX6 P2X Purino Receptor (P2RX4) Receptor for ATP that acts as a ligand-
gated ion channel. 
Plasma 
Membrane 
0.00256 0.00459 ▲1.758 
Q64133 Amine Oxidase (Flavin-
Containing) A (MAOA) 
Catalyzes the oxidative deamination of 
biogenic and xenobiotic amines and has 
important functions in the metabolism 
of neuroactive and vasoactive amines in 
the central nervous system and 
peripheral tissues.   
Cytoplasm 0.00578 0.00009 ▲1.754 
Q9R112 Sulfide:Quinone 
Oxidoreductase, Mitochonrdrial 
(SQRDL) 
Catalyzes the oxidation of hydrogen 
sulfide with the help of a quinone, such 
as ubiquinone, giving rise to thiosulfate 
and ultimately to sulfane (molecular 
sulfur) atoms. 
Cytoplasm 0.00866 0.00032 ▲1.709 
* Differentiated cell markers of goblet/enteroendocrine cells 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
Q9R112 Sulfide:Quinone 
Oxidoreductase, Mitochonrdrial 
(SQRDL) 
Catalyzes the oxidation of hydrogen 
sulfide with the help of a quinone, such 
as ubiquinone, giving rise to thiosulfate 
and ultimately to sulfane (molecular 
sulfur) atoms. 
Cytoplasm 0.00866 0.00032 ▲1.709 
       
E9Q1P8 
 
Interferon Regulatory Factor 2-
Binding Protein 2 (IRF2BP2) 
Acts as a transcriptional corepressor in a 
IRF2-dependent manner, this repression 
is not mediated by histone deacetylase 
activities.  
Cytoplasm 
Nucleoplasm
Nucleus 
0.00203 0.003313 ▼2.588 
Q3UZZ4 ^Olfactomedin-4 (OLFM4) Facilitates cell adhesion, most probably 
through interaction with cell surface 
lectins and cadherin. May promote 
proliferation of pancreatic cancer cells 
by favoring the transition from the S to 
G2/M phase.  
Extracellular 
Space 
0.02152 0.00001 ▼2.337 
P34022 Ran-Binding Protein 3 
(RANBP3) 
May act in an intracellular signaling 
pathway which may control the 
progression through the cell cycle by 
regulating the transport of protein and 
nucleic acids across the nuclear 
membrane. 
Nucleus 0.02179 0.00615 ▼2.297 
* Stem cell marker 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
Q8K2Z4 Non-SMC Condensin 1 
Complex, Subunit D2 
(NCAPD2) 
Regulatory subunit of the condensin 
complex, a complex required for 
conversion of interphase chromatin into 
mitotic-like condense chromosomes. 
The condensin complex probably 
introduces positive supercoils into 
relaxed DNA in the presence of type I 
topoisomerases and converts nicked 
DNA into positive knotted forms in the 
presence of type II topoisomerases. May 
target the condensin complex to DNA 
via its C-terminal domain (By 
similarity) 
Nucleus 0.02180 0.00305 ▼2.179 
P26350 Prothymosin alpha (PTMA) Prothymosin alpha may mediate 
immune function by conferring 
resistance to certain opportunistic 
infections. 
Nucleus 0.02125 0.00266 ▼2.091 
P34022 Ran-specific GTPase-activating 
protein (RANBP1) 
Inhibits GTP exchange on Ran. Forms a 
Ran-GTP-RANBP1 trimeric complex. 
Increase GTP hydrolysis induced by the 
Ran GTPase activating protein 
RANGAP1.  
Axon 
Cytoplasm 
Centrosome 
Nucleus 
0.00866 0.00014 ▼2.034 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
Q99LT0 Protein Dpy-30 Homolog 
(DPY30) 
In embryonic stem (ES) cells, plays a 
crucial role in the differentiation 
potential, particularly along the neural 
lineage, regulating gene induction and 
histone H3 'Lys-4' methylation at key 
developmental loci, including that 
mediated by retinoic acid.  
Nucleus 
Golgi 
Apparatus 
0.01358 0.00109 ▼2.013 
P62960 Y Box Binding Protein 1 
(YBX1) 
Mediates pre-mRNA alternative 
splicing regulation. The secreted form 
acts as an extracellular mitogen and 
stimulates cell migration and 
proliferation. 
Nucleus 0.02540 0.00436 ▼2.012 
Q8BT18 Serine/Arginine Repetitive 
Matrix Protein 2 (SRRM2) 
Uncharacterised Protein  Membrane 0.02951 0.00657 ▼1.947 
Q8BTM8 Filamin A (FLNA) Promotes orthogonal branching of actin 
filaments and links actin filaments to 
membrane glycoproteins. 
Cytoplasm 0.00884 0.00040 ▼1.877 
Q60973 Retinoblastoma Binding Protein 
7 (RBBP7) 
Core component of several complexes 
which regulate chromatin metabolism. 
Nucleus 0.00347 0.00004 ▼1.857 
P46061 Ran GTP-ase-Activating Protein 
1 (RANGAP1) 
GTPase activator for the nuclear Ras-
related regulatory protein Ran, 
converting it to the putatively inactive 
GDP-bound state.  
Nucleus 0.02932 0.00629 ▼1.856 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
       
Q8BG22 Calcium-Activated Chloride 
Channel Regulator 2 (CLCA2) 
Plays a role in modulating chloride 
current across the plasma membrane in 
a calcium-dependent manner, and cell 
adhesion.  
Plasma 
Membrane 
0.02104 0.00244 ▼1.828 
Q80X41 Serine/Threonine Protein Kinase 
(VRK1) 
Serine/threonine kinase involved in 
Golgi disassembly during the cell cycle. 
Nucleus 0.01350 0.00101 ▼1.811 
Q9QYR9 Acyl-coenzyme A Thioesterase 
2, Mitochondrial (ACOT2) 
Enzyme that catalyzes the hydrolysis of 
acyl-CoAs to the free fatty acid and 
coenzyme A (CoASH). 
Cytoplasm 0.01500 0.00127 ▼1.792 
Q99LP6 GrpE Protein Homolog 1 
(GRPEL1) 
Essential component of the PAM 
complex, a complex required for the 
translocation of transit peptide-
containing proteins from the inner 
membrane into the mitochondrial matrix 
in an ATP-dependent manner.  
Mitochondrio
n Matrix 
0.03594 0.01024 ▼1.780 
Q9CQF3 Cleavage and Polyadenylation 
Specificity Factor Subunit 5 
(NUDT21) 
Component of the cleavage factor Im 
(CFIm) complex that plays a key role in 
pre-mRNA 3'-processing. 
Nucleus 0.04090 0.01420 ▼1.766 
Q91VK1 Basic Leucine Zipper (BZW2) May be involved in neuronal 
differentiation. 
 
Cytoplasm 0.03490 0.00908 ▼1.757 
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Supplementary Table 2 Continued) Top 20 proteins up- and down-regulated in DAPT/IWP-2 (Goblet Skewed) organoids 
Protein 
Identifier 
Protein Name Protein Function 
Subcellular 
Location 
Q Value P Value 
Log2 Fold 
Change 
       
P51432 Phospholipase C, Beta 3 
(PLCB3) 
The production of the second messenger 
molecules diacylglycerol (DAG) and 
inositol 1,4,5-trisphosphate (IP3) is 
mediated by activated 
phosphatidylinositol-specific 
phospholipase C enzymes. 
Cytoplasm 0.00518 0.00007 ▼1.747 
P84228 Histone H3.2 (HIST1H3B)   0.04314 0.01627 ▼1.745 
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Supplementary Table 3) 17 Proteins were Uniquely Up-Regulated in DAPT & CHIR (Paneth Skew) organoids 
Protein Identifier Protein Name FC (log2) Q value 
Q9D816 Cytochrome P450 2C55 (CYP2C55)   ▲1.896 0.01 
Q10738 Matrilysin (MMP7)   ▲1.785 0.012 
P35441 Thrombospondin-1 (THBS1)   ▲1.561 0.009 
P52825 Carnitine O-palmitoyltransferase 2, mitochondrial (CPT2)   ▲1.509 0.021 
Q05421 Cytochrome P450 2E1 (CYP2E1    ▲1.499 0.029 
O88310 Intelectin-1a (ITLN1)   ▲1.49 0.005 
O88310 Intelectin-1a (ITLN1)   ▲1.49 0.005 
P14824 Annexin A6 (ANXA6)   ▲1.256 0.021 
Q91ZE0 Trimethyllysine dioxygenase, mitochondrial (TMLHE)   ▲1.195 0.015 
Q9FYw3 DnaJ homolog subfamily C member 3 (DNAJC3) ▲1.137 0.031 
Q921G7 Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETFDH)   ▲1.108 0.037 
Q9QZ88 Vacuolar protein sorting-associated protein 29 (VPS29)   ▲1.09 0.039 
Q9JMC8 Band 4.1-like protein 4B (EPB41L4B)   ▲1.081 0.028 
P50396 Rab GDP dissociation inhibitor alpha (GDI1)   ▲1.07 0.023 
P09528 Ferritin heavy chain (FTH1)   ▲1.069 0.027 
Q3TDQ1 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (STT3B)   ▲1.062 0.032 
Q9D379 Epoxide hydrolase 1 (EPHX1)   ▲1.013 0.004 
Q791V5 Mitochondrial carrier homolog 2 (MTCH2)   ▲1.008 0.020 
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Supplementary Table 4) 20 Proteins were Uniquely Down-regulated in DAPT & CHIR (Paneth Skew) organoids 
Protein Identifier Protein Name FC (log2) Q value 
    
Q3UW53 Protein Niban   (FAM129A)   ▼4.544 0.009 
P02798 Metallothionein-2   (MT2)   ▼1.890 0.038 
Q8BKS9 Pumilio domain-containing protein KIAA0020   (KIAA0020)   ▼1.439 0.043 
Q9CQM9 Glutaredoxin-3   (GLRX3)   ▼1.334 0.014 
Q62433 Protein NDRG1   (NDRG1)   ▼1.287 0.032 
Q8BTY2 Sodium bicarbonate cotransporter 3   (SLC4A7)   ▼1.258 0.032 
P53996 Cellular nucleic acid-binding protein   (CNBP)   ▼1.247 0.025 
Q80SU7 Interferon-induced very large GTPase 1   (GVIN1)   ▼1.238 0.017 
P97864 Caspase-7   (CASP7)   ▼1.208 0.003 
Q8K354 Carbonyl reductase [NADPH] 3   (CBR3)   ▼1.178 0.015 
P83882 60S ribosomal protein L36a   (RPL36A)   ▼1.169 0.039 
Q8CII2 Cell division cycle protein 123 homolog   (CDC123)   ▼1.167 0.041 
Q920E5 Farnesyl pyrophosphate synthase   (FDPS)   ▼1.142 0.005 
O70475 UDP-glucose 6-dehydrogenase   (UGDH)   ▼1.080 0.004 
P24270 Catalase   (CAT)   ▼1.063 0.010 
P62264 40S ribosomal protein S14   (RPS14)   ▼1.054 0.011 
P24472 Glutathione S-transferase A4   (GSTA4)   ▼1.041 0.019 
O55111 Desmoglein-2   (DSG2)   ▼1.039 0.005 
Q99JX4 Eukaryotic translation initiation factor 3 subunit M   (EIF3M)   ▼1.039 0.025 
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Supplementary Table 5) 42 Proteins were Uniquely Up-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q9D7Z6 Calcium-activated chloride channel regulator 1 (CLCA1) ▲3.33 0.00347 
P02772 Alpha-fetoprotein (AFP) ▲2.94 0.00866 
P09240 Cholecystokinin (CCK) ▲2.83 0.01683 
P20152 Vimentin (VIM) ▲2.48 0.01043 
Q62395 Trefoil factor 3 (TFF3) ▲2.38 0.04095 
P48756 Gastric inhibitory polypeptide (GIP) ▲2.36 0.01174 
Q8K0C5 Zymogen granule membrane protein 16 (ZG16) ▲2.27 0.03616 
P16110 Galectin-3 (LGALS3) ▲2.20 0.04314 
Q99P58 Ras-related protein Rab-27B (RAB27B) ▲2.14 0.04034 
Q8BND5 Sulfhydryl oxidase 1 (QSOX1) ▲2.09 0.0334 
O88312 Anterior gradient protein 2 homolog (AGR2) ▲1.86 0.04257 
P52624 Uridine phosphorylase 1 (UPP1) ▲1.83 0.02204 
Q9JJX6 P2X purinoceptor 4 (P2RX4) ▲1.76 0.02562 
Q91Y74 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 (ST3GAL4) ▲1.56 0.02204 
P12791 Cytochrome P450 2B10 (CYP2B10) ▲1.55 0.01732 
P03921 NADH-ubiquinone oxidoreductase chain 5 (MTND5) ▲1.50 0.03385 
P97742 Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A) ▲1.49 0.03385 
A2ASS6 Titin (TTN) ▲1.48 0.02332 
P56528 ADP-ribosyl cyclase 1 (CD38) ▲1.41 0.04424 
P63239 Neuroendocrine convertase 1 (PCSK1) ▲1.37 0.03162 
Q9D8V0 Minor histocompatibility antigen H13 (HM13) ▲1.35 0.00866 
O88451 Retinol dehydrogenase 7 (RDH7) ▲1.30 0.03687 
Q8R1M8 Mucosal pentraxin (MPTX1) ▲1.29 0.03487 
* Differentiated cell markers of goblet/enteroendocrine cells 
+ Proteins associated with secretion in other organs 
 
 Appendix A – Chapter 3 Supplementary Data    P a g e  | 271 
Supplementary Table 5 Continued) 42 Proteins were Uniquely Up-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q9CQX2 Cytochrome b5 type B (CYB5B) ▲1.26 0.04134 
P35276 Ras-related protein Rab-3D (RAB3D) ▲1.25 0.02708 
P17665 Cytochrome c oxidase subunit 7C, mitochondrial (COX7C) ▲1.23 0.04378 
P56391 Cytochrome c oxidase subunit 6B1 (COX6B1) ▲1.22 0.02089 
P17717 UDP-glucuronosyltransferase 2B17 (UGT2B17) ▲1.21 0.01349 
Q8BW75 Amine oxidase [flavin-containing] B (MAOB) ▲1.2 0.04034 
Q91W97 Putative hexokinase HKDC1 (HKDC1) ▲1.2 0.01349 
Q61847 Meprin A subunit beta (MEP1B) ▲1.19 0.03891 
Q64521 Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD2) ▲1.18 0.04085 
Q8BSY0 Aspartyl/asparaginyl beta-hydroxylase (ASPH) ▲1.17 0.0430 
P46978 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A) ▲1.17 0.03557 
Q8BU33 Acetolactate synthase-like protein (ILVBL) ▲1.15 0.02104 
Q9D8B4 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 (NDUFA11) ▲1.14 0.03595 
Q64464 Cytochrome P450 3A13 (CYP3A13) ▲1.10 0.02908 
P58021 Transmembrane 9 superfamily member 2 (TM9SF2) ▲1.09 0.03595 
Q8R0X7 Sphingosine-1-phosphate lyase 1 (SGPL1) ▲1.08 0.04633 
O88428 Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2) ▲1.03 0.03487 
Q9Z2A7 Diacylglycerol O-acyltransferase 1 (DGAT1) ▲1.02 0.01387 
Q791V5 Mitochondrial Carrier Homolog 2 (MTCH2) ▲1.00 0.0275 
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Supplementary Table 6) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
E9Q1P8 Interferon regulatory factor 2-binding protein 2 (IRF2BP2) ▼2.59 0.02204 
Q9CT10 Ran-binding protein 3 (RANBP3) ▼2.30 0.02908 
P62960 Nuclease-sensitive element-binding protein 1 (YBX1) ▼2.01 0.02540 
Q99LT0 Protein dpy-30 homolog (DPY30) ▼2.01 0.01359 
Q8BTI8 Serine/arginine repetitive matrix protein 2 (SRRM2) ▼1.95 0.02951 
Q8BTM8 Filamin-A (FLNA) ▼1.88 0.00884 
P46061 Ran GTPase-activating protein 1 (RANGAP1) ▼1.86 0.02936 
Q60973 Histone-binding protein RBBP7 (RBBP7) ▼1.86 0.00347 
Q80X41 Serine/threonine-protein kinase VRK1 (VRK1) ▼1.81 0.01349 
Q8CGP1 Histone H2B type 1-K (HIST1H2BK) ▼1.77 0.02539 
Q9CQF3 Cleavage and polyadenylation specificity factor subunit 5 (NUDT21) ▼1.77 0.04088 
Q91VK1 Basic leucine zipper and W2 domain-containing protein 2 (BZW2) ▼1.76 0.03487 
P51432 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (PLCB3) ▼1.75 0.00518 
P84228 Histone H3.2 (HIST1H3B) ▼1.74 0.04314 
P34884 Macrophage migration inhibitory factor (MIF) ▼1.73 0.03843 
Q61233 Plastin-2 (LCP1) ▼1.71 0.02042 
P30681 High mobility group protein B2 (HMGB2) ▼1.68 0.02180 
P61327 Protein mago nashi homolog (MAGOH) ▼1.68 0.02204 
Q8VCN5 Cystathionine gamma-lyase (CTH) ▼1.63 0.00854 
Q01320 DNA topoisomerase 2-alpha (TOP2A) ▼1.61 0.02786 
Q8CD91 SPARC-related modular calcium-binding protein 2 (SMOC2) ▼1.59 0.00866 
O08583 THO complex subunit 4 (ALYREF) ▼1.58 0.04017 
* Stem cell marker 
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Supplementary Table 6 Continued) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
P31786 Acyl-CoA-binding protein (DBI) ▼1.56 0.03944 
Q3UHX2 28 kDa heat- and acid-stable phosphoprotein (PDAP1) ▼1.54 0.04088 
Q62189 U1 small nuclear ribonucleoprotein A (SNRPA) ▼1.54 0.00884 
Q4VAA2 Protein CDV3 (CDV3) ▼1.52 0.04300 
Q60829 Protein phosphatase 1 regulatory subunit 1B (PPP1R1B) ▼1.51 0.02153 
Q60972 Histone-binding protein RBBP4 (RBBP4) ▼1.51 0.02332 
P46664 Adenylosuccinate synthetase isozyme 2 (ADSS) ▼1.47 0.01349 
P43275 Histone H1.1 (HIST1H1A) ▼1.47 0.02641 
Q9CR41 Huntingtin-interacting protein K (HYPK) ▼1.47 0.00621 
Q99020 Heterogeneous nuclear ribonucleoprotein A/B (HNRNPAB) ▼1.44 0.01551 
P17742 Peptidyl-prolyl cis-trans isomerase A (PPIA) ▼1.43 0.04980 
Q5SW19 Clustered mitochondria protein homolog (CLUH) ▼1.43 0.04660 
Q64433 10 kDa heat shock protein, mitochondrial (HSPE1) ▼1.42 0.02180 
P17751 Triosephosphate isomerase (TPI1) ▼1.41 0.02180 
P17182 Alpha-enolase (ENO1) ▼1.41 0.01359 
P06151 L-lactate dehydrogenase A chain (LDHA) ▼1.41 0.04604 
P51859 Hepatoma-derived growth factor (HDGF) ▼1.39 0.03557 
Q9DAW9 Calponin-3 (CNN3) ▼1.38 0.02933 
Q99JR8 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D 
member 2 (SMARCD2) 
▼1.37 0.04538 
P99027 60S acidic ribosomal protein P2 (RPLP2) ▼1.37 0.04085 
Q9DBJ1 Phosphoglycerate mutase 1 (PGAM1) ▼1.37 0.02344 
P06745 Glucose-6-phosphate isomerase (GPI) ▼1.35 0.01732 
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Supplementary Table 6 Continued) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q8R4N0 Citrate lyase subunit beta-like protein, mitochondrial (CLYBl) ▼1.35 0.04085 
O35226 26S proteasome non-ATPase regulatory subunit 4 (PSMD4) ▼1.34 0.04019 
Q9CY58 Plasminogen activator inhibitor 1 RNA-binding protein (SERBP1) ▼1.33 0.01732 
P70168 Importin subunit beta-1 (KPNB1) ▼1.33 0.01349 
P97386 DNA ligase 3 (LIG3) ▼1.32 0.04758 
P47791 Glutathione reductase, mitochondrial (GSR) ▼1.31 0.00989 
Q9DCL9 Multifunctional protein ADE2 (PAICS) ▼1.31 0.00866 
Q61133 Glutathione S-transferase theta-2 (GSTT2) ▼1.31 0.04034 
P56959 RNA-binding protein FUS (FUS) ▼1.28 0.00866 
Q8R2K1 Fucose mutarotase (FUOM) ▼1.28 0.02180 
Q8CIG8 Protein arginine N-methyltransferase 5 (PRMT5) ▼1.26 0.02126 
Q61029 Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma (TMPO) ▼1.26 0.04314 
Q04447 Creatine kinase B-type (CKB) ▼1.25 0.01683 
P62862 40S ribosomal protein S30 (FAU) ▼1.24 0.04088 
P70698 CTP synthase 1 (CTPS1) ▼1.24 0.04701 
P49717 DNA replication licensing factor MCM4 (MCM4) ▼1.23 0.02951 
Q9CR16 Peptidyl-prolyl cis-trans isomerase D (PPID) ▼1.23 0.00866 
P47968 Ribose-5-phosphate isomerase (RPIA) ▼1.22 0.03142 
Q9Z2N8 Actin-like protein 6A (ACTL6A) ▼1.22 0.03687 
P62075 Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13) ▼1.21 0.03487 
Q9R190 Metastasis-associated protein MTA2 (MTA2) ▼1.21 0.04085 
P57016 Ladinin-1 (LAD1) ▼1.20 0.02126 
P38647 Stress-70 protein, mitochondrial (HSPA9) ▼1.19 0.01551 
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Supplementary Table 6 Continued) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q9CQ65 S-methyl-5'-thioadenosine phosphorylase (MTAP) ▼1.19 0.03648 
P61982 14-3-3 protein gamma (YWHAG) ▼1.19 0.03812 
P11499 Heat shock protein HSP 90-beta (HSP90AB1) ▼1.18 0.04314 
Q8BH04 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PCK2) ▼1.18 0.00866 
Q9JKB1 Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) ▼1.18 0.04538 
Q8CGK3 Lon protease homolog, mitochondrial (LONP1) ▼1.17 0.02540 
P62897 Cytochrome c, somatic (CYCS) ▼1.17 0.01315 
Q9ERK4 Exportin-2 (CSE1L) ▼1.16 0.04701 
Q9CZX8 40S ribosomal protein S19 (RPS19) ▼1.15 0.03595 
P63242 Eukaryotic translation initiation factor 5A-1 (EIF5A) ▼1.15 0.02180 
P49722 Proteasome subunit alpha type-2 (PSMA2) ▼1.15 0.02907 
Q9R1P0 Proteasome subunit alpha type-4 (PSMA4) ▼1.15 0.03487 
Q91YR9 Prostaglandin reductase 1 (PTGR1) ▼1.14 0.02922 
Q99LX0 Protein DJ-1 (PARK7) ▼1.14 0.02584 
P54728 UV excision repair protein RAD23 homolog B (RAD23B) ▼1.14 0.04727 
P27612 Phospholipase A-2-activating protein (PLAA) ▼1.14 0.04065 
Q9CWZ3 RNA-binding protein 8A (RBM8A) ▼1.13 0.04321 
Q99KP6 Pre-mRNA-processing factor 19 (PRPF19) ▼1.13 0.04701 
Q9QXG4 Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2) ▼1.12 0.02126 
P07901 Heat shock protein HSP 90-alpha (HSP90AA1) ▼1.11 0.02863 
Q64737 Trifunctional purine biosynthetic protein adenosine-3 (GART) ▼1.10 0.01550 
B1AZI6 THO complex subunit 2 (THOC2) ▼1.10 0.03616 
P97855 Ras GTPase-activating protein-binding protein 1 (G3BP1) ▼1.10 0.02584 
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Supplementary Table 6 Continued) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q7TPV4 Myb-binding protein 1A (MYBBP1A) ▼1.09 0.02332 
P80317 T-complex protein 1 subunit zeta (CCT6A) ▼1.09 0.02562 
Q9CZ30 Obg-like ATPase 1 (OLA1) ▼1.09 0.01349 
Q01768 Nucleoside diphosphate kinase B (NME2) ▼1.09 0.03462 
Q9R1T2 SUMO-activating enzyme subunit 1 (SAE1) ▼1.09 0.04538 
Q9CPU0 Lactoylglutathione lyase (GLO1) ▼1.08 0.01551 
P70670 Nascent polypeptide-associated complex subunit alpha, muscle-specific form (NACA) ▼1.08 0.02951 
Q60864 Stress-induced-phosphoprotein 1 (STIP1) ▼1.08 0.01315 
Q8C1A5 Thimet oligopeptidase (THOP1) ▼1.08 0.00866 
Q93092 Transaldolase (TALDO1) ▼1.07 0.04538 
P28352 DNA-(apurinic or apyrimidinic site) lyase (APEX1) ▼1.07 0.04134 
P26638 Serine--tRNA ligase, cytoplasmic (SARS) ▼1.06 0.03385 
P70296 Phosphatidylethanolamine-binding protein 1 (PEBP1) ▼1.06 0.04300 
Q9Z2U1 Proteasome subunit alpha type-5 (PSMA5) ▼1.06 0.03291 
O08709 Peroxiredoxin-6 (PRDX6) ▼1.05 0.02483 
Q9JHU9 Inositol-3-phosphate synthase 1 (ISYNA1) ▼1.05 0.04315 
Q99L45 Eukaryotic translation initiation factor 2 subunit 2 (EIF2S2) ▼1.05 0.02180 
P49312 Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) ▼1.04 0.04134 
P05202 Aspartate aminotransferase, mitochondrial (GOT2) ▼1.04 0.04314 
P63017 Heat shock cognate 71 kDa protein (HSPA8) ▼1.04 0.04538 
Q61316 Heat shock 70 kDa protein 4 (HSPA4) ▼1.03 0.03698 
Q8BGD9 Eukaryotic translation initiation factor 4B (EIF4B) ▼1.03 0.03595 
Q9CQI6 Coactosin-like protein (COTL1) ▼1.03 0.04085 
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Supplementary Table 6 Continued) 120 Proteins were Uniquely Down-Regulated in DAPT & IWP-2 (Goblet/Enteroendocrine) organoids 
Protein Identifier Protein Name FC (log2) Q Value 
    
Q9R1P3 Proteasome subunit beta type-2 (PSMB2) ▼1.03 0.03023 
Q7TNC4 Putative RNA-binding protein Luc7-like 2 (LUC7L2) ▼1.02 0.04538 
Q9WUP7 Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) ▼1.02 0.02708 
P63085 Mitogen-activated protein kinase 1 (MAPK1) ▼1.01 0.04727 
Q09143 High affinity cationic amino acid transporter 1 (SLC7A1) ▼1.00 0.04321 
Q99MD9 Nuclear autoantigenic sperm protein (NASP) ▼1.00 0.02344 
Q9EPL8 Importin-7 (IPO7) ▼1.00 0.03487 
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Supplementary Table 7) 18 proteins are up-regulated in both Paneth and Goblet cell enteroid cultures following drug skew treatment 
including several secretory proteins such as secretogranin-1 and chromogranin-a. 
Protein 
Identifier 
Protein Name Q Value P Value 
Log2 Fold 
Change 
Group 
A2AFS3 UPF0577 protein KIAA1324 (KIAA1324) 
0.01058 0.00059 ▲1.361 Paneth 
0.00867 0.00023 ▲1.532 Goblet 
O55071 Cytochrome P450 2B19 (CYP2B19) 
0.00942 0.00025 ▲1.685 Paneth 
0.00578 0.00008 ▲1.387 Goblet 
P12791 Cytochrome P450 2B10 (CYP2B10) 
0.00560 0.00011 ▲1.523 Paneth 
0.01732 0.00173 ▲1.554 Goblet 
P16014 Secretogranin-1 (CHGB) 
0.01048 0.00048 ▲1.347 Paneth 
0.02089 0.00235 ▲2.039 Goblet 
P19324 Serpin H1 (SERPINH1) 
0.04760 0.01641 ▲1.737 Paneth 
0.01466 0.0415 ▲2.846 Goblet 
P21447 Multidrug resistance protein 1A (ABCB1A) 
0.00942 0.00026 ▲1.084 Paneth 
0.00101 0.00000 ▲1.070 Goblet 
P26339 Chromogranin-A (CHGA) 
0.00050 0.00007 ▲1.665 Paneth 
0.01350 0.00103 ▲2.859 Goblet 
P81117 Nucleobindin-2 (NUCB2) 
0.01101 0.00076 ▲2.432 Paneth 
0.00347 0.00004 ▲1.675 Goblet 
Q62425 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 
(NDUFA4) 
0.00612 0.00013 ▲1.336 Paneth 
0.01732 0.00175 ▲1.510 Goblet 
Q64133 Amine oxidase [flavin-containing] A (MAOA) 
0.01095 0.00073 ▲1.210 Paneth 
0.00578 0.00009 ▲1.755 Goblet 
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Supplementary Table 7 Continued) 18 proteins are up-regulated in both Paneth and Goblet cell enteroid cultures following drug skew treatment 
including several secretory proteins such as secretogranin-1 and chromogranin-a. 
Protein 
Identifier 
Protein Name Q Value P Value 
Log2 Fold 
Change 
Group 
Q64458 Cytochrome P450 2C29 (CYP2C29) 
0.00464 0.00007 ▲2.069 Paneth 
0.03943 0.01246 ▲1.441 Goblet 
Q64459 Cytochrome P450 3A11 (CYP3A11) 
0.00942 0.00027 ▲2.103 Paneth 
0.00866 0.00035 ▲2.810 Goblet 
Q78KK3 Solute carrier family 22 member 18 (SLC22A18) 
0.01151 0.00087 ▲1.463 Paneth 
0.00866 0.000310 ▲1.902 Goblet 
Q80W94 2-acylglycerol O-acyltransferase 2 (MOGAT2) 
0.01151 0.00086 ▲1.406 Paneth 
0.01174 0.00065 ▲1.259 Goblet 
Q8BND5 Sulfhydryl oxidase 1 (QSOX1) 
0.02204 0.00338 ▲1.533 Paneth 
0.03340 0.00793 ▲2.095 Goblet 
Q8CFJ7 Solute carrier family 25 member 45 (SLC25A45) 
0.01106 0.00058 ▲1.329 Paneth 
0.02790 0.00567 ▲1.078 Goblet 
Q91VE0 Long-chain fatty acid transport protein 4 (SLC27A4) 
0.03360 0.01094 ▲1.407 Paneth 
0.02951 0.00656 ▲1.372 Goblet 
Q9R112 Sulfide:quinone oxidoreductase, mitochondrial (SQRDL) 
0.02794 0.00536 ▲1.137 Paneth 
0.00867 0.00033 ▲1.710 Goblet 
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Supplementary Table 8) 45 proteins are down-regulated in both Paneth and Goblet cell enteroid cultures following drug skew treatment 
including stem cell marker olfactomedin-4 (olfm4). 
Protein 
Identifier 
Protein Name Q Value P Value 
Log2 Fold 
Change 
Group 
E9Q1P8 Interferon regulatory factor 2-binding protein 2   (IRF2BP2) 
0.01048 0.00053 ▼1.920 Paneth 
0.02204 0.00331 ▼2.590 Goblet 
O70435 Proteasome subunit alpha type-3   (PSMA3) 
0.02726 0.00510 ▼1.129 Paneth 
0.01194 0.00069 ▼1.400 Goblet 
P05064 Fructose-bisphosphate aldolase A   (ALDOA) 
0.03113 0.00734 ▼1.175 Paneth 
0.02104 0.00246 ▼1.450 Goblet 
P09411 Phosphoglycerate kinase 1   (PGK1) 
0.02909 0.00626 ▼1.118 Paneth 
0.02125 0.00261 ▼1.220 Goblet 
P17918 Proliferating cell nuclear antigen   (PCNA) 
0.01169 0.00093 ▼1.326 Paneth 
0.01359 0.00110 ▼1.620 Goblet 
P26350 Prothymosin alpha   (PTMA) 
0.01597 0.01457 ▼1.271 Paneth 
0.02126 0.00266 ▼2.090 Goblet 
P26645 Myristoylated alanine-rich C-kinase substrate   (MARCKS) 
0.04938 0.01780 ▼1.034 Paneth 
0.04980 0.02249 ▼1.540 Goblet 
P28656 Nucleosome assembly protein 1-like 1   (NAP1L1) 
0.01086 0.00063 ▼1.105 Paneth 
0.00951 0.00046 ▼1.630 Goblet 
P34022 Ran-specific GTPase-activating protein   (RANBP1) 
0.01238 0.00165 ▼1.194 Paneth 
0.00866 0.00025 ▼2.030 Goblet 
P35979 60S ribosomal protein L12   (RPL12) 
0.00429 0.00304 ▼1.025 Paneth 
0.04617 0.01938 ▼1.110 Goblet 
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Supplementary Table 8 Continued) 45 proteins are down-regulated in both Paneth and Goblet cell enteroid cultures following drug skew 
treatment including stem cell marker olfactomedin-4 (olfm4). 
Protein 
Identifier 
Protein Name Q Value P Value 
Log2 Fold 
Change 
Group 
P38647 Stress-70 protein, mitochondrial   (HSPA9) 
0.00392 0.00004 ▼1.114 Paneth 
0.01551 0.00138 ▼1.190 Goblet 
P40142 Transketolase   (TKT) 
0.01260 0.00110 ▼1.173 Paneth 
0.02562 0.00464 ▼1.620 Goblet 
P47915 60S ribosomal protein L29   (RPL29) 
0.01380 0.00138 ▼1.103 Paneth 
0.02562 0.00464 ▼1.020 Goblet 
P51432 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3   
(PLCB3) 
0.00782 0.00018 ▼1.631 Paneth 
0.00518 0.00007 ▼1.750 Goblet 
P52293 Importin subunit alpha-1   (KPNA2) 
0.02502 0.00422 ▼1.167 Paneth 
0.03385 0.00836 ▼1.360 Goblet 
P54227 Stathmin   (STMN1) 
0.03089 0.00710 ▼1.017 Paneth 
0.00347 0.00003 ▼1.650 Goblet 
P59325 Eukaryotic translation initiation factor 5   (EIF5) 
0.01405 0.00146 ▼1.257 Paneth 
0.02678 0.00503 ▼1.080 Goblet 
P61290 Proteasome activator complex subunit 3   (PSME3) 
0.03228 0.00779 ▼1.544 Paneth 
0.02180 0.02180 ▼1.700 Goblet 
P62960 Nuclease-sensitive element-binding protein 1   (YBX1) 
0.00980 0.00041 ▼1.608 Paneth 
0.02540 0.00436 ▼2.010 Goblet 
Q3UZZ4 Olfactomedin-4   (OLFM4) 
0.00391 0.00003 ▼2.138 Paneth 
0.00033 0.00006 ▼2.340 Goblet 
Q4VAA2 Protein CDV3   (CDV3) 
0.01145 0.00081 ▼1.616 Paneth 
0.04300 0.01575 ▼1.520 Goblet 
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Supplementary Table 8 Continued) 45 proteins are down-regulated in both Paneth and Goblet cell enteroid cultures following drug skew 
treatment including stem cell marker olfactomedin-4 (olfm4). 
Protein 
Identifier 
Protein Name Q Value P Value 
Log2 Fold 
Change 
Group 
Q5SW19 Clustered mitochondria protein homolog   (CLUH) 
0.01095 0.00069 ▼1.728 Paneth 
0.04660 0.01981 ▼1.430 Goblet 
Q61074 Protein phosphatase 1G   (PPM1G) 
0.02502 0.00427 ▼1.137 Paneth 
0.04701 0.20214 ▼1.070 Goblet 
Q61166 
Microtubule-associated protein RP/EB family member 1   
(MAPRE1) 
0.02107 0.00319 ▼1.354 Paneth 
0.02180 0.00308 ▼1.530 Goblet 
Q61753 D-3-phosphoglycerate dehydrogenase   (PHGDH) 
0.00391 0.00004 ▼1.510 Paneth 
0.00866 0.00026 ▼1.470 Goblet 
Q62189 U1 small nuclear ribonucleoprotein A   (SNRPA) 
0.03413 0.00918 ▼1.681 Paneth 
0.00884 0.00042 ▼1.540 Goblet 
Q62351 Transferrin receptor protein 1   (TFRC) 
0.01163 0.00089 ▼1.159 Paneth 
0.03166 0.00740 ▼1.010 Goblet 
Q64152 Transcription factor BTF3   (BTF3) 
0.00278 0.00001 ▼1.265 Paneth 
0.00866 0.00036 ▼1.380 Goblet 
Q7TMY8 E3 ubiquitin-protein ligase HUWE1   (HUWE1)  
0.02055 0.00286 ▼1.148 Paneth 
0.04859 0.02161 ▼1.460 Goblet 
Q8BG22 Calcium-activated chloride channel regulator 2   (CLCA2) 
0.03455 0.00939 ▼1.174 Paneth 
0.02104 0.00244 ▼1.830 Goblet 
Q8BHB9 Chloride intracellular channel protein 6   (CLIC6) 
0.00464 0.00006 ▼2.221 Paneth 
0.02855 0.00586 ▼1.620 Goblet 
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Supplementary Table 8 Continued) 45 proteins are down-regulated in both Paneth and Goblet cell enteroid cultures following drug skew 
treatment including stem cell marker olfactomedin-4 (olfm4). 
Protein 
Identifier 
Description Q Value P Value 
Log2 Fold 
Change 
Group 
Q8BW96 
Calcium/calmodulin-dependent protein kinase type 1D   
(CAMK1D) 
0.01169 0.00094 ▼1.261 Paneth 
0.03915 0.01229 ▼1.320 Goblet 
Q8CAY6 Acetyl-CoA acetyltransferase, cytosolic   (ACAT2) 
0.013802 0.00142 ▼1.501 Paneth 
0.01936 0.00203 ▼1.640 Goblet 
Q8CI11 Guanine nucleotide-binding protein-like 3   (GNL3) 
0.013802 0.00141 ▼1.108 Paneth 
0.00302 0.00001 ▼1.370 Goblet 
Q8K2Z4 Condensin complex subunit 1   (NCAPD2) 
0.02830 0.00566 ▼2.296 Paneth 
0.02178 0.00305 ▼2.180 Goblet 
Q8VCN5 Cystathionine gamma-lyase   (CTH) 
0.00955 0.00033 ▼1.519 Paneth 
0.00854 0.00018 ▼1.630 Goblet 
Q99K85 Phosphoserine aminotransferase   (PSAT1) 
0.00942 0.00030 ▼1.126 Paneth 
0.00101 0.00000 ▼1.150 Goblet 
Q99LP6 GrpE protein homolog 1, mitochondrial   (GRPEL1) 
0.03006 0.00652 ▼1.224 Paneth 
0.03595 0.01024 ▼1.780 Goblet 
Q9CT10 Ran-binding protein 3   (RANBP3) 
0.01202 0.00101 ▼2.104 Paneth 
0.02908 0.00616 ▼2.300 Goblet 
Q9CY58 Plasminogen activator inhibitor 1 RNA-binding protein   (SERBP1) 
0.01048 0.00054 ▼1.058 Paneth 
0.01732 0.00166 ▼1.330 Goblet 
Q9D2C2 Protein SAAL1   (SAAL1) 
0.04176 0.01310 ▼1.263 Paneth 
0.03444 0.00860 ▼1.420 Goblet 
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Supplementary Table 8 Continued) 45 proteins are down-regulated in both Paneth and Goblet cell enteroid cultures following drug skew 
treatment including stem cell marker olfactomedin-4 (olfm4). 
Protein 
Identifier 
Description Q Value P Value 
Log2 Fold 
Change 
Group 
Q9DB15 39S ribosomal protein L12, mitochondrial   (MRPL12) 
0.01095 0.00073 ▼1.156 Paneth 
0.01174 0.00067 ▼1.220 Goblet 
Q9DCL9 Multifunctional protein ADE2   (PAICS) 
0.03303 0.00853 ▼1.094 Paneth 
0.00866 0.00036 ▼1.310 Goblet 
Q9ER72 Cysteine--tRNA ligase, cytoplasmic   (CARS) 
0.02060 0.00291 ▼1.330 Paneth 
0.01349 0.00101 ▼1.590 Goblet 
Q9QYR9 Acyl-coenzyme A thioesterase 2, mitochondrial   (ACOT2) 
0.01145 0.00081 ▼1.101 Paneth 
0.01501 0.00127 ▼1.790 Goblet 
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Appendix B – Chapter 5 Supplementary Tables and Figures 
 
 
Supplementary Table 9) 6 significantly differentially expressed proteins following 4 hr infection with T. gondii Veg 
Accession P Value 
Log2 fold 
change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
P11930 0.04265 ▼2.41595 NI 4 Hour Veg 4 Hour 
Nucleoside diphosphate-linked moiety X motif 19 
(NUDT19) 
Q00623 0.04501 ▼1.12368 NI 4 Hour Veg 4 Hour Apolipoprotein A-I (APOA1) 
Q9CYR0 0.04862 ▲2.74808 Veg 4 Hour NI 4 Hour 
Single-stranded DNA-binding protein, mitochondrial 
(SSBP1) 
O09110 0.01667 ▲1.42508 Veg 4 Hour NI 4 Hour 
Dual specificity mitogen-activated protein kinase 
kinase 3 (MAP2K3) 
O70400 0.00892 ▲1.12391 Veg 4 Hour NI 4 Hour PDZ and LIM domain protein 1 (PDLIM1) 
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Supplementary Table 10) 7 significantly differentially expressed proteins following 4 hr infection with T. gondii RH 
Accession P Value 
Log2 fold 
change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
Q8BND5 0.02580 ▼3.14181 NI 4 Hour RH 4 Hour Sulfhydryl oxidase 1 (QSOX1) 
P62274 0.01610 ▼2.15817 NI 4 Hour RH 4 Hour 40S ribosomal protein S29 (RPS29) 
Q8VCA8 0.03860 ▼1.23863 NI 4 Hour RH 4 Hour Secernin-2 (SCRN2) 
P97370 0.00184 ▼1.16750 NI 4 Hour RH 4 Hour 
Sodium/potassium-transporting ATPase subunit beta-3 
(ATP1B3) 
P48774 0.01928 ▼1.02345 NI 4 Hour RH 4 Hour Glutathione S-transferase Mu 5 (GSTM5) 
P42225 0.03891 ▼1.00922 NI 4 Hour RH 4 Hour 
Signal transducer and activator of transcription 1 
(STAT1) 
Q9JLJ5 0.02658 ▲1.63966 RH 4 Hour NI 4 Hour 
Elongation of very long chain fatty acids protein 1 
(ELOVL1) 
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Supplementary Table 11)  22 significantly down-regulated host  proteins following 40 hr infection with T. gondii Veg 
Accession P Value Log2 fold change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
P11087 0.01317 ▼2.56163 NI 40 Hours Veg 40 Hours Collagen alpha-1(I) chain (COL1A1) 
Q80X41 0.03638 ▼2.18669 NI 40 Hours Veg 40 Hours Serine/threonine-protein kinase VRK1 (VRK1) 
Q61074 0.04837 ▼2.13302 NI 40 Hours Veg 40 Hours Protein phosphatase 1G (PPM1G) 
P43275 0.02111 ▼1.90468 NI 40 Hours Veg 40 Hours Histone H1.1 (HIST1H1A) 
Q3UZZ4 0.04411 ▼1.77315 NI 40 Hours Veg 40 Hours Olfactomedin-4 (OLFM4) 
Q8BXK9 0.03322 ▼1.68080 NI 40 Hours Veg 40 Hours Chloride intracellular channel protein 5 (CLIC5) 
Q5SW19 0.01377 ▼1.61416 NI 40 Hours Veg 40 Hours Clustered mitochondria protein homolog (CLUH) 
Q9D0G0 0.01831 ▼1.35600 NI 40 Hours Veg 40 Hours 28S ribosomal protein S30, mitochondrial (MRPS30) 
Q922V4 0.02939 ▼1.31806 NI 40 Hours Veg 40 Hours Pleiotropic regulator 1 (PLRG1) 
Q8R0I0 0.04483 ▼1.24742 NI 40 Hours Veg 40 Hours Angiotensin-converting enzyme 2 (ACE2) 
Q9WU84 0.02672 ▼1.23968 NI 40 Hours Veg 40 Hours Copper chaperone for superoxide dismutase (CCS) 
Q64674 0.01018 ▼1.23267 NI 40 Hours Veg 40 Hours Spermidine synthase (SRM) 
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Supplementary Table 11 Continued) 22 significantly down-regulated host  proteins following 40 hr infection with T. gondii Veg 
Accession P Value Max fold change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
      
P14115 0.02075 ▼1.21573 NI 40 Hours Veg 40 Hours 60S ribosomal protein L27a (RPL27A) 
P24547 0.04824 ▼1.12300 NI 40 Hours Veg 40 Hours 
Inosine-5'-monophosphate dehydrogenase 2 
(IMPDH2) 
B2RX12 0.00696 ▼1.11254 NI 40 Hours Veg 40 Hours 
Canalicular multispecific organic anion transporter 2 
(ABCC3) 
O88696 0.04252 ▼1.07706 NI 40 Hours Veg 40 Hours 
ATP-dependent Clp protease proteolytic subunit, 
mitochondrial (CLPP) 
Q9CZ83 0.01364 ▼1.06303 NI 40 Hours Veg 40 Hours 39S ribosomal protein L55, mitochondrial (MRPL55) 
Q8BW75 0.03560 ▼1.06091 NI 40 Hours Veg 40 Hours Amine oxidase [flavin-containing] B (MAOB) 
Q99LE6 0.03232 ▼1.02520 NI 40 Hours Veg 40 Hours 
ATP-binding cassette sub-family F member 2 
(ABCF2) 
Q62189 0.03506 ▼1.02444 NI 40 Hours Veg 40 Hours U1 small nuclear ribonucleoprotein A (SNRPA) 
Q8VDN2 0.02246 ▼1.01081 NI 40 Hours Veg 40 Hours 
Sodium/potassium-transporting ATPase subunit alpha-
1 (ATP1A1) 
Q8VCW8 0.04813 ▼1.00025 NI 40 Hours Veg 40 Hours 
Acyl-CoA synthetase family member 2, mitochondrial 
(ACSF2) 
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Supplementary Table 12) 8 significantly up-regulated host proteins following 40 hr infection with T. gondii Veg 
Accession P Value Log2 fold change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
O35704 0.00651 ▲1.91999 Veg 40 Hours NI 40 Hours Serine palmitoyltransferase 1 (SPTLC1) 
Q91Z98 0.01299 ▲1.65462 Veg 40 Hours NI 40 Hours Chitinase-like protein 4 (CHIL4) 
P06728 0.01094 ▲1.62479 Veg 40 Hours NI 40 Hours Apolipoprotein A-IV (APOA4) 
Q00623 0.01880 ▲1.51152 Veg 40 Hours NI 40 Hours Apolipoprotein A-I (APOA1) 
Q9WU03 0.03012 ▲1.27395 Veg 40 Hours NI 40 Hours Kunitz-type protease inhibitor 2 (SPINT2) 
Q8VHF2 0.03767 ▲1.11234 Veg 40 Hours NI 40 Hours Cadherin-related family member 5 (CDHR5) 
O70439 0.02158 ▲1.02476 Veg 40 Hours NI 40 Hours Syntaxin-7 (STX7) 
Q8BHL4 0.02495 ▲1.01771 Veg 40 Hours NI 40 Hours Retinoic acid-induced protein 3 (GPRC5A) 
 
 
 
 
 
 
 
 Appendix B – Chapter 5 Supplementary Data     P a g e  | 290 
Supplementary Table 13) 14 significantly down-regulated proteins following 40 hr infection with T. gondii RH 
Accession P Value 
Log2 fold 
change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
Q922V4 0.00185 ▼2.19892 NI 40 Hours RH 40 Hours Pleiotropic regulator 1 (PLRG1) 
Q7TMC8 0.01778 ▼1.83413 NI 40 Hours RH 40 Hours L-fucose kinase (FUK) 
Q8BTY2 0.01167 ▼1.73019 NI 40 Hours RH 40 Hours Sodium bicarbonate cotransporter 3 (SLC4A7) 
B2RX12 0.00254 ▼1.60019 NI 40 Hours RH 40 Hours 
Canalicular multispecific organic anion transporter 2 
(ABCC3) 
Q8K1R3 0.00856 ▼1.41438 NI 40 Hours RH 40 Hours 
Polyribonucleotide nucleotidyltransferase 1, 
mitochondrial (PNPT1) 
Q62266 0.01148 ▼1.25045 NI 40 Hours RH 40 Hours Cornifin-A (SPRR1A) 
Q9D071 0.03740 ▼1.17241 NI 40 Hours RH 40 Hours 
MMS19 nucleotide excision repair protein homolog 
(MMS19) 
Q8BHG1 0.03159 ▼1.15852 NI 40 Hours RH 40 Hours Nardilysin (NRDC) 
P07744 0.00241 ▼1.13182 NI 40 Hours RH 40 Hours Keratin, type II cytoskeletal 4 (KRT4) 
Q9D024 0.02041 ▼1.09104 NI 40 Hours RH 40 Hours Coiled-coil domain-containing protein 47 (CCDC47) 
Q9CQQ8 0.03781 ▼1.07536 NI 40 Hours RH 40 Hours U6 snRNA-associated Sm-like protein LSm7 (LSM7) 
Q6PDQ2 0.04810 ▼1.04153 NI 40 Hours RH 40 Hours 
Chromodomain-helicase-DNA-binding protein 4 
(CHD4) 
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Supplementary Table 13 Continued) 14 significantly down-regulated proteins following 40 hr infection with T. gondii RH 
Accession P Value 
Log2 fold 
change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
P0C0S6; 
TGME49_300200 
0.02624 ▼1.02445 NI 40 Hours RH 40 Hours Histone H2A.Z (H2AFZ) 
Q99LE6 0.02574 ▼1.00862 NI 40 Hours RH 40 Hours ATP-binding cassette sub-family F member 2 (ABCF2) 
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Supplementary Table 14) 11 significantly up-regulated proteins following 40 hr infection with T. gondii RH 
Accession P Value 
Log2 fold 
change 
Highest mean 
condition 
Lowest mean 
condition 
Description 
Q00623 0.00999 ▲2.43261 RH 40 Hours NI 40 Hours Apolipoprotein A-I (APOA1) 
Q91Z98 0.01045 ▲2.03083 RH 40 Hours NI 40 Hours Chitinase-like protein 4 (CHIL4) 
Q6Q473 0.02806 ▲1.87577 RH 40 Hours NI 40 Hours 
Calcium-activated chloride channel regulator 4A 
(CLCA4A) 
P06728 0.04176 ▲1.86969 RH 40 Hours NI 40 Hours Apolipoprotein A-IV (APOA4) 
O70318 0.00781 ▲1.30632 RH 40 Hours NI 40 Hours Band 4.1-like protein 2 (EPB41L2) 
Q08652 0.02998 ▲1.29869 RH 40 Hours NI 40 Hours Retinol-binding protein 2 (RBP2) 
Q9R008 0.02756 ▲1.22539 RH 40 Hours NI 40 Hours Mevalonate kinase (MVK) 
Q8C1N8 0.00736 ▲1.20815 RH 40 Hours NI 40 Hours Alpha-defensin 22 (DEFA22) 
Q8K3X6 0.04827 ▲1.12850 RH 40 Hours NI 40 Hours 
Ankyrin repeat and SAM domain-containing protein 4B 
(ANKS4B) 
Q9D312 0.02482 ▲1.05905 RH 40 Hours NI 40 Hours Keratin, type I cytoskeletal 20 (KRT20) 
E9Q7P9 0.04759 ▲1.03794 RH 40 Hours NI 40 Hours Cadherin-related family member 2 (CDHR2) 
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Supplementary Table 15) 6 significantly up- or down-regulated proteins shared between 40 hour Veg and RH incubated epithelial sheets 
Accession Description P Value Log2 fold change Condition 
Q922V4 Pleiotropic regulator 1 (PLRG1) 
0.02939 ▼1.31806 Veg 40 Hours 
0.00185 ▼2.19892 RH 40 Hours 
B2RX12 Canalicular multispecific organic anion transporter 2 (ABCC3) 
0.00696 ▼1.11254 Veg 40 Hours 
0.00254 ▼1.60019 RH 40 Hours 
Q99LE6 ATP-binding cassette sub-family F member 2 (ABCF2) 
0.03232 ▼1.02520 Veg 40 Hours 
0.02574 ▼1.00862 RH 40 Hours 
Q91Z98 Chitinase-like protein 4 (CHIL4) 
0.01299 ▲1.65462 Veg 40 Hours 
0.01045 ▲2.03083 RH 40 Hours 
P06728 Apolipoprotein A-IV (APOA4) 
0.01094 ▲1.62479 Veg 40 Hours 
0.04176 ▲1.86969 RH 40 Hours 
Q00623 Apolipoprotein A-I (APOA1) 
0.01880 ▲1.51152 Veg 40 Hours 
0.00999 ▲2.43261 RH 40 Hours 
